Coty (COTY) 10-Q 9 May 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Mar. 31, 2022	Apr. 29, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-35964
Entity Registrant Name	COTY INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-3823358
Entity Address, Address Line One	350 Fifth Avenue,
Entity Address, City or Town	New York,
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10118
City Area Code	212
Local Phone Number	389-7300
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth	false
Entity Shell Company	false
Title of 12(b) Security	Class A Common Stock, $0.01 par value
Trading Symbol	COTY
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding (in shares)		839,191,079
Amendment Flag	false
Entity Central Index Key	0001024305
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--06-30

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Net revenues	$ 1,186.2	$ 1,027.8	$ 4,136.1	$ 3,567.5
Cost of sales	423.1	391.7	1,489	1,440.6
Gross profit	763.1	636.1	2,647.1	2,126.9
Selling, general and administrative expenses	659.3	545.6	2,154.5	1,770.5
Amortization expense	50.2	62.2	158.6	189.4
Restructuring costs	(6.8)	0	1.5	89.7
Acquisition- and divestiture-related costs	3.3	29.7	14.2	127.7
Operating income (loss)	57.1	(1.4)	318.3	(50.4)
Interest expense, net	62.9	50.3	183.6	171.6
Other income, net	(60.6)	(62.5)	(572.9)	(50.7)
Income (loss) from continuing operations before income taxes	54.8	10.8	707.6	(171.3)
Provision (benefit) for income taxes on continuing operations	0.5	(19.2)	164.5	(304.9)
Net income from continuing operations	54.3	30	543.1	133.6
Net income (loss) from discontinued operations	0.7	(17.3)	4.5	(148.2)
Net income (loss)	55	12.7	547.6	(14.6)
Net loss attributable to noncontrolling interests	(0.9)	(9.4)	(2.3)	(11.5)
Net income attributable to redeemable noncontrolling interests	2.3	6.5	8.9	12.2
Net income (loss) attributable to Coty Inc.	53.6	15.6	541	(15.3)
Amounts attributable to Coty Inc.
Net income from continuing operations	52.9	32.9	536.5	132.9
Convertible Series B Preferred Stock dividends	(3.3)	(34.1)	(195)	(78.1)
Net income (loss) from continuing operations attributable to common stockholders	49.6	(1.2)	341.5	54.8
Net income (loss) from discontinued operations	0.7	(17.3)	4.5	(148.2)
Net income (loss) attributable to common stockholders	$ 50.3	$ (18.5)	$ 346	$ (93.4)
Earnings per common share:
Earnings from continuing operations per common share - basic (in dollars per share)	$ 0.06	$ 0	$ 0.42	$ 0.07
Earnings from continuing operations per common share - diluted (in dollars per share)	0.06	0	0.42	0.07
Losses from discontinued operations - basic (in dollars per share)	0	(0.02)	0	(0.19)
Losses from discontinued operations - diluted (in dollars per share)	0	(0.02)	0	(0.19)
Earnings (losses) per common share - basic (in dollars per share)	0.06	(0.02)	0.42	(0.12)
Earnings (losses) per common share - diluted (in dollars per share)	$ 0.06	$ (0.02)	$ 0.42	$ (0.12)
Weighted-average common shares outstanding:
Basic (in shares)	838.4	765.4	814.8	764.6
Diluted (in shares)	852.9	765.4	827.5	932.1

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 55	$ 12.7	$ 547.6	$ (14.6)
Other comprehensive income (loss):
Foreign currency translation adjustment	35.4	(107.1)	(215.4)	22
Net unrealized derivative gain (loss) on cash flow hedges, net of taxes of $(0.8) and $(2.4), and $(4.2) and $(7.2) during the three and nine months ended, respectively	4.6	7.8	14.5	23.2
Pension and other post-employment benefits adjustment, net of tax of $(0.6) and $0.2, and $(0.6) and $4.5 during the three and nine months ended, respectively	(0.2)	(0.4)	2.1	(15.1)
Total other comprehensive income (loss), net of tax	39.8	(99.7)	(198.8)	30.1
Comprehensive income (loss)	94.8	(87)	348.8	15.5
Comprehensive income attributable to noncontrolling interests:
Net loss	(0.9)	(9.4)	(2.3)	(11.5)
Foreign currency translation adjustment	(0.1)	(0.2)	(0.4)	(0.1)
Total comprehensive loss attributable to noncontrolling interests	(1)	(9.6)	(2.7)	(11.6)
Comprehensive income attributable to redeemable noncontrolling interests:
Net income	2.3	6.5	8.9	12.2
Comprehensive income (loss) attributable to Coty Inc.	$ 93.5	$ (83.9)	$ 342.6	$ 14.9

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parentheticals) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Change in derivative gains on cash flow hedges, tax expense (benefit)	$ (0.8)	$ (2.4)	$ (4.2)	$ (7.2)
Pension and other post-employment benefits (losses), tax expense (benefit)	$ (0.6)	$ 0.2	$ (0.6)	$ 4.5

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Current assets:
Cash and cash equivalents	$ 668.6	$ 253.5
Restricted cash	31.6	56.9
Trade receivables—less allowances of $38.8 and $47.7, respectively	479.2	348
Inventories	643.1	650.8
Prepaid expenses and other current assets	381.7	473.9
Total current assets	2,204.2	1,783.1
Property and equipment, net	740.3	918.1
Goodwill	4,025.2	4,118.1
Other intangible assets, net	4,139.2	4,463
Equity investments	1,038.9	1,276.2
Operating lease right-of-use assets	351.4	318.5
Deferred income taxes	709.4	758.5
Other noncurrent assets	60.5	55.9
TOTAL ASSETS	13,269.1	13,691.4
Current liabilities:
Accounts payable	1,280.5	1,166.1
Accrued expenses and other current liabilities	1,226	1,096
Short-term debt and current portion of long-term debt	516.5	24.2
Current operating lease liabilities	68.5	75.7
Income and other taxes payable	104.7	53.4
Total current liabilities	3,196.2	2,415.4
Long-term debt, net	4,316.9	5,401
Long-term operating lease liabilities	307.3	269.3
Pension and other post-employment benefits	394.1	420.6
Deferred income taxes	713.6	674.9
Other noncurrent liabilities	333.8	327.6
Total liabilities	9,261.9	9,508.8
COMMITMENTS AND CONTINGENCIES (See Note 20)
CONVERTIBLE SERIES B PREFERRED STOCK, $0.01 par value; 1.0 shares authorized; 0.1 and 1.0 issued and 0.1 and 1.0 and outstanding, respectively, at March 31, 2022 and June 30, 2021	142.4	1,036.3
REDEEMABLE NONCONTROLLING INTERESTS	71.9	84.1
EQUITY:
Preferred Stock, $0.01 par value; 20.0 shares authorized, 1.5 issued and outstanding at March 31, 2022 and June 30, 2021	0	0
Class A Common Stock, $0.01 par value; 1,250.0 shares authorized, 905.5 and 832.3 issued and 839.2 and 766.0 outstanding, respectively, at March 31, 2022 and June 30, 2021	9	8.3
Additional paid-in capital	10,770.9	10,376.2
Accumulated deficit	(5,214.6)	(5,755.6)
Accumulated other comprehensive income	(520.3)	(321.9)
Treasury stock—at cost, shares: 66.3 at March 31, 2022 and at June 30, 2021	(1,446.3)	(1,446.3)
Total Coty Inc. stockholders’ equity	3,598.7	2,860.7
Noncontrolling interests	194.2	201.5
Total equity	3,792.9	3,062.2
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY	$ 13,269.1	$ 13,691.4

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Statement of Financial Position [Abstract]
Trade receivables, allowances	$ 38.8	$ 47.7
Convertible Series B preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Convertible Series B preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Convertible Series B preferred stock, shares issued (in shares)	100,000	1,000,000
Convertible Series B preferred stock, shares outstanding (in shares)	100,000	1,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000
Preferred stock, shares issued (in shares)	1,500,000	1,500,000
Preferred stock, shares outstanding (in shares)	1,500,000	1,500,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	1,250,000,000	1,250,000,000
Common stock, shares issued (in shares)	905,500,000	832,300,000
Common stock, shares outstanding (in shares)	839,200,000	766,000,000
Treasury stock, at cost, shares (in shares)	66,300,000	66,300,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Millions, $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Total Coty Inc. Stockholders’ Equity	Total Coty Inc. Stockholders’ EquityCumulative Effect, Period of Adoption, Adjustment	Total Coty Inc. Stockholders’ EquityCumulative Effect, Period of Adoption, Adjusted Balance	Preferred Stock	Preferred StockCumulative Effect, Period of Adoption, Adjusted Balance	Common StockClass A Common Stock	Common StockClass A Common StockCumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in CapitalCumulative Effect, Period of Adoption, Adjusted Balance	(Accumulated Deficit)	(Accumulated Deficit)Cumulative Effect, Period of Adoption, Adjustment	(Accumulated Deficit)Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive (Loss) Income	Accumulated Other Comprehensive (Loss) IncomeCumulative Effect, Period of Adoption, Adjusted Balance	Treasury Stock	Treasury StockCumulative Effect, Period of Adoption, Adjusted Balance	Noncontrolling Interests	Noncontrolling InterestsCumulative Effect, Period of Adoption, Adjusted Balance
Balance, beginning of period (in shares) at Jun. 30, 2020							1.5	1.5	830.6	830.6								65.5	65.5
Balance, beginning of period at Jun. 30, 2020	$ 3,228.8	$ (5.7)	$ 3,223.1	$ 3,004.6	$ (5.7)	$ 2,998.9	$ 0	$ 0	$ 8.3	$ 8.3	$ 10,447.4	$ 10,447.4	$ (5,548.6)	$ (5.7)	$ (5,554.3)	$ (456.2)	$ (456.2)	$ (1,446.3)	$ (1,446.3)	$ 224.2	$ 224.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of employee stock options and restricted stock unit (in shares)									0.6
Shares withheld for employee taxes	(1)			(1)							(1)
Share-based compensation expense	6.2			6.2							6.2
Changes in dividends accrued	0.8			0.8							0.8
Dividends accrued- Convertible Series B Preferred Stock	(20.8)			(20.8)							(20.8)
Net income (loss)	221.8			221.4									221.4							0.4
Other comprehensive loss	(6)			(5.9)												(5.9)				(0.1)
Adjustment of redeemable noncontrolling interests to redemption value	1.5			1.5							1.5
Balance, end of period (in shares) at Sep. 30, 2020							1.5		831.2									65.5
Balance, end of period at Sep. 30, 2020	3,425.6			3,201.1			$ 0		$ 8.3		10,434.1		(5,332.9)			(462.1)		$ (1,446.3)		224.5
Balance, beginning of period at Jun. 30, 2020	79.1		79.1
Balance, beginning of period at Jun. 30, 2020	715.8		715.8
Redeemable Noncontrolling Interests
Issuance of Preferred Stock	242.4
Dividends accrued- Convertible Series B Preferred Stock	20.8
Net income (loss)	5.5
Adjustment of redeemable noncontrolling interests to redemption value	(1.5)
Balance, end of period at Sep. 30, 2020	83.1
Balance, end of period at Sep. 30, 2020	979
Balance, beginning of period (in shares) at Jun. 30, 2020							1.5	1.5	830.6	830.6								65.5	65.5
Balance, beginning of period at Jun. 30, 2020	3,228.8	$ (5.7)	3,223.1	3,004.6	$ (5.7)	$ 2,998.9	$ 0	$ 0	$ 8.3	$ 8.3	10,447.4	$ 10,447.4	(5,548.6)	$ (5.7)	$ (5,554.3)	(456.2)	$ (456.2)	$ (1,446.3)	$ (1,446.3)	224.2	$ 224.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss	30.1
Balance, end of period (in shares) at Mar. 31, 2021							1.5		832.3									66.2
Balance, end of period at Mar. 31, 2021	3,170.5			2,962.2			$ 0		$ 8.3		10,395.8		(5,569.6)			(426)		$ (1,446.3)		208.3
Balance, beginning of period at Jun. 30, 2020	79.1		79.1
Balance, beginning of period at Jun. 30, 2020	715.8		$ 715.8
Balance, end of period at Mar. 31, 2021	87.4
Balance, end of period at Mar. 31, 2021	1,036.3
Balance, beginning of period (in shares) at Sep. 30, 2020							1.5		831.2									65.5
Balance, beginning of period at Sep. 30, 2020	3,425.6			3,201.1			$ 0		$ 8.3		10,434.1		(5,332.9)			(462.1)		$ (1,446.3)		224.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of employee stock options and restricted stock unit (in shares)									0.4
Shares withheld for employee taxes	(0.9)			(0.9)							(0.9)
Share-based compensation expense	14.4			14.4							14.4
Changes in dividends accrued	0.4			0.4							0.4
Dividends accrued- Convertible Series B Preferred Stock	(23.2)			(23.2)							(23.2)
Net income (loss)	(254.8)			(252.3)									(252.3)							(2.5)
Other comprehensive loss	135.8			135.6												135.6				0.2
Distribution to noncontrolling interests, net	(4.3)																			(4.3)
Adjustment of redeemable noncontrolling interests to redemption value	1.8			1.8							1.8
Equity Investment contribution for share-based compensation	0.5			0.5							0.5
Balance, end of period (in shares) at Dec. 31, 2020							1.5		831.6									65.5
Balance, end of period at Dec. 31, 2020	3,295.3			3,077.4			$ 0		$ 8.3		10,427.1		(5,585.2)			(326.5)		$ (1,446.3)		217.9
Balance, beginning of period at Sep. 30, 2020	83.1
Balance, beginning of period at Sep. 30, 2020	979
Redeemable Noncontrolling Interests
Dividends accrued- Convertible Series B Preferred Stock	23.2
Net income (loss)	0.3
Distribution to noncontrolling interests, net	(2.1)
Adjustment of redeemable noncontrolling interests to redemption value	(1.8)
Balance, end of period at Dec. 31, 2020	79.5
Balance, end of period at Dec. 31, 2020	1,002.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of employee stock options and restricted stock unit (in shares)									0.7
Shares withheld for employee taxes	(2.3)			(2.3)							(2.3)
Share-based compensation expense	6			6							6
Changes in dividends accrued	0.5			0.5							0.5
Dividends accrued- Convertible Series B Preferred Stock	(23.6)			(23.6)							(23.6)
Deemed Dividends - Conversion of Convertible Series B Preferred Stock	(10.5)			(10.5)							(10.5)
Cancellation of Restricted Stock (in shares)																		0.7
Net income (loss)	6.2			15.6									15.6							(9.4)
Other comprehensive loss	(99.7)			(99.5)												(99.5)				(0.2)
Adjustment of redeemable noncontrolling interests to redemption value	(1.4)			(1.4)							(1.4)
Balance, end of period (in shares) at Mar. 31, 2021							1.5		832.3									66.2
Balance, end of period at Mar. 31, 2021	3,170.5			2,962.2			$ 0		$ 8.3		10,395.8		(5,569.6)			(426)		$ (1,446.3)		208.3
Redeemable Noncontrolling Interests
Dividends accrued- Convertible Series B Preferred Stock	23.6
Deemed Dividends - Conversion of Convertible Series B Preferred Stock	10.5
Net income (loss)	6.5
Adjustment of redeemable noncontrolling interests to redemption value	1.4
Balance, end of period at Mar. 31, 2021	87.4
Balance, end of period at Mar. 31, 2021	1,036.3
Balance, beginning of period (in shares) at Jun. 30, 2021							1.5		832.3									66.3
Balance, beginning of period at Jun. 30, 2021	3,062.2			2,860.7			$ 0		$ 8.3		10,376.2		(5,755.6)			(321.9)		$ (1,446.3)		201.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of employee stock options and restricted stock unit (in shares)									51
Shares withheld for employee taxes	(4.2)			(4.2)							(4.2)
Share-based compensation expense	107.8			107.8							107.8
Equity Investment contribution for share-based compensation	1.6			1.6							1.6
Changes in dividends accrued	0.5			0.5							0.5
Conversion of Convertible Series B Preferred Stock	307.9			307.9					$ 0.5		307.4
Dividends accrued- Convertible Series B Preferred Stock	(22.7)			(22.7)							(22.7)
Deemed Dividends - Conversion of Convertible Series B Preferred Stock	(6.7)			(6.7)							(6.7)
Deemed Dividends - Exchange Agreement	(93.6)			(93.6)							(93.6)
Net income (loss)	225.5			226									226							(0.5)
Other comprehensive loss	(138.2)			(138)												(138)				(0.2)
Adjustment of redeemable noncontrolling interests to redemption value	4.1			4.1							4.1
Balance, end of period (in shares) at Sep. 30, 2021							1.5		883.3									66.3
Balance, end of period at Sep. 30, 2021	3,444.2			3,243.4			$ 0		$ 8.8		10,670.4		(5,529.6)			(459.9)		$ (1,446.3)		200.8
Balance, beginning of period at Jun. 30, 2021	84.1
Balance, beginning of period at Jun. 30, 2021	1,036.3
Redeemable Noncontrolling Interests
Conversion of Convertible Series B Preferred Stock	(307.9)			(307.9)					$ (0.5)		(307.4)
Reclassification to Mandatorily redeemable Convertible Series B Preferred Stock	(394.2)
Dividends accrued- Convertible Series B Preferred Stock	22.7
Deemed Dividends - Conversion of Convertible Series B Preferred Stock	6.7
Deemed Dividends - Exchange Agreement	93.6
Dividends Paid - Convertible Series B Preferred Stock	(3.5)
Net income (loss)	3.4
Adjustment of redeemable noncontrolling interests to redemption value	(4.1)
Balance, end of period at Sep. 30, 2021	83.4
Balance, end of period at Sep. 30, 2021	453.7
Balance, beginning of period (in shares) at Jun. 30, 2021							1.5		832.3									66.3
Balance, beginning of period at Jun. 30, 2021	3,062.2			2,860.7			$ 0		$ 8.3		10,376.2		(5,755.6)			(321.9)		$ (1,446.3)		201.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in dividends accrued	0.8
Other comprehensive loss	(198.8)
Balance, end of period (in shares) at Mar. 31, 2022							1.5		905.5									66.3
Balance, end of period at Mar. 31, 2022	3,792.9			3,598.7			$ 0		$ 9		10,770.9		(5,214.6)			(520.3)		$ (1,446.3)		194.2
Balance, beginning of period at Jun. 30, 2021	84.1
Balance, beginning of period at Jun. 30, 2021	1,036.3
Balance, end of period at Mar. 31, 2022	71.9
Balance, end of period at Mar. 31, 2022	142.4
Balance, beginning of period (in shares) at Sep. 30, 2021							1.5		883.3									66.3
Balance, beginning of period at Sep. 30, 2021	3,444.2			3,243.4			$ 0		$ 8.8		10,670.4		(5,529.6)			(459.9)		$ (1,446.3)		200.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of employee stock options and restricted stock unit (in shares)									(48.2)
Shares withheld for employee taxes	(7.1)			(7.1)							(7.1)
Share-based compensation expense	26.9			26.9							26.9
Equity Investment contribution for share-based compensation	(3)			(3)							(3)
Changes in dividends accrued	0.2			0.2							0.2
Conversion of Convertible Series B Preferred Stock (in shares)									69.9
Conversion of Convertible Series B Preferred Stock	121.6			121.6					$ 0.2		121.4
Dividends accrued- Convertible Series B Preferred Stock	(5.9)			(5.9)							(5.9)
Deemed Dividends - Conversion of Convertible Series B Preferred Stock	(0.8)			(0.8)							(0.8)
Deemed Dividends - Redemption of Convertible Series B Preferred Stock	(66.4)			(66.4)							(66.4)
Deemed Contributions - Convertible Series B Preferred Stock	4.4			4.4							4.4
Net income (loss)	260.5			261.4									261.4							(0.9)
Other comprehensive loss	(100.4)			(100.3)												(100.3)				(0.1)
Distribution to noncontrolling interests, net	(2.7)																			(2.7)
Adjustment of redeemable noncontrolling interests to redemption value	(2.9)			(2.9)							(2.9)
Balance, end of period (in shares) at Dec. 31, 2021							1.5		905									66.3
Balance, end of period at Dec. 31, 2021	3,668.6			3,471.5			$ 0		$ 9		10,737.2		(5,268.2)			(560.2)		$ (1,446.3)		197.1
Balance, beginning of period at Sep. 30, 2021	83.4
Balance, beginning of period at Sep. 30, 2021	453.7
Redeemable Noncontrolling Interests
Conversion of Convertible Series B Preferred Stock	(121.6)			(121.6)					$ (0.2)		(121.4)
Exchange Transaction	(212.7)
Dividends accrued- Convertible Series B Preferred Stock	5.9
Deemed Dividends - Conversion of Convertible Series B Preferred Stock	0.8
Deemed Dividends - Redemption of Convertible Series B Preferred Stock	66.4
Deemed Contributions - Convertible Series B Preferred Stock	(4.4)
Dividends Paid - Convertible Series B Preferred Stock	(45.7)
Net income (loss)	3.2
Distribution to noncontrolling interests, net	(5.8)
Adjustment of redeemable noncontrolling interests to redemption value	2.9
Balance, end of period at Dec. 31, 2021	83.7
Balance, end of period at Dec. 31, 2021	142.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of employee stock options and restricted stock unit (in shares)									0.5
Shares withheld for employee taxes	(0.7)			(0.7)							(0.7)
Share-based compensation expense	29.1			29.1							29.1
Equity Investment contribution for share-based compensation	1			1							1
Changes in dividends accrued	0.1			0.1							0.1
Dividends accrued- Convertible Series B Preferred Stock	(3.3)			(3.3)							(3.3)
Net income (loss)	52.7			53.6									53.6							(0.9)
Other comprehensive loss	39.8			39.9												39.9				(0.1)
Distribution to noncontrolling interests, net	(1.9)																			(1.9)
Adjustment of redeemable noncontrolling interests to redemption value	7.5			7.5							7.5
Balance, end of period (in shares) at Mar. 31, 2022							1.5		905.5									66.3
Balance, end of period at Mar. 31, 2022	3,792.9			$ 3,598.7			$ 0		$ 9		$ 10,770.9		$ (5,214.6)			$ (520.3)		$ (1,446.3)		$ 194.2
Redeemable Noncontrolling Interests
Dividends accrued- Convertible Series B Preferred Stock	3.3
Dividends Paid - Convertible Series B Preferred Stock	(3.3)
Net income (loss)	2.3
Distribution to noncontrolling interests, net	(6.6)
Adjustment of redeemable noncontrolling interests to redemption value	(7.5)
Balance, end of period at Mar. 31, 2022	71.9
Balance, end of period at Mar. 31, 2022	$ 142.4

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 547.6	$ (14.6)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	389.5	436.1
Non-cash lease expense	55.6	61.6
Deferred income taxes	48.6	(238.8)
Provision (releases) for bad debts	2.6	(9.6)
Provision for pension and other post-employment benefits	11.9	8.3
Share-based compensation	164.3	28.9
Gains on disposals of long-term assets	(111.1)	0
(Gain) loss on sale of business in discontinued operations	(6.1)	246.6
Realized and unrealized gains from equity investments, net	(576.7)	(60.9)
Foreign exchange effects	1	26.8
Deferred financing fees write-offs	3.8	0
Other	11.5	44.7
Change in operating assets and liabilities
Trade receivables	(161.4)	(57.3)
Inventories	(10.1)	114.2
Prepaid expenses and other current assets	23	(133)
Accounts payable	137.3	(137.8)
Accrued expenses and other current liabilities	246.4	64.8
Operating lease liabilities	(54.8)	(104.4)
Income and other taxes payable	59.9	(44.4)
Other noncurrent assets	(8.5)	30.5
Other noncurrent liabilities	(14.8)	24.7
Net cash provided by operating activities	759.5	286.4
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(133)	(143.7)
Proceeds from sale of long-term assets	169.7	4.3
Proceeds from contingent consideration from sale of discontinued business	34	0
Proceeds from sale of business, net of cash disposed	0	27
Proceeds from sale of discontinued business, net of cash disposed	0	2,374.1
Return of capital from equity investments	210.7	448
Payment for equity investment and related asset acquisition	0	(200)
Termination of currency swaps designated as net investment hedges	0	(37.6)
Net cash provided by investing activities	281.4	2,472.1
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from short-term debt, original maturity less than three months	4.8	0.5
Proceeds from revolving loan facilities	444.3	2,147.9
Repayments of revolving loan facilities	(1,114.7)	(2,963.7)
Proceeds from issuance of other long-term debt	500	0
Repayments of term loans and other long-term debt	(256.1)	(2,162)
Dividend payment on Class A Common Stock	(1.3)	(1.5)
Dividend payment on Convertible Series B Preferred Stock	(52.5)	0
Proceeds from issuance of Convertible Series B Preferred Stock	0	227.2
Net (payments of) proceeds from foreign currency contracts	(94.1)	20.3
Purchase of remaining mandatorily redeemable noncontrolling interest	(7.1)	0
Distributions to noncontrolling interests, redeemable noncontrolling interests and mandatorily redeemable financial instruments	(15.1)	(6.3)
Payment of deferred financing fees	(39.3)	0
All other	(11.6)	(4.8)
Net cash used in financing activities	(642.7)	(2,742.4)
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(8.4)	(10.1)
NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	389.8	6
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period	310.4	352
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period	700.2	358
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Cash paid during the period for interest	120.7	164
Net cash payments (refunds) for income taxes	68.1	(5.5)
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accrued capital expenditure additions	65.4	44.5
Redemption of Series B Preferred Stock in exchange for Wella Equity Investment	603.3	0
Conversion of Series B Preferred Stock into Class A Common Stock	429.5	0
Non-cash Series B Preferred Stock dividends and deemed (contributions) dividends	$ (1.1)	$ 78.1

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS	9 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS	DESCRIPTION OF BUSINESS Coty Inc. and its subsidiaries (collectively, the “Company” or “Coty”) manufacture, market, sell and distribute branded beauty products, including fragrances, color cosmetics and skin & body related products throughout the world. Coty is a global beauty company with a rich entrepreneurial history and an iconic portfolio of brands. The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2022” refer to the fiscal year ending June 30, 2022. When used in this Quarterly Report on Form 10-Q, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. The Company’s sales generally increase during the second fiscal quarter as a result of increased demand associated with the winter holiday season. Financial performance, working capital requirements, sales, cash flows and borrowings generally experience variability during the three to six months preceding the holiday season. Product innovations, new product launches and the size and timing of orders from the Company’s customers may also result in variability. On November 30, 2020, the Company completed the previously announced strategic transaction with Rainbow UK Bidco Limited (“KKR Bidco”) (an affiliate of funds and/or separately managed accounts (“KKR Funds”) advised and/or managed by Kohlberg Kravis Roberts & Co. L.P. and its affiliates (“KKR”)), for the sale of a majority stake in Coty’s Professional and Retail Hair businesses, including the Wella, Clairol, OPI and ghd brands, (together, the “Wella Business”). As a result, Coty owned a 40% stake in Rainbow JVCO LTD and subsidiaries (together, "Wella") immediately after the transaction. As of March 31, 2022, the Company owned a 25.9% stake in Wella. See Note 9—Equity Investments for additional information. During the first quarter of fiscal 2022, the Company's chief operating decision maker ("CODM") finalized the Company's organizational structure and how performance will be assessed, and the Company realigned its reportable segments to a principally product category-based structure, comprised of a Prestige business segment and a Consumer Beauty business segment. See Note 4—Segment Reporting for information on the Company's segments.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and include the Company’s consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company’s Consolidated Financial Statements as of and for the year ended June 30, 2021. In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three and nine months ended March 31, 2022 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2022. All dollar amounts (other than per share amounts) in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated. Restricted Cash Restricted cash represents funds that are not readily available for general purpose cash needs due to contractual limitations. Restricted cash is classified as a current or long-term asset based on the timing and nature of when or how the cash is expected to be used or when the restrictions are expected to lapse. As of March 31, 2022 and June 30, 2021, the Company had restricted cash of $31.6 and $56.9, respectively, included in Restricted cash in the Condensed Consolidated Balance Sheets. The Restricted cash balance as of March 31, 2022 primarily provides collateral for certain bank guarantees on rent, customs and duty accounts and also consists of collections on factored receivables that remain unremitted to the factor as of March 31, 2022. Restricted cash is included as a component of Cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows. Equity Investments The Company elected the fair value option to account for its investment in Wella to align with the Company’s strategy for this investment. The fair value is updated on a quarterly basis. The investment is classified within Level 3 in the fair value hierarchy because the Company estimates the fair value of the investment using a combination of the income approach, the market approach and private transactions, when applicable. Changes in the fair value of equity investment under the fair value option are recorded in Other income, net within the Condensed Consolidated Statements of Operations (see Note 9—Equity Investments). Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the net realizable value of inventory, the fair value of acquired assets and liabilities associated with acquisitions, the fair value of equity investments, the assessment of goodwill, other intangible assets and long-lived assets for impairment and income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the Condensed Consolidated Financial Statements in future periods. Tax Information The effective income tax rate for the three and nine months ended March 31, 2022 and 2021 was 0.9% and (177.8)%, respectively, and 23.2% and 178.0%, respectively. The positive effective tax rate for the nine months ended March 31, 2022 results from reporting income before taxes and a provision for income taxes. The positive effective tax rate for the nine months ended March 31, 2021 results from reporting losses before income taxes and a benefit for income taxes. The change in the effective tax rate for the three months ended March 31, 2022, as compared with the three months ended March 31, 2021, is primarily due to the resolution of foreign uncertain tax positions having a greater proportional effect in the prior year, as well as the limitation on the deductibility of executive stock compensation in the current period. The change in the effective tax rate for the nine months ended March 31, 2022, as compared with the nine months ended March 31, 2021, is primarily due to the limitation on the deductibility of executive stock compensation and large fair value gains related to the investment in the Wella business in the current period, as well as a benefit related to a change in the Company's main principal location of $220.5 recorded in the prior period. The benefit recorded in the prior period was the result of a tax rate differential on the deferred taxes recognized on the transfer of assets and liabilities, following the relocation of the Company's main principal location from Geneva to Amsterdam. The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. As of March 31, 2022 and June 30, 2021, the gross amount of UTBs was $271.5 and $279.9, respectively. As of March 31, 2022, the total amount of UTBs that, if recognized, would impact the effective income tax rate is $151.3. As of March 31, 2022 and June 30, 2021, the liability associated with UTBs, including accrued interest and penalties, was $173.9 and $181.2, respectively, which was recorded in Income and other taxes payable and Other noncurrent liabilities in the Condensed Consolidated Balance Sheets. The total interest and penalties recorded in the Condensed Consolidated Statements of Operations related to UTBs was $1.3 and $(1.4) for the three months ended March 31, 2022 and 2021, respectively, and $1.0 and $0.3, for the nine months ended March 31, 2022 and 2021, respectively. The total gross accrued interest and penalties recorded in the Condensed Consolidated Balance Sheets as of March 31, 2022 and June 30, 2021 was $22.7 and $21.7, respectively. On the basis of the information available as of March 31, 2022, it is reasonably possible that a decrease of up to $22.2 in UTBs may occur within twelve months as a result of projected resolutions of global tax examinations and a potential lapse of the applicable statutes of limitations. Recently Adopted Accounting Pronouncements In January 2020, the FASB issued ASU No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) , which clarifies certain interactions between the accounting for equity securities, equity method investments, and certain derivative instruments. The Company adopted this guidance in the first quarter of fiscal 2022. The adoption of this standard did not have a material impact on the Company's financial position and its results of operations. Recently Issued Accounting Pronouncements In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The new guidance under ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. As of March 31, 2022, the Company has not applied any of the optional expedients or exceptions allowed under this ASU. The Company does not believe that this ASU will have a material impact on its consolidated financial position, results of operations or cash flows. In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity’s Own Equity (Subtopic 815-40) , which removes certain separation models for convertible debt instruments and convertible preferred stock that require the separation of a convertible debt instrument into a debt component and an equity or derivative component. The Company will adopt the guidance effective fiscal year 2023 and does not expect the adoption to have a material impact on its consolidated financial statements. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers . This guidance will be effective for the Company in the first quarter of fiscal year 2024 on a prospective basis, with early adoption permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	9 Months Ended
	Mar. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS	DISCONTINUED OPERATIONS On June 1, 2020, the Comp any entered into a definitive agreement with KKR Bidco, regarding a strategic transaction for the sale of the Wella Business, valuing the business at $4,300.0 on a cash- and debt-free basis. The transaction was completed on November 30, 2020 and Coty retained an initial ownership of 40% of the Wella Business. As of March 31, 2022, the Company owned a 25.9% stake in Wella. See Note 9—Equity Investments for additional information. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the Wella Business are presented as discontinued operations in the prior period leading up to the date of the sale, and, as such, have been excluded from both continuing operations and segment results for all periods presented. The Wella Business was comprised of the Professional Beauty and Retail Hair businesses. The following table has selected financial information included in Net income (loss) from discontinued operations for the Wella Business. Three Months Ended Nine Months Ended 2022 (a) 2021 2022 (a) 2021 Net revenues $ — $ — $ — $ 986.3 Cost of sales — — — 322.5 Gross profit — — — 663.8 Selling, general and administrative expenses — — — 443.7 Restructuring costs — — — (0.7) Operating income — — — 220.8 Interest expense, net — — — 21.3 (Gain) loss on sale of business (1.3) 27.5 (6.1) 246.6 Other income, net — — — (1.0) Income (loss) from discontinued operations before income taxes 1.3 (27.5) 6.1 (46.1) Provision for income taxes on discontinued operations 0.6 (10.2) 1.6 102.1 Net income (loss) from discontinued operations $ 0.7 $ (17.3) $ 4.5 $ (148.2) (a) Net income from discontinued operations for the three and nine months ended March 31, 2022 reflect certain working capital adjustments net of the related income tax impact. The following is selected financial information included in cash flows from discontinued operations for the Wella Business held for sale: Nine Months Ended March 31, 2021 NON-CASH OPERATING ITEMS Depreciation and amortization $ — CASH FLOW FROM INVESTING ACTIVITIES Capital expenditures $ 8.7 On December 22, 2021, the Company entered into an agreement with KKR Bidco related to post-closing adjustments to the purchase consideration for the Wella Business. As part of this agreement, the Company may receive future contingent proceeds. Earning the contingent proceeds is based on the future recovery of certain tax credits of the Wella Business. The Company accounts for the initial measurement of contingent consideration under a loss recovery approach. As of the time the contingent consideration arrangement was entered into, the Company was unable to determine that it was probable that any of the contingent consideration would be earned. Therefore, no contingent consideration gain was initially recognized. Subsequent measurement of the total contingent consideration will be based on the guidance for gain contingencies and any gain will be recorded at the time the consideration is earned. During the second quarter of fiscal 2022, a $34.0 advance of future contingent proceeds was paid to the Company and is subject to claw back if recovery targets related to the Wella Business tax credits are not achieved. The $34.0 advanced to the Company is unearned and is included in Other noncurrent liabilities in the Condensed Consolidated Balance Sheet. The advance payment will be reflected as a liability until the contingency is resolved.

SEGMENT REPORTING

SEGMENT REPORTING	9 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
SEGMENT REPORTING	SEGMENT REPORTING Operating and reportable segments (referred to as “segments”) reflect the way the Company is managed and for which separate financial information is available and evaluated regularly by the Company’s CODM in deciding how to allocate resources and assess performance. The Company has designated its Chief Executive Officer ("CEO") as the CODM. During the first quarter of fiscal 2022, the CODM finalized the Company's organizational structure and how performance will be assessed, and the Company realigned its reportable segments to a principally product category-based structure, comprised of a Prestige business segment and a Consumer Beauty business segment beginning in the first quarter of fiscal 2022. The Company recast its results for fiscal 2021 to reflect the changes in its segments. Certain income and shared costs and the results of corporate initiatives are managed by Corporate. Corporate primarily includes stock compensation expense, restructuring and realignment costs, costs related to acquisition and divestiture activities, and impairments of long-lived assets, goodwill and intangibles that are not attributable to ongoing operating activities of the segments. Corporate costs are not used by the CODM to measure the underlying performance of the segments. With the exception of goodwill, the Company does not identify or monitor assets by segment. The Company does not present assets by reportable segment since various assets are shared between reportable segments. The allocation of goodwill by segment is presented in Note 10—Goodwill and Other Intangible Assets, net. Three Months Ended Nine Months Ended SEGMENT DATA 2022 2021 2022 2021 Net revenues: Prestige $ 726.4 $ 601.3 $ 2,605.1 $ 2,149.5 Consumer Beauty 459.8 426.5 1,531.0 1,418.0 Total $ 1,186.2 $ 1,027.8 $ 4,136.1 $ 3,567.5 Operating income (loss): Prestige 83.8 30.9 357.5 175.7 Consumer Beauty (20.4) 9.1 34.3 25.8 Corporate (6.3) (41.4) (73.5) (251.9) Total $ 57.1 $ (1.4) $ 318.3 $ (50.4) Reconciliation: Operating income (loss) 57.1 (1.4) 318.3 (50.4) Interest expense, net 62.9 50.3 183.6 171.6 Other income, net (60.6) (62.5) (572.9) (50.7) Income (loss) from continuing operations before income taxes $ 54.8 $ 10.8 $ 707.6 $ (171.3) Presented below are the percentage of revenues associated with the Company’s product categories: Three Months Ended Nine Months Ended PRODUCT CATEGORY 2022 2021 2022 2021 Fragrance 57.6 % 56.2 % 60.3 % 59.1 % Color Cosmetics 29.6 31.2 27.8 27.9 Body Care & Other 12.8 12.6 11.9 13.0 Total 100.0 % 100.0 % 100.0 % 100.0 %

BUSINESS COMBINATIONS, ASSET AC

BUSINESS COMBINATIONS, ASSET ACQUISITIONS AND DIVESTITURES	9 Months Ended
	Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]
BUSINESS COMBINATIONS, ASSET ACQUISITIONS AND DIVESTITURES	BUSINESS COMBINATIONS, ASSET ACQUISITIONS AND DIVESTITURES Business Combinations and Asset Acquisitions There were no business combination or asset acquisition transactions during the three and nine months ended March 31, 2022. KKW Beauty Business Transaction On January 4, 2021, the Company completed its purchase of 20% of the outstanding equity of KKW Holdings, LLC (“KKW Holdings”), pursuant to a purchase agreement entered into between the Company, KKW Holdings and other parties listed as signatories (the “KKW Purchase Agreement”). On the same date, as contemplated by the KKW Purchase Agreement, the Company entered into a collaboration agreement, pursuant to which, in exchange for a marketing fee and a license fee, it received the right and license to manufacture, advertise, promote, distribute and sell certain Kim Kardashian West products outside of the existing KKW Holdings scope of fragrances and cosmetics, and use certain intellectual property owned by or licensed to KKW Holdings in connection with the development, manufacture, labelling, packaging, advertising, display, distribution and sale of such products (the “KKW Collaboration Agreement”). Under the KKW Collaboration Agreement, products will be sold by the Company’s consolidated subsidiaries. Therefore, the related revenues generated and expenses incurred by such subsidiaries will be reported in the Company’s Condensed Consolidated Statements of Operations. The KKW Purchase Agreement also gives the Company an option to acquire, and the sellers the option to compel the Company to acquire, an additional 31% of the outstanding equity of KKW (the “KKW Call Option” and “KKW Put Option”, respectively). The seller’s ability to exercise the KKW Put Option is contingent upon the achievement of certain contractually defined targets. The KKW Call Option and KKW Put Option expire on the seventh anniversary of the KKW Collaboration Agreement. Future exercise of the KKW Call Option or KKW Put Option has been deemed by the Company to be remote. However, if exercise were to occur such exercise may result in a material cash outflow for the Company. The purchase consideration paid for the equity interest, the KKW Call Option and rights under the KKW Collaboration Agreement was $200.0 and was allocated as follows using a relative fair value approach at the acquisition date: Estimated fair value Estimated useful life (in years) KKW Collaboration Agreement $ 180.6 20 20% equity interest in KKW Holdings 19.4 Total purchase consideration $ 200.0 The fair value of the KKW Collaboration Agreement and the Company’s 20% equity investment were estimated using an income approach. The Company accounts for its 20% investment in the equity of KKW Holdings under the equity method. The fair value of the KKW Collaboration Agreement is recognized within Other intangible assets, net and the Company’s equity investment in KKW Holdings is recognized within Equity investments, each within the Condensed Consolidated Balance Sheets. The fair value of the KKW Call Option was deemed to be de minimis. Business Divestitures There were no divestiture transactions during the three and nine months ended March 31, 2022. Wella Business On November 30, 2020, the Company completed the strategic transaction with KKR for the sale of a majority stake in the Wella Business (see Note 3—Discontinued Operations). Following the sale, Coty deconsolidated the Wella Business as KKR owns approximately 60% of the separately managed business, and the Company owned the remaining 40%. As of March 31, 2022, the Company owned a 25.9% stake in Wella. See Note 9—Equity Investments for additional information. Initial cash proceeds received for the sale of the 60% stake in Wella were $2,451.7 (less cash disposed of $65.5, resulted in net cash proceeds of $2,386.2). Coty utilized $2,015.5 of the net proceeds to pay down its 2018 Coty Term A and B Facilities (as defined in Note 12—Debt) on a pro rata basis and reserved a maximum of $500.0 for reinvestment in the Company's business, pursuant to the 2018 Coty Credit Agreement, as amended (as defined in Note 12—Debt). In connection with the November 30, 2021 amendment to the 2018 Coty Credit Agreement, the Company received consent from the participating banks to eliminate the requirements to utilize or repay the Reinvestment Balance (as defined in Note 12—Debt). Additionally, as contemplated in the Sale and Purchase Agreement (as amended) relating to the sale of the Wella Business (the “Wella SPA”), the purchase consideration was subject to further adjustments for other working capital and contractually specified items. See Note 3—Discontinued Operations for more information. As a result of the sale of the majority interest in Wella, the Company determined that it no longer had a controlling interest in the Wella Business. The Company, therefore, deconsolidated its ownership of the Wella assets and liabilities and no longer reported the assets and liabilities of Wella. The operations of Wella were consolidated in the results of the Company through the date of sale. The Company accounted for its stake in the Wella Business under the fair value option (see Note 9—Equity Investments).

ACQUISITION AND DIVESTITURE-REL

ACQUISITION AND DIVESTITURE-RELATED COSTS	9 Months Ended
	Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]
ACQUISITION AND DIVESTITURE-RELATED COSTS	ACQUISITION- AND DIVESTITURE-RELATED COSTS Acquisition-related costs, which are expensed as incurred, represent non-restructuring costs directly related to acquiring and integrating an entity, for both completed and contemplated acquisitions and can include finder’s fees, legal, accounting, valuation, other professional or consulting fees, and other internal costs which can include compensation related expenses for dedicated internal resources. The Company recognized no acquisition-related costs for the three and nine months ended March 31, 2022 and $3.3 and $2.8 of acquisition-related costs for the three and nine months ended March 31, 2021, respectively. Divestiture-related costs, which are expensed as incurred, represent non-restructuring costs directly related to divesting and selling an entity, including partial sales, for both completed and contemplated divestitures. These costs can include legal, accounting, information technology, other professional or consulting fees and other internal costs. Internal costs can include compensation related expenses for dedicated internal resources. Additionally, for divestitures, the Company includes write-offs of assets that are no longer recoverable and contract related costs due to the divestiture. The Company recognized divestiture-related costs of $3.3 and $14.2 for the three and nine months ended March 31, 2022, respectively, and $26.4 and $124.9 for the

RESTRUCTURING COSTS

RESTRUCTURING COSTS	9 Months Ended
	Mar. 31, 2022
Restructuring and Related Activities [Abstract]
RESTRUCTURING COSTS	RESTRUCTURING COSTS Restructuring costs for the three and nine months ended March 31, 2022 and 2021 are presented below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Transformation Plan $ (6.8) $ 4.7 $ 1.5 $ 98.4 Other Restructuring — (4.7) — (8.7) Total $ (6.8) $ — $ 1.5 $ 89.7 Transformation Plan In connection with the four-year plan announced on July 1, 2019 to drive substantial improvement and optimization in the Company's businesses (the “Turnaround Plan”), the Company has and expects to continue to incur restructuring and related costs. On May 11, 2020, the Company announced an expansion of the Turnaround Plan to further reduce fixed costs, (the “Transformation Plan”). Of the expected costs, the Company has incurred cumulative restructuring charges of $231.3 related to approved initiatives through March 31, 2022, which have been recorded in Corporate. Over the next two fiscal years, the Company expects to incur approximately $15.0 of additional restructuring charges pertaining to the approved actions, primarily related to employee termination benefits, contract terminations and other exit-related costs. The following table presents aggregate restructuring charges for the program: Severance and Employee Benefits Fixed Asset Write-offs Other Exit Costs Total Fiscal 2020 $ 151.2 $ (1.1) $ 6.5 $ 156.6 Fiscal 2021 73.4 (0.5) 0.3 73.2 Fiscal 2022 1.8 — (0.3) 1.5 Cumulative through March 31, 2022 $ 226.4 $ (1.6) $ 6.5 $ 231.3 The related liability balance and activity of restructuring costs for the Transformation Plan restructuring costs are presented below: Severance and Employee Benefits Fixed Asset Write-offs Other Exit Costs Total Balance—July 1, 2021 $ 122.5 $ — $ 0.3 $ 122.8 Restructuring charges 13.5 — — 13.5 Payments (38.7) — (0.2) (38.9) Changes in estimates (11.7) — (0.3) (12.0) Non-cash utilization (0.8) — — (0.8) Effect of exchange rates (5.5) — 0.2 (5.3) Balance—March 31, 2022 $ 79.3 $ — $ — $ 79.3 The Company currently estimates that the total remaining accrual of $79.3 will result in cash expenditures of approximately $20.5, $58.2 and $0.6 in fiscal 2022, 2023 and thereafter, respectively.

INVENTORIES

INVENTORIES	9 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories as of March 31, 2022 and June 30, 2021 are presented below: March 31, June 30, Raw materials $ 162.7 $ 159.5 Work-in-process 7.5 12.5 Finished goods 472.9 478.8 Total inventories $ 643.1 $ 650.8

EQUITY INVESTMENTS

EQUITY INVESTMENTS	9 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
EQUITY INVESTMENTS	EQUITY INVESTMENTS The Company's equity investments, classified as Equity investments in the Condensed Consolidated Balance Sheets are represented by the following: March 31, June 30, Equity method investments: KKW Holdings (a) $ 13.9 $ 16.2 Equity investments at fair value: Wella (b) 1,025.0 1,260.0 Total equity investments $ 1,038.9 $ 1,276.2 (a) On January 4, 2021, the Company completed its purchase of 20% of the outstanding equity of KKW Holdings. The Company accounts for this minority investment under the equity method, given it has the ability to exercise significant influence over, but not control, the investee. The carrying value of the Company’s investment includes basis differences allocated to amortizable intangible assets. (b) On November 30, 2020, the Company completed the previously announced strategic transaction with KKR for the sale of a 60% stake in Coty’s Wella Business. As of March 31, 2022 and June 30, 2021, the Company's stake in Wella was 25.9% and 40.0%, respectively. On October 20, 2021, the Company completed the sale of a 9.4% stake in Wella to an affiliate of KKR, KKR Rainbow Aggregator L.P. ("KKR Aggregator”) in exchange for the redemption of 290,465 shares of KKR Aggregator's Series B Convertible Preferred Stock shares in Coty and a portion of unpaid dividends (the "First Exchange"). On November 30, 2021, Coty completed the sale of an additional 4.7% stake in Wella to KKR Aggregator in exchange for the redemption of KKR Aggregator's remaining convertible preferred shares in Coty (the "Second Exchange"), reducing the Company’s total shareholding in Wella to 25.9%. Refer to Note 16—Equity and Convertible Preferred Stock. On March 3, 2022, Wella approved an interim distribution to its shareholders. As part of the transaction, Wella refinanced its third party debt and used $210.7 of such funds to make a distribution to the Company, which the Company has accounted for as a return of capital. The following table presents summarized financial information of the Company’s equity method investees for the period ending March 31, 2022. Amounts presented represent combined totals at the investee level and not the Company’s proportionate share: Three Months Ended Nine Months Ended 2022 2021 (a) 2022 2021 (a) Summarized Statements of Operations information: Net revenues $ 552.8 $ 528.5 $ 1,916.3 $ 743.7 Gross profit 376.4 361.4 1,314.5 508.4 Operating income 18.1 (56.6) 119.9 (61.7) Income before income taxes (50.6) (89.2) 6.3 (102.7) Net income (31.5) (78.8) 10.5 (91.5) (a) As the sale of the Wella Business occurred on November 30, 2020, Wella's prior year summarized financials only comprise of four month of activity. The following table summarizes movements in equity investments with fair value option that are classified within Level 3 for the period ended March 31, 2022. There were no internal movements to or from Level 3 from Level 1 or Level 2 for the period ended March 31, 2022. Equity investments at fair value: Balance as of June 30, 2021 $ 1,260.0 First Exchange (390.6) Second Exchange (212.7) Wella Distribution (210.7) Total gains/(losses) included in earnings 579.0 Balance as of March 31, 2022 $ 1,025.0 Level 3 significant unobservable inputs sensitivity The following table summarizes the significant unobservable inputs used in Level 3 valuation of the Company's investments carried at fair value as of March 31, 2022. Included in the table are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments. Fair value Valuation technique Unobservable Range Equity investments at fair value $ 1,025.0 Discounted cash flows Discount rate 11.75% (a) Growth rate 1.5% - 7.2% (a) Market multiple Revenue multiple 2.0x (b) EBITDA multiple 12.0x – 19.0x (b) (a) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a discounted cash flow method, are the discount rate and revenue growth rate. Significant increases (decreases) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement. The Company estimates the discount rate based on the investees' projected cost of equity and debt. The revenue growth rate is forecasted for future years by the investee based on their best estimates. Significant increases (decreases) in the revenue growth rate in isolation would result in a significantly higher (lower) fair value measurement. (b) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a market multiple method, are the revenue multiple and EBITDA multiple. Significant increases (decreases) in the revenue multiple or EBITDA multiple in isolation would result in a significantly higher (lower) fair value measurement. The market multiples are derived from a group of guideline public companies.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS, NET	9 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS, NET	GOODWILL AND OTHER INTANGIBLE ASSETS, NET Goodwill Goodwill as of March 31, 2022 and June 30, 2021 is presented below: Prestige Consumer Beauty Total Gross balance at June 30, 2021 $ 6,384.0 $ 1,774.2 $ 8,158.2 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at June 30, 2021 $ 3,273.7 $ 844.4 $ 4,118.1 Changes during the period ended March 31, 2022 Foreign currency translation (74.8) (18.1) (92.9) Gross balance at March 31, 2022 $ 6,309.2 $ 1,756.1 $ 8,065.3 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at March 31, 2022 $ 3,198.9 $ 826.3 $ 4,025.2 Other Intangible Assets, net Other intangible assets, net as of March 31, 2022 and June 30, 2021 are presented below: March 31, June 30, Indefinite-lived other intangible assets $ 992.6 $ 1,018.7 Finite-lived other intangible assets, net 3,146.6 3,444.3 Total Other intangible assets, net $ 4,139.2 $ 4,463.0 The changes in the carrying amount of indefinite-lived other intangible assets are presented below: Trademarks Total Gross balance at June 30, 2021 $ 1,932.2 $ 1,932.2 Accumulated impairments (913.5) (913.5) Net balance at June 30, 2021 $ 1,018.7 $ 1,018.7 Changes during the period ended March 31, 2022 Foreign currency translation (26.1) (26.1) Gross balance at March 31, 2022 $ 1,906.1 $ 1,906.1 Accumulated impairments (913.5) (913.5) Net balance at March 31, 2022 $ 992.6 $ 992.6 Intangible assets subject to amortization are presented below: Cost Accumulated Amortization Accumulated Impairment Net June 30, 2021 License agreements and collaboration agreements $ 4,192.9 $ (1,229.1) $ (19.6) $ 2,944.2 Customer relationships 803.1 (486.3) (5.5) 311.3 Trademarks 330.2 (168.7) (0.5) 161.0 Product formulations and technology 90.2 (62.4) — 27.8 Total $ 5,416.4 $ (1,946.5) $ (25.6) $ 3,444.3 March 31, 2022 License agreements and collaboration agreements $ 4,023.0 $ (1,306.3) $ (19.6) $ 2,697.1 Customer relationships 760.3 (477.6) (5.5) 277.2 Trademarks 325.4 (176.6) (0.5) 148.3 Product formulations and technology 87.9 (63.9) — 24.0 Total $ 5,196.6 $ (2,024.4) $ (25.6) $ 3,146.6 Amortization expense was $50.2 and $62.2 for the three months ended March 31, 2022 and 2021, respectively and $158.6 and $189.4 for the nine months ended March 31, 2022 and 2021, respectively.

LEASES

LEASES	9 Months Ended
	Mar. 31, 2022
Leases [Abstract]
LEASES	LEASES The Company leases office facilities under non-cancelable operating leases with terms generally ranging between 5 and 25 years. The Company utilizes these leased office facilities for use by its employees in countries in which the Company conducts its business. Leases are negotiated with third parties and, in some instances contain renewal, expansion and termination options. The Company also subleases certain office facilities to third parties when the Company no longer intends to utilize the space. None of the Company’s leases restricts the payment of dividends or the incurrence of debt or additional lease obligations, or contain significant purchase options. The following chart provides additional information about the Company’s operating leases: Three Months Ended Nine Months Ended Lease Cost: 2022 2021 2022 2021 Operating lease cost $ 22.1 $ 21.4 $ 64.2 $ 60.4 Short-term lease cost 0.4 0.1 1.0 0.5 Variable lease cost 9.9 8.3 28.8 38.6 Sublease income (5.1) (5.6) (15.8) (10.1) Net lease cost $ 27.3 $ 24.2 $ 78.2 $ 89.4 Other information: Operating cash outflows from operating leases $ (18.7) $ (29.2) $ (64.0) $ (109.1) Right-of-use assets obtained in exchange for lease obligations $ 73.1 $ 16.6 $ 100.1 $ 27.4 Weighted-average remaining lease term - real estate 7.8 years 6.5 years Weighted-average discount rate - real estate leases 3.81 % 3.55 % Future minimum lease payments for the Company’s operating leases are as follows: Fiscal Year Ending June 30, 2022, remaining $ 21.9 2023 77.7 2024 66.3 2025 54.6 2026 45.8 Thereafter 177.9 Total future lease payments 444.2 Less: imputed interest (68.4) Total present value of lease liabilities 375.8 Current operating lease liabilities 68.5 Long-term operating lease liabilities 307.3 Total operating lease liabilities $ 375.8 Table excludes obligations for leases with original terms of twelve months or less which have not been recognized as ROU assets or liabilities in the Condensed Consolidated Balance Sheets.

DEBT

DEBT	9 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
DEBT	DEBT The Company’s debt balances consisted of the following as of March 31, 2022 and June 30, 2021, respectively: March 31, June 30, Short-term debt $ 4.8 $ — Senior Secured Notes 2026 Dollar Senior Secured Notes due April 2026 900.0 900.0 2026 Euro Senior Secured Notes due April 2026 781.2 833.3 2029 Dollar Senior Secured Notes due January 2029 500.0 — 2018 Coty Credit Agreement 2018 Coty Revolving Credit Facility due April 2023 — 670.0 2021 Coty Revolving Credit Facility due April 2025 — — 2018 Coty Term A Facility due April 2023 — 114.0 2018 Coty Term B Facility due April 2025 1,277.4 1,461.7 Senior Unsecured Notes 2026 Dollar Notes due April 2026 550.0 550.0 2023 Euro Notes due April 2023 613.8 654.7 2026 Euro Notes due April 2026 279.0 297.6 Other long-term debt and capital lease obligations 0.1 0.2 Total debt 4,906.3 5,481.5 Less: Short-term debt and current portion of long-term debt (516.5) (24.2) Total Long-term debt 4,389.8 5,457.3 Less: Unamortized financing fees (45.8) (51.7) Less: Discount on long-term debt (27.1) (4.6) Total Long-term debt, net $ 4,316.9 $ 5,401.0 Short-Term Debt The Company maintains short-term lines of credit and other short-term debt with financial institutions around the world. As of March 31, 2022, total short-term debt increased to $4.8 from nil as of June 30, 2021. In addition, the Company had undrawn letters of credit of $14.3 and $15.0, and bank guarantees of $20.3 and $31.2 as of March 31, 2022 and June 30, 2021, respectively. Long-Term Debt Recent Developments Early Bond Redemption On February 15, 2022, the Company issued a notice of full redemption of the 2023 Euro Notes (as defined below) in the amount of €550.0 million (approximately $613.8 as of March 31, 2022). The Company planned to utilize cash on hand of $488.1 and draw down $125.7 on the 2021 Coty Revolving Credit Facility (as defined below) for the redemption. As of March 31, 2022, the portion of the 2023 Euro Notes to be redeemed utilizing cash on hand was included in Short-term debt and current portion of long-term debt in the Condensed Consolidated Balance Sheet and the portion to be redeemed utilizing funds from the 2021 Coty Revolving Credit Facility was included in Long-term debt, net in the Condensed Consolidated Balance Sheet. The Company redeemed the 2023 Euro Notes on April 15, 2022. Revolving Credit Facility On September 30, 2021, the Company entered into an amendment to the 2018 Coty Credit Agreement (as defined below) to permanently reduce the existing 2018 Coty Revolving Credit Facility (as defined below) by $700.0 and add a new class of incremental revolving facilities in an aggregate principal amount of $700.0 that matures on April 5, 2025 (the "September 2021 Coty Revolving Credit Facility"). On November 30, 2021, the Company entered into an amendment to the 2018 Coty Credit Agreement (as defined below) that established a new class of senior secured revolving credit facility of $2,000.0 maturing on April 5, 2025 (the "2021 Coty Revolving Credit Facility"), which refinanced and replaced the 2018 Coty Revolving Credit Facility due April 5, 2023 and the September 2021 Coty Revolving Credit Facility due April 5, 2025 (the "2021 Revolver Refinancing"). Debt Paydowns and Waiver of Reinvestment Balance In October 2021 and January 2022, the Company completed the sale of certain real estate holdings, and in accordance with the 2018 Coty Credit Agreement, as amended, the Company utilized the proceeds from the sale to pay down a portion of the outstanding balances of the 2018 Coty Term A Facility and 2018 Coty Term B Facility (as defined below). As a result of the October 2021 prepayments, the outstanding principal balances of the 2018 Coty Term A Facility and the U.S. dollar portion of the 2018 Coty Term B Facility were reduced by €6.2 million (approximately $7.2) and $91.9, respectively. As a result of the January 2022 prepayments, the outstanding principal balances of the euro and U.S. dollar portions of the 2018 Coty Term B Facility were reduced by €13.9 million (approximately $15.7) and $22.3, respectively. In connection with the November 30, 2021 amendment to the 2018 Coty Credit Agreement, the Company received consent from the participating banks to eliminate the requirements to utilize or repay the Reinvestment Balance (as defined below). Offering of Senior Secured Notes On November 30, 2021, the Company issued an aggregate principal amount of $500.0 of 4.75% senior secured notes due 2029 ("2029 Dollar Senior Secured Notes"). Coty received gross proceeds of $500.0 in connection with the offering of the 2029 Dollar Senior Secured Notes. In accordance with the 2018 Coty Credit Agreement, as amended, a portion of the gross proceeds received were utilized to pay down the remaining outstanding principal balance of the 2018 Coty Revolving Credit Facility of $394.0 and the 2018 Coty Term A Facility of €89.5 million (approximately $100.4). Deferred Financing Costs and Write-offs During the three and nine months ended March 31, 2022, the Company capitalized original issue debt discounts of $0.0 and $27.0, respectively, and deferred issuance costs of $0.5 and $8.9, respectively, and wrote off unamortized deferred issuance costs of $0.1 and $3.4, respectively, and original issue debt discounts of $0.1 and $0.4, respectively, which were recorded in Other income, net in the Condensed Consolidated Statement of Operations. Senior Secured Notes On June 16, 2021, the Company issued an aggregate principal amount of €700.0 million of 3.875% senior secured notes due 2026 (the “2026 Euro Senior Secured Notes”) in a private offering. Coty received gross proceeds of €700.0 million in connection with the offering of the 2026 Euro Senior Secured Notes. On April 21, 2021, the Company issued an aggregate principal amount of $900.0 of 5.00% senior secured notes due 2026 (the “2026 Dollar Senior Secured Notes” and, together with the 2026 Euro Senior Secured Notes and 2029 Dollar Senior Secured Notes, the “Senior Secured Notes”). Coty received gross proceeds of $900.0 in connection with the offering of the 2026 Dollar Senior Secured Notes. Coty used the gross proceeds of the offerings of the Senior Secured Notes to repay a portion of the term loans outstanding under the existing credit facilities and to pay related fees and expenses thereto. See the above Recent Developments section for the 2029 Dollar Senior Secured Notes offering issued in November 2021. The Senior Secured Notes are senior secured obligations of Coty and are guaranteed on a senior secured basis by each of Coty’s wholly-owned domestic subsidiaries that guarantees Coty’s obligations under its existing senior secured credit facilities and are secured by first priority liens on the same collateral that secures Coty’s obligations under its existing senior secured credit facilities, as described below. The Senior Secured Notes and the guarantees are equal in right of payment with all of Coty’s and the guarantors’ respective existing and future senior indebtedness and are pari passu with all of Coty’s and the guarantors’ respective existing and future indebtedness that is secured by a first priority lien on the collateral, including the existing senior secured credit facilities, to the extent of the value of such collateral. Optional Redemption Applicable Premium The indentures governing the Senior Secured Notes specify the Applicable Premium (as defined in the respective indentures) to be paid upon early redemption of some or all of the Senior Secured Notes prior to, and on or after, April 15, 2023 for the 2026 Euro Senior Secured Notes and 2026 Dollar Senior Secured Notes, and January 15, 2025 for the 2029 Dollar Senior Secured Notes (the "Early Redemption Dates"). The Applicable Premium related to the respective Senior Secured Notes on any redemption date and as calculated by the Company is the greater of: (1) 1.0% of the then outstanding principal amount of the respective Senior Secured Notes; and (2) the excess, if any, of (a) the present value at such redemption date of (i) the redemption price of such respective Senior Secured Notes that would apply if such respective notes were redeemed on the respective Early Redemption Dates, (such redemption price is expressed as a percentage of the principal amount being set forth in the table appearing in the Redemption Pricing section below), plus (ii) all remaining scheduled payments of interest due on the respective Senior Secured Notes to and including the respective Early Redemption Dates, (excluding accrued but unpaid interest, if any, to, but excluding, the redemption date), with respect to each of subclause (i) and (ii), computed using a discount rate equal to the Treasury Rate in the case of the 2026 Dollar Senior Secured Notes and 2029 Dollar Senior Secured Notes, or Bund Rate in the case of the 2026 Euro Senior Secured Notes (both Treasury Rate and Bund Rate as defined in the respective indentures) as of such redemption date plus 50 basis points; over (b) the principal amount of the respective Senior Secured Notes. Redemption Pricing At any time and from time to time prior to the Early Redemption Dates, the Company may redeem some or all of the respective notes at redemption prices equal to 100% of the respective principal amounts being redeemed plus the Applicable Premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates. At any time on or after the Early Redemption Dates, the Company may redeem some or all of the respective notes at the redemption prices (expressed in percentage of principal amount) set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates, if redeemed during the twelve-month period beginning on respective dates of each of the years indicated below: Price For the period beginning 2026 Dollar Senior Secured Notes 2026 Euro Senior Secured Notes 2029 Dollar Senior Secured Notes Year April 15, January 15, 2023 102.500% 101.938% N/A 2024 101.250% 100.969% N/A 2025 100.000% 100.000% 102.375% 2026 N/A N/A 101.188% 2027 and thereafter N/A N/A 100.000% 2018 Coty Credit Agreement On April 5, 2018, the Company entered into a new credit agreement (the "2018 Coty Credit Agreement"), which amended and restated the prior Coty credit agreement. The 2018 Coty Credit Agreement provided for (a) the incurrence by the Company of (1) a senior secured term A facility in an aggregate principal amount of (i) $1,000.0 denominated in U.S. dollars and (ii) €2,035.0 million denominated in euros (the “2018 Coty Term A Facility”) and (2) a senior secured term B facility in an aggregate principal amount of (i) $1,400.0 denominated in U.S. dollars and (ii) €850.0 million denominated in euros (the “2018 Coty Term B Facility”) and (b) the incurrence by the Company and Coty B.V., a Dutch subsidiary of the Company (the “Dutch Borrower” and, together with the Company, the “Borrowers”), of a senior secured revolving facility in an aggregate principal amount of $3,250.0 denominated in U.S. dollars, specified alternative currencies or other currencies freely convertible into U.S. dollars and readily available in the London interbank market (the “2018 Coty Revolving Credit Facility”) (the 2018 Coty Term A Facility, together with the 2018 Coty Term B Facility and the 2018 Coty Revolving Credit Facility, the “2018 Coty Credit Facilities”). The 2018 Coty Credit Agreement provides that with respect to the 2018 Coty Revolving Credit Facility, up to $150.0 is available for letters of credit and up to $150.0 is available for swing line loans. The 2018 Coty Credit Agreement also permits, subject to certain terms and conditions, the incurrence of incremental facilities thereunder in an aggregate amount of (i) $1,700.0 plus (ii) an unlimited amount if the First Lien Net Leverage Ratio (as defined in the 2018 Coty Credit Agreement), at the time of incurrence of such incremental facilities and after giving effect thereto on a pro forma basis, is less than or equal to 3.00 to 1.00. The obligations of the Company under the 2018 Coty Credit Agreement are guaranteed by the material wholly-owned subsidiaries of the Company organized in the U.S., subject to certain exceptions (the “Guarantors”) and the obligations of the Company and the Guarantors under the 2018 Coty Credit Agreement are secured by a perfected first priority lien (subject to permitted liens) on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions. The Dutch Borrower does not guarantee the obligations of the Company under the 2018 Coty Credit Agreement or grant any liens on its assets to secure any obligations under the 2018 Coty Credit Agreement. On June 27, 2019, the Company entered into an amendment (“2019 Amendment”) to the 2018 Coty Credit Agreement. The 2019 Amendment modified the 2018 Coty Credit Agreement by amending the financial covenants to (i) delay until March 31, 2022 the total net leverage ratio step down from 5.25 to 5.0 (as further described in the Covenants section below), (ii) extend the applicable window for certain cost savings add-backs in the calculation of Adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”) for purpose of determining the total net leverage ratio, and (iii) amend the determination of the exchange rate to be used for purposes of calculating “Total Indebtedness” (as defined in the 2018 Coty Credit Agreement) for purposes of the total net leverage ratio, and decreasing the total commitments under the revolving credit facility by $500.0 to $2,750.0. On November 30, 2020, the Company completed the strategic transaction with KKR for the sale of a majority stake in the Wella Business. As part of the transaction, Coty received initial cash proceeds of $2,451.7 for the sale of its 60% stake in Wella and its pro rata share of Wella's return of capital distribution of $448.0, and retained a 40% stake in Wella. In accordance with the 2018 Coty Credit Agreement, as amended, the Company utilized $2,015.5 of the net proceeds to pay down its 2018 Coty Term A and B Facilities on a pro rata basis and reserved a maximum of $500.0 for reinvestment in the business, as defined in the 2018 Coty Credit Agreement, as amended, ("the Reinvestment Balance"). As a result of the prepayments, the outstanding balances of the 2018 Coty Term A and B Facilities were reduced by $1,135.7 and $879.8, respectively. See the above Recent Developments section for information on the amendments to the 2018 Coty Credit Agreement during fiscal 2022, the prepayments made in October 2021, the Reinvestment Balance waiver and the 2021 Revolver Refinancing. Senior Unsecured Notes On April 5, 2018 the Company issued, at par, $550.0 of 6.50% senior unsecured notes due 2026 (the “2026 Dollar Notes”), €550.0 million of 4.00% senior unsecured notes due 2023 (the “2023 Euro Notes”) and €250.0 million of 4.75% senior unsecured notes due 2026 (the “2026 Euro Notes” and, together with the 2023 Euro Notes, the “Euro Notes,” and the Euro Notes together with the 2026 Dollar Notes, the “Senior Unsecured Notes”) in a private offering. The Senior Unsecured Notes are senior unsecured debt obligations of the Company and will be pari passu in right of payment with all of the Company’s existing and future senior indebtedness (including the 2018 Coty Credit Facilities described below). The Senior Unsecured Notes are guaranteed, jointly and severally, on a senior basis by the Guarantors. The Senior Unsecured Notes are senior unsecured obligations of the Company and are effectively junior to all existing and future secured indebtedness of the Company to the extent of the value of the collateral securing such secured indebtedness. The related guarantees are senior unsecured obligations of each Guarantor and are effectively junior to all existing and future secured indebtedness of such Guarantor to the extent of the value of the collateral securing such indebtedness. The 2026 Dollar Notes will mature on April 15, 2026. The 2026 Dollar Notes will bear interest at a rate of 6.50% per annum. Interest on the 2026 Dollar Notes is payable semi-annually in arrears on April 15 and October 15 of each year. The 2023 Euro Notes will mature on April 15, 2023 and the 2026 Euro Notes will mature on April 15, 2026. The 2023 Euro Notes will bear interest at a rate of 4.00% per annum, and the 2026 Euro Notes will bear interest at a rate of 4.75% per annum. Interest on the Euro Notes is payable semi-annually in arrears on April 15 and October 15 of each year. Upon the occurrence of certain change of control triggering events with respect to a series of Senior Unsecured Notes, the Company will be required to offer to repurchase all or part of the Senior Unsecured Notes of such series at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the purchase date applicable to such Senior Unsecured Notes. The Senior Unsecured Notes contain customary covenants that place restrictions in certain circumstances on, among other things, incurrence of liens, entry into sale or leaseback transactions, sales of all or substantially all of the Company’s assets and certain merger or consolidation transactions. The Senior Unsecured Notes also provide for customary events of default. Scheduled Amortization The Company makes quarterly payments of 0.25%, of the initial aggregate principal amounts of the 2018 Coty Term B Facility. The remaining balance of the initial aggregate principal amount of the 2018 Coty Term B Facility will be payable on the maturity date of the facility. Interest The 2018 Coty Credit Agreement facilities will bear interest at rates equal to, at the Company’s option, either: (1) LIBOR of the applicable qualified currency, of which the Company can elect the applicable one, two, three, six or twelve month rate, plus the applicable margin; or (2) Alternate base rate (“ABR”) plus the applicable margin. In the case of the 2021 Coty Revolving Credit Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below: Pricing Tier Total Net Leverage Ratio: LIBOR plus: Alternative Base Rate Margin: 1.0 Greater than or equal to 4.75:1 2.000% 1.000% 2.0 Less than 4.75:1 but greater than or equal to 4.00:1 1.750% 0.750% 3.0 Less than 4.00:1 but greater than or equal to 2.75:1 1.500% 0.500% 4.0 Less than 2.75:1 but greater than or equal to 2.00:1 1.250% 0.250% 5.0 Less than 2.00:1 but greater than or equal to 1.50:1 1.125% 0.125% 6.0 Less than 1.50:1 1.000% —% Pricing Tier Debt Ratings S&P/Moody’s: LIBOR plus: Alternative Base Rate Margin: 5.0 Less than BB+/Ba1 2.000% 1.000% 4.0 BB+/Ba1 1.750% 0.750% 3.0 BBB-/Baa3 1.500% 0.500% 2.0 BBB/Baa2 1.250% 0.250% 1.0 BBB+/Baa1 or higher 1.125% 0.125% In the case of the U.S. dollar portion of the 2018 Coty Term B Facility, the applicable margin means 2.25% per annum, in the case of LIBOR loans, and 1.25% per annum, in the case of ABR loans. In the case of the Euro portion of the 2018 Coty Term B Facility, the applicable margin means 2.50% per annum, in the case of EURIBOR loans. In no event will LIBOR be deemed to be less than 0.00% per annum. Fair Value of Debt March 31, 2022 June 30, 2021 Carrying Fair Carrying Fair Senior Secured Notes $ 2,181.2 $ 2,109.0 $ 1,733.3 $ 1,749.1 2018 Coty Credit Agreement 1,277.4 1,248.0 2,245.7 2,188.5 Senior Unsecured Notes 1,442.8 1,434.0 1,502.3 1,500.5 The Company uses the market approach to value its debt instruments. The Company obtains fair values from independent pricing services to determine the fair value of these debt instruments. Based on the assumptions used to value these liabilities at fair value, these debt instruments are categorized a Level 2 in the fair value hierarchy. Debt Maturities Schedule Aggregate maturities of the Company’s long-term debt, including the current portion of long-term debt and excluding capital lease obligations as of March 31, 2022, are presented below: Fiscal Year Ending June 30, 2022, remaining $ 493.9 2023 23.5 2024 23.5 2025 1,350.3 2026 2,510.2 Thereafter 500.0 Total $ 4,901.4 Covenants The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period. Quarterly Test Period Ending Total Net Leverage Ratio (a) March 31, 2022 5.00 to 1.00 June 30, 2022 4.75 to 1.00 September 30, 2022 4.50 to 1.00 December 31, 2022 4.25 to 1.00 March 31, 2023 through April 5, 2025 4.00 to 1.00 (a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended). Adjusted EBITDA, as defined in the 2018 Coty Credit Agreement, as amended, includes certain add backs related to cost savings, unusual events such as COVID-19, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement, as amended. In the four fiscal quarters following the closing of any Material Acquisition (as defined in the 2018 Coty Credit Agreement, as amended), including the fiscal quarter in which such Material Acquisition occurs, the maximum Total Net Leverage Ratio shall be the lesser of (i) 5.95 to 1.00 and (ii) 1.00 higher than the otherwise applicable maximum Total Net Leverage Ratio for such quarter (as set forth in the table above). Immediately after any such four fiscal quarter period, there shall be at least two consecutive fiscal quarters during which the Company's Total Net Leverage Ratio is no greater than the maximum Total Net Leverage Ratio that would otherwise have been required in the absence of such Material Acquisition, regardless of whether any additional Material Acquisitions are consummated during such period. As of March 31, 2022, the Company was in compliance with all covenants contained within the 2018 Coty Credit Agreement, as amended.

INTEREST EXPENSE, NET

INTEREST EXPENSE, NET	9 Months Ended
	Mar. 31, 2022
Interest Income (Expense), Net [Abstract]
INTEREST EXPENSE, NET	INTEREST EXPENSE, NET Interest expense, net for the three and nine months ended March 31, 2022 and 2021, respectively, is presented below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Interest expense $ 60.9 $ 51.7 $ 185.4 $ 171.3 Foreign exchange losses (gains), net of derivative contracts 3.4 (0.6) 1.0 3.1 Interest income (1.4) (0.8) (2.8) (2.8) Total interest expense, net $ 62.9 $ 50.3 $ 183.6 $ 171.6

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	9 Months Ended
	Mar. 31, 2022
Retirement Benefits [Abstract]
EMPLOYEE BENEFIT PLANS	EMPLOYEE BENEFIT PLANS As part of the Transformation Plan, the Company concluded that restructuring actions resulted in a significant reduction of future services of active employees in certain of the Company's non-U.S. pension plans. As a result, the Company recognized curtailment gains of nil and $2.7 for the three months ended March 31, 2022 and 2021, respectively, and $0.2 and $8.0 for the nine months ended March 31, 2022 and 2021, respectively. Additionally, the Company recognized a settlement loss of $0.1 and $2.1 for the three months and nine months ended March 31, 2022, respectively, of which $0.7 was related to restructuring actions. The impact of the curtailment and settlement activity on the current and prior comparative periods is included in Other income, net in the Condensed Consolidated Statements of Operations. The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below: Three Months Ended March 31, Pension Plans Other Post- Employment Benefits U.S. International Total 2022 2021 2022 2021 2022 2021 2022 2021 Service cost $ — $ — $ 2.4 $ 2.6 $ 0.2 $ 0.3 $ 2.6 $ 2.9 Interest cost 0.1 0.1 1.6 1.7 0.3 0.3 2.0 2.1 Expected return on plan assets — — (1.2) (1.1) — — (1.2) (1.1) Amortization of prior service credit — — — — (0.1) (0.9) (0.1) (0.9) Amortization of net loss 0.1 0.4 (0.1) (0.1) — — — 0.3 Settlement loss recognized — — 0.1 — — — 0.1 — Curtailment gain recognized — — — (2.7) — — — (2.7) Net periodic benefit cost (credit) $ 0.2 $ 0.5 $ 2.8 $ 0.4 $ 0.4 $ (0.3) $ 3.4 $ 0.6 Nine Months Ended March 31, Pension Plans Other Post- U.S. International Total 2022 2021 2022 2021 2022 2021 2022 2021 Service cost $ — $ — $ 7.1 $ 14.5 $ 0.6 $ 0.9 $ 7.7 $ 15.4 Interest cost 0.3 0.3 4.8 6.4 0.9 0.9 6.0 7.6 Expected return on plan assets — — (3.4) (4.8) — — (3.4) (4.8) Amortization of prior service cost (credit) — — — (0.2) (0.3) (2.6) (0.3) (2.8) Amortization of net (gain) loss 0.3 1.1 (0.3) (0.2) — — — 0.9 Settlement loss recognized — — 2.1 — — — 2.1 — Curtailment gain recognized — — (0.2) (8.0) — — (0.2) (8.0) Net periodic benefit cost (credit) $ 0.6 $ 1.4 $ 10.1 $ 7.7 $ 1.2 $ (0.8) $ 11.9 $ 8.3 Net periodic benefit costs include amounts related to discontinued operations of $0.0 and $6.2 for the three and nine months ended March 31, 2021.

DERIVATIVE INSTRUMENTS

DERIVATIVE INSTRUMENTS	9 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS Foreign Exchange Risk Management The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings and cross-currency swaps as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions. The Company is exposed to foreign currency exchange rate fluctuations in the normal course of business, including through exposure to inventory expenditures made by the Company’s international subsidiaries whose functional currency is other than the transaction currency. To manage this exposure, beginning in June 2021, the Company entered into non-deliverable forward foreign-exchange contracts (the “NDF contracts”) that are intended to offset changes in cash flow attributable to currency exchange movements. The NDF contracts have been designated as foreign exchange cash flow hedges. The Company entered into these contracts with counterparties that are banks or other financial institutions, and the Company considers the risk of non-performance by such counterparties not to be material. The Company also continued to use certain derivatives as economic hedges of foreign currency exposure on firm commitments, which do not qualify for hedge accounting. Although these derivatives were not designated for hedge accounting, the overall objective of mitigating foreign currency exposure is the same for all derivative instruments. The Company does not enter into derivative financial instruments for trading or speculative purposes, nor is the Company a party to leveraged derivatives. For derivatives not designated as hedging instruments, changes in fair value are recorded in the line item in the Condensed Consolidated Statements of Operations to which the derivative relates. In September 2020, the Company terminated its existing net investment cross currency swap derivatives with notional amount of $550.0 in exchange for cash payment of $37.6. The related loss from this termination is included in accumulated other comprehensive income (loss) (“AOCI/(L)”) until the sale or substantial liquidation of the underlying net investments. Beginning in July 2021, the Company entered into foreign exchange forward contracts to naturally hedge up to 80% of the Company's euro denominated external debt as part of management's strategy to minimize the impact of currency movements on those debt instruments. The notional amount of those contracts was €1,500.0 million as of March 31, 2022. As a result, foreign currency denominated borrowings designated as net investment hedges decreased from nominal exposures of €1,809.5 million as of June 30, 2021 to €352.6 million as of March 31, 2022. Interest Rate Risk The Company is exposed to interest rate fluctuations related to its variable rate debt instruments. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in the variable interest rates by entering into offsetting positions through the use of derivative instruments, such as interest rate swap contracts. The interest rate swap contracts result in recognizing a fixed interest rate for the portion of the Company’s variable rate debt that was hedged. This will reduce the negative and positive impact of increases in the variable rates over the term of the contracts. Hedge effectiveness of interest rate swap contracts is based on a long-haul hypothetical derivative methodology and includes all changes in value. These interest rate swaps are designated and qualify as cash flow hedges. In December 2021, the Company terminated certain existing interest rate swaps with a notional amount of $200.0 in exchange for a settlement of $1.9. The related loss from this termination is included in Interest expense, net in the Condensed Consolidated Statement of Operations. As of March 31, 2022 and June 30, 2021, the Company had interest rate swap contracts designated as effective hedges in the notional amount of $800.0 and $1,900.0, respectively. Derivative and non-derivative financial instruments which are designated as hedging instruments: The accumulated (loss)/gain on foreign currency borrowings classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $29.6 and $5.4 as of March 31, 2022 and June 30, 2021, respectively. The accumulated loss on derivative instruments classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $(37.6) as of March 31, 2022 and June 30, 2021. The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below: Gain (Loss) Recognized in OCI Three Months Ended Nine Months Ended 2022 2021 2022 2021 Foreign exchange forward contracts $ (4.7) $ — $ (3.0) $ (0.4) Interest rate swap contracts 7.9 3.9 9.8 4.3 Cross-currency swap contracts — — — (25.1) Net investment hedges 5.3 156.4 24.2 (191.1) The accumulated loss on derivative instruments classified as cash flow hedges in AOCI/(L), net of tax, was $(1.0) and $(15.5) as of March 31, 2022 and June 30, 2021, respectively. The estimated net loss related to these effective hedges that is expected to be reclassified from AOCI/(L) into earnings, net of tax, within the next twelve months is $(0.3). As of March 31, 2022, all of the Company's remaining foreign currency forward contracts designated as hedges were highly effective. The amount of gains and losses reclassified from AOCI/(L) to the Condensed Consolidated Statements of Operations related to the Company’s derivative financial instruments which are designated as hedging instruments is presented below: Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Three Months Ended March 31, 2022 2021 Net revenues Cost of sales Interest expense, net Net revenues Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ — $ 1.2 $ — $ — $ — $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — — (2.2) — — (6.3) Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Nine Months Ended March 31, 2022 2021 Net revenues Cost of sales Interest expense, net Net revenues Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ — $ 1.4 $ — $ 1.0 $ — $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — — (12.0) — — (27.6) Derivatives not designated as hedging: The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below: Condensed Consolidated Statements of Operations Three Months Ended Nine Months Ended 2022 2021 2022 2021 Foreign exchange contracts Selling, general and administrative expenses $ (0.4) $ — $ (0.3) $ 0.1 Foreign exchange contracts Interest expense, net (1.5) 7.5 18.7 23.7 Foreign exchange contracts Other expense, net 2.8 (0.1) 2.3 (0.5)

EQUITY AND CONVERTIBLE PREFERRE

EQUITY AND CONVERTIBLE PREFERRED STOCK	9 Months Ended
	Mar. 31, 2022
Equity [Abstract]
EQUITY AND CONVERTIBLE PREFERRED STOCK	EQUITY AND CONVERTIBLE PREFERRED STOCK Common Stock As of March 31, 2022, the Company’s common stock consisted of Class A Common Stock with a par value of $0.01 per share. The holders of Class A Common Stock are entitled to one vote per share. As of March 31, 2022, total authorized shares of Class A Common Stock was 1,250.0 million and total outstanding shares of Class A Common Stock was 839.2 million. As of March 31, 2022, the Company’s largest stockholder was Cottage Holdco B.V., which owned approximately 54% of Coty’s outstanding Class A Common Stock. Cottage Holdco B.V., a wholly-owned subsidiary of JAB Cosmetics B.V. (“JABC”), is indirectly controlled by Lucresca SE, Agnaten SE and JAB Holdings B.V. (“JAB”). The Company’s CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units (the “Award”) on June 30, 2021. On October 29, 2021, Cottage Holdco B.V. completed the transfer of 10.0 million shares of Common Stock to Ms. Nabi in connection with her sign-on award of restricted stock units. See Note 17—Share-Based Compensation Plans for additional information. Series A and A-1 Preferred Stock As of March 31, 2022, total authorized shares of preferred stock are 20.0 million. There are two classes of Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock, both with a par value of $0.01 per share. As of March 31, 2022, there were 1.5 million shares of Series A and no shares of Series A-1 Preferred Stock authorized, issued and outstanding. Series A Preferred Stock and Series A-1 Preferred Stock are not entitled to receive any dividends and have no voting rights except as required by law. As of March 31, 2022, the Company has $1.0 Series A Preferred Stock classified as a liability recorded in Other noncurrent liabilities in the Condensed Consolidated Balance Sheet. Convertible Series B Preferred Stock On May 11, 2020, the Company entered into an Investment Agreement with KKR Aggregator, relating to the issuance and sale by the Company to KKR Aggregator of up to 1,000,000 shares of the Company’s new Convertible Series B Preferred Stock, par value $0.01 per share (the “Series B Preferred Stock”), for an aggregate purchase price of up to $1,000.0, or $1,000 per share (the “Issuance”). The Issuance was proposed to be issued in two tranches: (i) an initial issuance of 750,000 shares of Series B Preferred Stock (the “Initial Issuance”) and (ii) a subsequent issuance of 250,000 shares of Series B Preferred Stock (the “Second Issuance”), which was subject to the execution and delivery of a definitive purchase agreement between the Company and KKR Aggregator or certain of its affiliates in respect of the Wella Business. On May 26, 2020 (the “Closing Date”), the Company and KKR Aggregator completed the issuance and sale of 750,000 shares of Series B Preferred Stock for an aggregate purchase price of $750.0. On July 31, 2020, the Company completed the sale of 250,000 shares of the Company’s Series B Preferred Stock to KKR Aggregator for an aggregate purchase price of $250.0. On November 16, 2020, KKR Aggregator and affiliated investment funds agreed to sell 146,057 shares of Series B Preferred Stock, to HFS Holdings S.à r.l, that is beneficially owned by Peter Harf, a director of the Company. The transaction, which was subject to customary closing conditions, closed on August 27, 2021. On September 10, 2021, KKR Aggregator converted 285,576 shares of Series B Preferred Stock, and $26.4 of unpaid dividends into 50,000,088 shares of Class A common stock. Immediately after the conversion, KKR Aggregator completed the public secondary offering of 50,000,088 shares of Class A common stock. The Company did not receive any proceeds from the sale of the shares of Class A Common Stock by KKR Aggregator. As a result of the conversion, the Company measured the accrued dividends at fair value, which resulted in an increase of $6.7. Such adjustment is considered a deemed dividend for purposes of calculating basic and diluted EPS. On September 30, 2021, the Company entered into a definitive agreement to sell a 9.4% stake in Wella to KKR Aggregator in exchange for the redemption of 290,465 shares of Series B Preferred Stock and $22.5 of unpaid dividends, as previously defined as the First Exchange. As a result, the Series B Preferred Stock, net of issuance costs, and related accrued dividends were reclassified from temporary equity to a liability as Mandatorily redeemable Convertible Series B Preferred Stock as of September 30, 2021. Upon reclassification, the Company measured the Series B Preferred Stock and accrued dividends at fair value, which resulted in an increase of $93.6. The excess in fair value is considered a deemed dividend for purposes of calculating basic and diluted EPS. The First Exchange was completed on October 20, 2021. Upon closing, the Company re-measured the Series B Preferred Stock and accrued dividends at fair value, which resulted in a decrease of $6.5. Such adjustment is considered a gain on extinguishment and is included in Other (income) expense, net in the Consolidated Statements of Operations. A key input in determining the fair value of the liability was based on the Company's share price as of the measurement date. As this liability is not actively traded, it is classified as a Level 2 fair value measurements. Upon closing of the First Exchange, the Company recognized a non-monetary loss of $2.9 and is included in Other income, net in the Consolidated Statements of Operations. See Note 9—Equity Investments for additional information. On November 10, 2021, KKR Aggregator converted 123,219 shares of Series B Preferred Stock, and $1.2 of unpaid dividends into 19,944,701 shares of Class A common stock. Immediately after the conversion, KKR Aggregator completed a sale of 19,944,701 shares of Class A common stock. The Company did not receive any proceeds from the sale of the shares of Class A Common Stock by KKR Aggregator. As a result of the conversion, the Company measured the accrued dividends at fair value, which resulted in an increase of $0.8. Such adjustment is considered a deemed dividend for purposes of calculating basic and diluted EPS. On November 6, 2021, the Company entered into a definitive agreement to sell an additional 4.7% stake in Wella to KKR Aggregator in exchange for the redemption or conversion of 154,683 shares of Series B Preferred Stock, as previously defined as the Second Exchange. The Second Exchange closed on November 30, 2021. Upon closing, the Company recognized $66.4 in excess of the fair value of the consideration transferred in exchange for the redemption of the Series B Preferred Stock. The excess in fair value is considered a deemed dividend for purposes of calculating basic and diluted EPS. As of December 31, 2021, KKR has fully redeemed/exchanged all of their Series B Preferred Stock. See Note 9—Equity Investments for additional information. In October 2021, the Company paid the remaining accrued dividends on the Series B Preferred Stock that were outstanding as of June 30, 2021, totaling $25.1. As a result, $4.4 of previously recorded fair value adjustments for unpaid dividends were reversed through additional paid-in capital (“APIC”) and is considered a deemed contribution. Cumulative preferred dividends accrue daily on the Series B Preferred Stock at a rate of 9.0% per year. During the three months ended March 31, 2022, the Board of Directors declared dividends on the Series B Preferred Stock of $3.3, which was paid on April 1, 2022. Additionally, the Company paid previously accrued dividends that were outstanding as of December 31, 2021, totaling $3.3. During the nine months ended March 31, 2022, the Board of Directors declared dividends on the Series B Preferred Stock of $31.9 of which $27.4 was paid and $1.2 was converted as part of the November 10, 2021 conversion. As of March 31, 2022 and June 30, 2021, the Series B Preferred Stock had outstanding accrued dividends of $3.3 and $74.1, respectively. Treasury Stock Share Repurchase Program Since February 2014, the Board has authorized the Company to repurchase its Class A Common Stock under approved repurchase programs. On February 3, 2016, the Board authorized the Company to repurchase up to $500.0 of its Class A Common Stock (the “Incremental Repurchase Program”). Repurchases may be made from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its Class A Common Stock, and general market conditions. For the three and nine months ended March 31, 2022, the Company did not repurchase any shares of its Class A Common Stock. As of March 31, 2022, the Company had authority for $396.8 remaining under the Incremental Repurchase Program. Other Repurchases There were no other stock repurchases during the three and nine months ended March 31, 2022 and 2021. Dividends On April 29, 2020, the Board of Directors suspended the payment of dividends. During fiscal 2020, prior to the Board’s decision to suspend the payment of dividends, the Company maintained a Stock Dividend Reinvestment Program and had registered a total of 19.3 million shares of Class A Common Stock for purchase under the program. All holders of records of Class A Common Stock had the opportunity to participate in the program; if a holder elected to participate in the program fifty percent (50%) of their cash dividends were reinvested in additional shares of Class A Common Stock. The change in dividends accrued recorded to APIC in the Condensed Consolidated Balance Sheet as of March 31, 2022 was $0.8, which represent dividends no longer expected to vest as a result of forfeitures of outstanding restricted stock units (“RSUs”). In addition to the activity noted above, the Company made a payment of $1.3 for the previously accrued dividends on RSUs that vested during the nine months ended March 31, 2022. Total accrued dividends on unvested RSUs and phantom units of $1.5 and $0.5 are included in Accrued expenses and other current liabilities and Other noncurrent liabilities, respectively, in the Condensed Consolidated Balance Sheet as of March 31, 2022. Accumulated Other Comprehensive Income (Loss) Foreign Currency Translation Adjustments (Loss) gain on Cash Flow Hedges (Loss) gain on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans (a) Total Balance—July 1, 2021 $ (15.5) $ (32.2) $ (259.3) $ (14.9) $ (321.9) Other comprehensive income (loss) before reclassifications 6.3 24.2 (239.2) — (208.7) Net amounts reclassified from AOCI/(L) 8.2 — — 2.1 10.3 Net current-period other comprehensive income (loss) 14.5 24.2 (239.2) 2.1 (198.4) Balance—March 31, 2022 $ (1.0) $ (8.0) $ (498.5) $ (12.8) $ (520.3) (a) For the nine months ended March 31, 2022, net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial gains of $2.7, net of tax of $0.6. Foreign Currency Translation Adjustments Loss on Cash Flow Hedges Gain (loss) on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans Total Balance—July 1, 2020 $ (43.0) $ 261.9 $ (683.8) $ 8.7 $ (456.2) Other comprehensive income (loss) before reclassifications 2.8 (228.7) 250.8 — 24.9 Net amounts reclassified from AOCI/(L) 20.4 — — (15.1) 5.3 Net current-period other comprehensive income (loss) 23.2 (228.7) 250.8 (15.1) 30.2 Balance—March 31, 2021 $ (19.8) $ 33.2 $ (433.0) $ (6.4) $ (426.0)

SHARE-BASED COMPENSATION PLANS

SHARE-BASED COMPENSATION PLANS	9 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
SHARE-BASED COMPENSATION PLANS	SHARE-BASED COMPENSATION PLANS Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Equity plan expense (a) $ 29.1 $ 6.0 $ 163.8 $ 24.6 Equity plan modified and cash settled — — — 0.9 Liability plan (income) expense (0.6) 0.7 0.5 1.4 Fringe expense 0.3 — 2.5 0.4 Total share-based compensation expense $ 28.8 $ 6.7 $ 166.8 $ 27.3 (a) Equity plan share-based compensation expense of $29.1 and $6.0 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the three months ended March 31, 2022 and 2021, respectively. Equity plan share-based compensation expense of $163.8 and $26.6 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the nine months ended March 31, 2022 and 2021, respectively. Of the $6.0 and $26.6 for the three and nine months ended March 31, 2021, $0.0 and $2.0, respectively, were reclassified to discontinued operations. The share-based compensation expense for the three and nine months ended March 31, 2022, respectively, of $28.8 and $166.8, includes $28.8 and $171.0 of expense offset by $0.0 and $(4.2) of income primarily due to significant executive forfeitures of share-based compensation instruments. The share-based compensation expense for the three and nine months ended March 31, 2021, respectively, of $6.7 and $27.3, includes $6.7 and $30.4 of expense offset by nil and $(3.1) of income primarily due to significant executive forfeitures of share-based compensation instruments. As of March 31, 2022, the total unrecognized share-based compensation expense related to stock options, Series A Preferred Stock, restricted stock, and restricted stock units and other share awards is $2.5, $0.0, $3.6 and $184.7, respectively. The unrecognized share-based compensation expense related to stock options, Series A Preferred stock, restricted stock, and restricted stock units and other share awards is expected to be recognized over a weighted-average period of 2.16, 0.00, 1.67 and 1.60 years, respectively. Restricted Stock Units and Other Share Awards The Company granted 0.7 million and 5.1 million shares of RSUs and other share awards during the three and nine months ended March 31, 2022, respectively. The Company recognized share-based compensation expense of $29.4 and $4.5 for the three months ended March 31, 2022 and 2021, respectively, of which $22.6 and $0.0, respectively, related to Ms. Nabi's award, as described below. For the nine months ended March 31, 2022 and 2021, the Company recognized share-based compensation expense of $166.6 and $21.6, respectively, of which, $146.6 and $0.0 related to Ms. Nabi's award. The Company’s CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units (the “Award”) on June 30, 2021. The Award will vest and settle in 10,000,000 shares of the Company’s Class A Common Stock, par value $0.01 per share, on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to her continued employment through each such date. The Company will recognize the share-based compensation expense, on a straight-line basis over the vesting period, based on the fair value on the grant date. The amount of compensation cost recognized at each vesting date must at least equal the portion of the award legally vested. In connection with this Award, Cottage Holdco B.V., the Company’s largest stockholder and a wholly-owned subsidiary of JAB Holding Company S.à r.l., agreed, pursuant to an equity transfer agreement, to transfer to Ms. Nabi (either directly or through contributing to the Company) 10,000,000 shares of Common Stock no later than sixty days following the first vesting date. On October 29, 2021, Cottage Holdco B.V. completed the transfer of 10,000,000 shares of Common Stock to Ms. Nabi. If, however, Ms. Nabi is terminated without cause or due to death or disability on or following the first vesting date but prior to the second vesting date, the Company has agreed to issue to Cottage Holdco B.V. the number of shares of Common Stock determined on pro-rata basis in accordance with the equity transfer agreement. In the event Ms. Nabi remains employed through the third vesting date, Cottage Holdco B.V. has agreed to transfer an additional 5,000,000 shares of Common Stock to Ms. Nabi. Restricted Stock The Company granted no shares and 0.4 million shares of restricted stock, during the three and nine months ended March 31, 2022, respectively. The Company recognized share-based compensation expense of $0.7 and $0.2 for the three months ended March 31, 2022 and 2021, respectively, and $1.2 and $0.7 for the nine months ended March 31, 2022 and 2021, respectively. Series A Preferred Stock and Series A-1 Preferred Stock The Company granted no shares of Series A Preferred Stock and no shares of Series A-1 Preferred Stock during the three and nine months ended March 31, 2022. The Company recognized share-based compensation expense (income) of $(0.7) and $0.4 for the three months ended March 31, 2022 and 2021, respectively, and $0.2 and $0.8 for the nine months ended March 31, 2022 and 2021, respectively. Non-Qualified Stock Options The Company granted no non-qualified stock options during the three and nine months ended March 31, 2022. The Company recognized share-based compensation (income)expense of $(0.6) and $1.6 for the three months ended March 31, 2022 and 2021, respectively, and $(1.2) and $4.2 for the nine months ended March 31, 2022 and 2021, respectively.

NET INCOME (LOSS) ATTRIBUTABLE

NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC. PER COMMON SHARE	9 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC. PER COMMON SHARE	NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC. PER COMMON SHARE Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Amounts attributable to Coty Inc.: Net income from continuing operations $ 52.9 $ 32.9 $ 536.5 $ 132.9 Convertible Series B Preferred Stock dividends (3.3) (34.1) (195.0) (78.1) Net income from continuing operations attributable to common stockholders 49.6 (1.2) 341.5 54.8 Net income from discontinued operations, net of tax 0.7 (17.3) 4.5 (148.2) Net income (loss) attributable to common stockholders $ 50.3 $ (18.5) $ 346.0 $ (93.4) Weighted-average common shares outstanding: Weighted-average common shares outstanding—Basic 838.4 765.4 814.8 764.6 Effect of dilutive stock options and Series A Preferred Stock (a) — — — — Effect of restricted stock and RSUs (b) 14.5 — 12.7 5.4 Effect of Convertible Series B Preferred Stock (c) — — — 162.1 Weighted-average common shares outstanding—Diluted 852.9 765.4 827.5 932.1 Earnings per common share: Earnings from continuing operations per common share - basic $ 0.06 $ — $ 0.42 $ 0.07 Earnings from continuing operations per common share - diluted (d) 0.06 — 0.42 0.07 Losses from discontinued operations - basic — (0.02) — (0.19) Losses from discontinued operations - diluted — (0.02) — (0.19) Earnings (losses) per common share - basic 0.06 (0.02) 0.42 (0.12) Earnings (losses) per common share - diluted (d) 0.06 (0.02) 0.42 (0.12) (a) For the three months ended March 31, 2022, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 6.6 million weighted average shares of Common Stock, were anti-dilutive and excluded from the computation of diluted EPS. For the three months ended March 31, 2021, there were outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase shares of Common Stock were excluded in the computation of diluted loss per share due to the net loss incurred during the period. For the nine months ended March 31, 2022 and 2021, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 8.9 million and 15.4 million weighted average shares of Common Stock, respectively, were excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. (b) For the three months ended March 31, 2022, there were 0.7 million weighted average anti-dilutive RSUs, excluded from the computation of diluted EPS. For the three months ended March 31, 2021, RSUs were excluded in the computation of diluted loss per share due to the net loss incurred during the period. For the nine months ended March 31, 2022 and 2021, there were 2.3 million and 6.2 million weighted average anti-dilutive RSUs, respectively, excluded from the computation of diluted EPS. (c) For the three months ended March 31, 2022, there were 23.7 million dilutive shares of Convertible Series B Preferred Stock excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. For the three months ended March 31, 2021, Convertible Series B Preferred Stock shares were excluded from the computation of diluted EPS due to the net loss incurred during the period. For the nine months ended March 31, 2022, and 2021, there were 79.2 million and 0.0 million, respectively, weighted average dilutive shares of Convertible Series B Preferred Stock excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. (d) Diluted EPS is adjusted by the effect of dilutive securities, including awards under the Company's equity compensation plans and the convertible Series B Preferred Stock. When calculating any potential dilutive effect of stock options, Series A Preferred Stock, restricted stock and RSUs, the Company uses the treasury method and the if-converted method for the Convertible Series B Preferred Stock. The treasury method typically does not adjust the net income attributable to Coty Inc., while the if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $3.3 and $34.1 for the three months ended March 31, 2022 and 2021, respectively, and $195.0 and $78.1 for the nine months ended March 31, 2022 and 2021, respectively, on net income applicable to common stockholders during the period.

MANDATORILY REDEEMABLE FINANCIA

MANDATORILY REDEEMABLE FINANCIAL INTERESTS AND REDEEMABLE NONCONTROLLING INTERESTS	9 Months Ended
	Mar. 31, 2022
Noncontrolling Interest [Abstract]
MANDATORILY REDEEMABLE FINANCIAL INTERESTS AND REDEEMABLE NONCONTROLLING INTERESTS	MANDATORILY REDEEMABLE FINANCIAL INTERESTS AND REDEEMABLE NONCONTROLLING INTERESTS Mandatorily Redeemable Financial Interest Convertible Series B Preferred Stock As a result of the Exchange Agreement, discussed in Note 16—Equity and Convertible Preferred Stock, Series B Preferred Stock and related accrued dividends were reclassified from temporary equity to liability as Mandatorily redeemable Convertible Series B Preferred Stock, as of September 30, 2021, and subsequently settled. United Arab Emirates subsidiary In July 2021, the Company purchased the remaining 25% noncontrolling interest of a certain subsidiary in the United Arab Emirates from the noncontrolling interest holder for $7.1, pursuant to the related U.A.E. Shareholders Agreement. The termination was effective on December 31, 2020 and immediately prior to the cash payment, the noncontrolling interest balance was recorded as a mandatorily redeemable financial instrument liability. Redeemable Noncontrolling Interests Subsidiary in the Middle East As of March 31, 2022, the noncontrolling interest holder in the Company’s subsidiary in the Middle East had a 25% ownership share. The Company adjusts the redeemable noncontrolling interests (“RNCI”) to redemption value at the end of each reporting period with changes recognized as adjustments to APIC. The Company recognized $71.9 and $84.1 as the RNCI balances as of March 31, 2022 and June 30, 2021, respectively.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Legal Matters The Company is involved, from time to time, in various litigation, administrative and other legal proceedings, including regulatory actions, incidental or related to its business, including consumer class or collective actions, personal injury (including asbestos claims related to the Company’s talc-based cosmetic products), intellectual property, competition, compliance and advertising claims litigation and disputes, among others (collectively, “Legal Proceedings”). While the Company cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon its business, prospects, financial condition, results of operations, cash flows or the trading price of the Company’s securities. However, management’s assessment of the Company’s current Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings not presently known to the Company, further legal analysis, or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, the Company is in discussions with regulators, including discussions initiated by the Company, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks and liabilities or penalties. As the outcomes of such proceedings are unpredictable, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, prospects, financial condition, results of operations, cash flows or the trading price of its securities. Certain Litigation . A consolidated purported stockholder class action and derivative complaint concerning the tender offer by Cottage Holdco B.V. (the “Cottage Tender Offer”) and the Schedule 14D-9 is pending against certain current and former directors of the Company, JAB Holding Company S.à r.l., JAB Holdings B.V., JAB Cosmetics B.V., and Cottage Holdco B.V. in the Court of Chancery of the State of Delaware. The Company was named as a nominal defendant. The case, which was filed on May 6, 2019, was captioned Massachusetts Laborers’ Pension Fund v. Harf et al., Case No. 2019-0336-AGB. On June 14, 2019, plaintiffs in the consolidated action filed a Verified Amended Class Action and Derivative Complaint (“Amended Complaint”). After defendants responded to the Amended Complaint, on October 21, 2019, plaintiffs filed a Verified Second Amended Class Action and Derivative Complaint (the “Second Amended Complaint”), alleging that the directors and JAB Holding Company S.à r.l., JAB Holdings B.V., JAB Cosmetics B.V., and Cottage Holdco B.V. breached their fiduciary duties to the Company’s stockholders and breached the Stockholders Agreement. The Second Amended Complaint seeks, among other things, monetary relief. On November 21, 2019, the defendants moved to dismiss certain claims asserted in the Second Amended Complaint, and certain of the director defendants also answered the complaint. On May 7, 2020, plaintiffs stipulated to the dismissal without prejudice of JAB Holding Company S.à r.l. from the action. On August 17, 2020, the court denied the remaining motions to dismiss. The case is currently at the discovery stage with a trial date scheduled for November 2022. A purported stockholder class action complaint, alleging violations of the U.S. securities laws in connection with the P&G beauty brands acquisition is pending against the Company as well as certain current and former officers of the Company in the U.S. District Court for the Southern District of New York. The case, which was filed on September 4, 2020, is captioned Crystal Garrett-Evans v. Coty Inc. et al., Case No. 1:20-cv-07277 (the “Evans Action”). On November 23, 2020, the court appointed the individual Susan Nock as lead plaintiff and the Rosen Firm as lead counsel. The plaintiff filed an amended complaint on January 22, 2021. The Amended Complaint asserts claims under the federal securities laws and seeks, among other things, monetary relief. On March 8, 2021, the Company filed a motion to dismiss the amended complaint, and on August 4, 2021, the court dismissed the amended complaint, holding that it failed to set forth a valid claim. There has been no appeal of the dismissal and the Evans Action has been concluded. A second purported stockholder class action and derivative complaint, alleging violations of the U.S. securities laws in connection with the P&G beauty brands acquisition and the Kylie Brands transaction as well as claims for breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets by certain current and former officers and directors of the Company, is pending in the U.S. District Court for the Southern District of New York. The case, which was filed on November 17, 2020, is captioned Chris Lewis v. Becht et al., Case No. 1:20-cv-09685 (the “Lewis Action”). The Company was named as a nominal defendant. The plaintiff seeks, among other things, injunctive and/or monetary relief. This action was voluntarily stayed during the pendency of the motion to dismiss the Evans Action. Following the dismissal of the Evans Action, counsel for the plaintiff in the Lewis Action agreed to dismiss the case and the court has approved the dismissal of the action as of October 2021. At this time, the Company cannot reasonably estimate a range of loss, if any, not covered by available insurance, that may result given the current status of these lawsuits. Brazilian Tax Assessments The Company’s Brazilian subsidiaries receive tax assessments from local, state and federal tax authorities in Brazil from time to time. Current open tax assessments as of March 31, 2022 are: Assessment received Type of assessment Type of Tax Tax period impacted Estimated amount, including interest and penalties as of March 31, 2022 Mar-18 State sales tax credits, which the Treasury Office of the State of Goiás considers as improperly registered ICMS 2016-2017 R$1.0 million (approximately $0.2) (a) Aug-20 ICMS 2017-2019 R$686.5 million (approximately $143.9) Oct-20 Federal excise taxes, which the Treasury Office of the Brazil’s Internal Revenue Service considers as improperly calculated IPI 2016-2017 R$355.7 million (approximately $74.6) Nov-20 State sales taxes, which the Treasury Office of the State of Minas Gerais considers as improperly calculated ICMS 2016-2019 R$193.8 million (approximately $40.6) Jun-21 State sales tax, which the Treasury Office of the State of Goiás considers as improperly calculated ICMS 2016-2020 R$78.3 million (approximately $16.4) (a) During the first quarter of fiscal 2022, assessments amounting in R$360.7 million (approximately $66.6) were dismissed by the Goiás State Treasury's Attorney Office in favor of the Company. All cases are currently in the administrative process. The Company is seeking favorable administrative decisions on the tax enforcement actions filed by the tax authorities for these assessments. The Company believes it has meritorious defenses and it has not recognized a loss for these assessments as the Company does not believe a loss is probable. Due to the fiscal environment in Brazil, the possibility of further tax assessments related to the same or similar matters cannot be ruled out.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Equity Transfer Agreement In connection with the Award granted to the Company’s CEO on June 30, 2021, Cottage Holdco B.V. has agreed to transfer to her (either directly or through contributing to the Company) one-half of the total number of shares of Common Stock owed to her if and when the Award vests. See Note 17—Share-Based Compensation Plans for more information on the Award. Relationship with KKR As noted in Note 16—Equity and Convertible Preferred Stock, in fiscal 2020 KKR Aggregator purchased Series B Preferred Stock. This preferred stock conveys to KKR Aggregator the right to designate two directors to the Company’s Board of Directors and voting rights on an as-converted basis. In June of 2020, KKR Bidco and Coty entered into a separate definitive agreement regarding a strategic transaction (“Wella Transaction”) for the sale of the Company’s Professional and Retail Hair business, which was completed on November 30, 2020. Refer to Note 16—Equity and Convertible Preferred Stock for the definitive agreement entered into with KKR that closed on October 20, 2021. On September 10, 2021, KKR Aggregator converted a portion of its Series B Preferred Stock into Class A common stock of the Company and completed a secondary public offering of the converted shares of Class A common stock. Refer to Note 16—Equity and Convertible Preferred Stock. On October 20, 2021, the Company completed the sale of a 9.4% stake in Wella to KKR Aggregator in the First Exchange. On November 10, 2021, KKR Aggregator converted 123,219 shares of Series B Preferred Stock, and $1.2 of unpaid dividends into 19,944,701 shares of Class A common stock. Immediately after the conversion, KKR Aggregator completed a sale of 19,944,701 shares of Class A common stock. On November 30, 2021, Coty completed the sale of an additional 4.7% stake in Wella to KKR Aggregator in the Second Exchange, reducing the Company’s total shareholding in Wella to 25.9%. Refer to Note 16—Equity and Convertible Preferred Stock. Following the Second Exchange, KKR no longer holds any preferred stock of the Company and no longer has the right to designate any directors to the Company's Board of Directors. During fiscal 2021, fees of $7.6 were incurred with KKR in connection with the second closing of the Series B Preferred Stock; these fees reduced the carrying value of the stock. The Company also entered into agreements with KKR for potential consulting and advisory services. No fees were incurred under such agreements in fiscal 2022 or 2021. From time to time, certain funds held by KKR may hold the Company’s Senior Secured and Unsecured Notes (as defined in Note 12—Debt). These funds may receive principal and interest payments on the same terms as other investors in the Company’s Senior Secured and Unsecured Notes. Wella As of March 31, 2022, Coty owned 25.9% of the Wella Business as an equity investment and performs certain services to Wella. Refer to Note 9— Equity Investments. In connection with the sale of the Wella Business, the Company and Wella entered into a Transitional Services Agreement (“TSA”). Subject to the terms of this TSA, the Company will perform services for Wella in exchange for related service fees. Such services include billing and collecting from Wella customers, certain logistics and warehouse services, as well as other administrative and systems support. The Company and Wella have mutually agreed to end the contracted TSA services on January 31, 2022. The Company and Wella have also entered into other manufacturing and distribution arrangements to facilitate the Wella Business transition in the U.S. and Brazil. TSA fees and other fees earned were $15.7 and $1.7, respectively, for the three months ended March 31, 2022 and $86.0 and $4.8, respectively, for the nine months ended March 31, 2022. TSA fees and other fees earned were $40.0 and $1.0, respectively, for the three months ended March 31, 2021 and were $54.7 and $1.6, respectively, for the four months ended March 31, 2021. The TSA fees are principally invoiced on a cost plus basis. The TSA fees and other fees were included in Selling, general and administrative expenses and Cost of sales, respectively, in the Company's Condensed Consolidated Statement of Operations. As of March 31, 2022, accounts receivable from and accounts payable to Wella of $81.0 and $26.3, respectively, were included in Prepaid expenses and other current assets and Accrued expenses and other current liabilities, respectively, in the Company's Condensed Consolidated Balance Sheets. Additionally, as of March 31, 2022, the Company has accrued $72.0 related to long-term payables due to Wella included in Other noncurrent liabilities in the Company's Condensed Consolidated Balance Sheet. In accordance with the separation agreement with Wella, Coty shall retain and be solely responsible for any amounts payable to former Coty employees transferred to Wella (“Wella employees”), who participated in the Coty Long-Term Incentive Plan. The Wella employees will continue to participate and vest on the current terms for the remaining vesting period after the separation. As such, Coty will continue to recognize the share-based compensation expense for Wella employees until the existing equity awards reach their vesting date. For the three and nine months ended March 31, 2022, Coty recorded $1.0 and $(0.4), respectively, of share-based compensation expense related to Wella employees, which was presented as part of Other income, net in the Condensed Consolidated Statements of Operations. For the three and nine months ended March 31, 2021, Coty recorded $0.0 and $0.5, respectively of share-based compensation expense related to Wella employees, which was presented as part of Other income, net in the Condensed Consolidated Statements of Operations. The Company has certain sublease arrangements with Wella after the sale. The Company reported sublease income from Wella of $3.0 and $10.1 for the three and nine months ended March 31, 2022, respectively, and $4.1 and $5.5 for the three and four months ended March 31, 2021. Orveda The disinterested members of the Board reviewed and approved the entry into a license agreement with Orveda, an ultra-premium skincare brand co-founded by Coty’s CEO, Sue Nabi. Ms. Nabi has no continuing formal role at Orveda or economic interest in Orveda as a result of divesting her interests which was settled in cash in December 2021; however her business partner and co-founder, Nicolas Vu, is the sole owner and CEO of Orveda, and Mr. Vu also provides consulting services, related to the skincare category and Orveda positioning, to Coty under the terms of a separate agreement. The initial term of the Orveda license agreement is five years, with two five-year automatic renewals subject to the achievement of certain net revenue milestones. The principal terms of the license agreement are consistent with other Coty prestige licenses and the Board determined that the terms were no more favorable than to an unaffiliated third party.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS Wind Down of Russian Operations On April 27, 2022, the Company announced the Board's decision to wind down its Russian operations effective immediately. Management estimates that the fourth quarter pretax charges of the wind down could be $100.0 or more, including related net cash charges that are not expected to exceed $40.0. These charges would include the impact on the carrying value of certain indefinite-lived trademarks, long-lived assets and right-of-use-assets; separation costs; and accruals for contractual liabilities. Additionally, management anticipates derecognizing the cumulative translation adjustment balance pertaining to the Russian subsidiary. The wind down process of Coty’s Russian subsidiary is at an early stage and the execution of the wind down may result in changes to its estimated losses due to uncertainties surrounding the actions of the local government, customers, vendors and other counterparties.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Fiscal Period	The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2022” refer to the fiscal year ending June 30, 2022.
Basis of Presentation	Basis of Presentation The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and include the Company’s consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company’s Consolidated Financial Statements as of and for the year ended June 30, 2021. In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three and nine months ended March 31, 2022 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2022. All dollar amounts (other than per share amounts) in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.
Restricted Cash	Restricted CashRestricted cash represents funds that are not readily available for general purpose cash needs due to contractual limitations. Restricted cash is classified as a current or long-term asset based on the timing and nature of when or how the cash is expected to be used or when the restrictions are expected to lapse.Restricted cash is included as a component of Cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows.
Equity Investments	Equity Investments The Company elected the fair value option to account for its investment in Wella to align with the Company’s strategy for this investment. The fair value is updated on a quarterly basis. The investment is classified within Level 3 in the fair value
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the net realizable value of inventory, the fair value of acquired assets and liabilities associated with acquisitions, the fair value of equity investments, the assessment of goodwill, other intangible assets and long-lived assets for impairment and income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the Condensed Consolidated Financial Statements in future periods.
Tax Information	Tax Information The effective income tax rate for the three and nine months ended March 31, 2022 and 2021 was 0.9% and (177.8)%, respectively, and 23.2% and 178.0%, respectively. The positive effective tax rate for the nine months ended March 31, 2022 results from reporting income before taxes and a provision for income taxes. The positive effective tax rate for the nine months ended March 31, 2021 results from reporting losses before income taxes and a benefit for income taxes. The change in the effective tax rate for the three months ended March 31, 2022, as compared with the three months ended March 31, 2021, is primarily due to the resolution of foreign uncertain tax positions having a greater proportional effect in the prior year, as well as the limitation on the deductibility of executive stock compensation in the current period. The change in the effective tax rate for the nine months ended March 31, 2022, as compared with the nine months ended March 31, 2021, is primarily due to the limitation on the deductibility of executive stock compensation and large fair value gains related to the investment in the Wella business in the current period, as well as a benefit related to a change in the Company's main principal location of $220.5 recorded in the prior period. The benefit recorded in the prior period was the result of a tax rate differential on the deferred taxes recognized on the transfer of assets and liabilities, following the relocation of the Company's main principal location from Geneva to Amsterdam. The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements	Recently Adopted Accounting Pronouncements In January 2020, the FASB issued ASU No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) , which clarifies certain interactions between the accounting for equity securities, equity method investments, and certain derivative instruments. The Company adopted this guidance in the first quarter of fiscal 2022. The adoption of this standard did not have a material impact on the Company's financial position and its results of operations. Recently Issued Accounting Pronouncements In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The new guidance under ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. As of March 31, 2022, the Company has not applied any of the optional expedients or exceptions allowed under this ASU. The Company does not believe that this ASU will have a material impact on its consolidated financial position, results of operations or cash flows. In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity’s Own Equity (Subtopic 815-40) , which removes certain separation models for convertible debt instruments and convertible preferred stock that require the separation of a convertible debt instrument into a debt component and an equity or derivative component. The Company will adopt the guidance effective fiscal year 2023 and does not expect the adoption to have a material impact on its consolidated financial statements. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers . This guidance will be effective for the Company in the first quarter of fiscal year 2024 on a prospective basis, with early adoption permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
Derivative Instruments	Foreign Exchange Risk Management The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings and cross-currency swaps as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions. The Company is exposed to foreign currency exchange rate fluctuations in the normal course of business, including through exposure to inventory expenditures made by the Company’s international subsidiaries whose functional currency is other than the transaction currency. To manage this exposure, beginning in June 2021, the Company entered into non-deliverable forward foreign-exchange contracts (the “NDF contracts”) that are intended to offset changes in cash flow attributable to currency exchange movements. The NDF contracts have been designated as foreign exchange cash flow hedges. The Company entered into these contracts with counterparties that are banks or other financial institutions, and the Company considers the risk of non-performance by such counterparties not to be material. The Company also continued to use certain derivatives as economic hedges of foreign currency exposure on firm commitments, which do not qualify for hedge accounting. Although these derivatives were not designated for hedge accounting, the overall objective of mitigating foreign currency exposure is the same for all derivative instruments. The Company does not enter into derivative financial instruments for trading or speculative purposes, nor is the Company a party to leveraged derivatives. For derivatives not designated as hedging instruments, changes in fair value are recorded in the line item in the Condensed Consolidated Statements of Operations to which the derivative relates.

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	9 Months Ended
	Mar. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Schedule of discontinued operations	The following table has selected financial information included in Net income (loss) from discontinued operations for the Wella Business. Three Months Ended Nine Months Ended 2022 (a) 2021 2022 (a) 2021 Net revenues $ — $ — $ — $ 986.3 Cost of sales — — — 322.5 Gross profit — — — 663.8 Selling, general and administrative expenses — — — 443.7 Restructuring costs — — — (0.7) Operating income — — — 220.8 Interest expense, net — — — 21.3 (Gain) loss on sale of business (1.3) 27.5 (6.1) 246.6 Other income, net — — — (1.0) Income (loss) from discontinued operations before income taxes 1.3 (27.5) 6.1 (46.1) Provision for income taxes on discontinued operations 0.6 (10.2) 1.6 102.1 Net income (loss) from discontinued operations $ 0.7 $ (17.3) $ 4.5 $ (148.2) (a) Net income from discontinued operations for the three and nine months ended March 31, 2022 reflect certain working capital adjustments net of the related income tax impact. The following is selected financial information included in cash flows from discontinued operations for the Wella Business held for sale: Nine Months Ended March 31, 2021 NON-CASH OPERATING ITEMS Depreciation and amortization $ — CASH FLOW FROM INVESTING ACTIVITIES Capital expenditures $ 8.7

SEGMENT REPORTING (Tables)

SEGMENT REPORTING (Tables)	9 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of reportable segments	Three Months Ended Nine Months Ended SEGMENT DATA 2022 2021 2022 2021 Net revenues: Prestige $ 726.4 $ 601.3 $ 2,605.1 $ 2,149.5 Consumer Beauty 459.8 426.5 1,531.0 1,418.0 Total $ 1,186.2 $ 1,027.8 $ 4,136.1 $ 3,567.5 Operating income (loss): Prestige 83.8 30.9 357.5 175.7 Consumer Beauty (20.4) 9.1 34.3 25.8 Corporate (6.3) (41.4) (73.5) (251.9) Total $ 57.1 $ (1.4) $ 318.3 $ (50.4) Reconciliation: Operating income (loss) 57.1 (1.4) 318.3 (50.4) Interest expense, net 62.9 50.3 183.6 171.6 Other income, net (60.6) (62.5) (572.9) (50.7) Income (loss) from continuing operations before income taxes $ 54.8 $ 10.8 $ 707.6 $ (171.3)
Schedule of percentage of revenues associated with product categories	Presented below are the percentage of revenues associated with the Company’s product categories: Three Months Ended Nine Months Ended PRODUCT CATEGORY 2022 2021 2022 2021 Fragrance 57.6 % 56.2 % 60.3 % 59.1 % Color Cosmetics 29.6 31.2 27.8 27.9 Body Care & Other 12.8 12.6 11.9 13.0 Total 100.0 % 100.0 % 100.0 % 100.0 %

BUSINESS COMBINATIONS, ASSET _2

BUSINESS COMBINATIONS, ASSET ACQUISITIONS AND DIVESTITURES (Tables)	9 Months Ended
	Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of estimated allocation of purchase price to net assets	The purchase consideration paid for the equity interest, the KKW Call Option and rights under the KKW Collaboration Agreement was $200.0 and was allocated as follows using a relative fair value approach at the acquisition date: Estimated fair value Estimated useful life (in years) KKW Collaboration Agreement $ 180.6 20 20% equity interest in KKW Holdings 19.4 Total purchase consideration $ 200.0

RESTRUCTURING COSTS (Tables)

RESTRUCTURING COSTS (Tables)	9 Months Ended
	Mar. 31, 2022
Restructuring and Related Activities [Abstract]
Schedule of restructuring costs	Restructuring costs for the three and nine months ended March 31, 2022 and 2021 are presented below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Transformation Plan $ (6.8) $ 4.7 $ 1.5 $ 98.4 Other Restructuring — (4.7) — (8.7) Total $ (6.8) $ — $ 1.5 $ 89.7 The following table presents aggregate restructuring charges for the program: Severance and Employee Benefits Fixed Asset Write-offs Other Exit Costs Total Fiscal 2020 $ 151.2 $ (1.1) $ 6.5 $ 156.6 Fiscal 2021 73.4 (0.5) 0.3 73.2 Fiscal 2022 1.8 — (0.3) 1.5 Cumulative through March 31, 2022 $ 226.4 $ (1.6) $ 6.5 $ 231.3
Schedule of related liability balance and restructuring costs	The related liability balance and activity of restructuring costs for the Transformation Plan restructuring costs are presented below: Severance and Employee Benefits Fixed Asset Write-offs Other Exit Costs Total Balance—July 1, 2021 $ 122.5 $ — $ 0.3 $ 122.8 Restructuring charges 13.5 — — 13.5 Payments (38.7) — (0.2) (38.9) Changes in estimates (11.7) — (0.3) (12.0) Non-cash utilization (0.8) — — (0.8) Effect of exchange rates (5.5) — 0.2 (5.3) Balance—March 31, 2022 $ 79.3 $ — $ — $ 79.3

INVENTORIES (Tables)

INVENTORIES (Tables)	9 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Schedule of inventory	Inventories as of March 31, 2022 and June 30, 2021 are presented below: March 31, June 30, Raw materials $ 162.7 $ 159.5 Work-in-process 7.5 12.5 Finished goods 472.9 478.8 Total inventories $ 643.1 $ 650.8

EQUITY INVESTMENTS (Tables)

EQUITY INVESTMENTS (Tables)	9 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Summary of equity investments	The Company's equity investments, classified as Equity investments in the Condensed Consolidated Balance Sheets are represented by the following: March 31, June 30, Equity method investments: KKW Holdings (a) $ 13.9 $ 16.2 Equity investments at fair value: Wella (b) 1,025.0 1,260.0 Total equity investments $ 1,038.9 $ 1,276.2 (a) On January 4, 2021, the Company completed its purchase of 20% of the outstanding equity of KKW Holdings. The Company accounts for this minority investment under the equity method, given it has the ability to exercise significant influence over, but not control, the investee. The carrying value of the Company’s investment includes basis differences allocated to amortizable intangible assets. (b) On November 30, 2020, the Company completed the previously announced strategic transaction with KKR for the sale of a 60% stake in Coty’s Wella Business. As of March 31, 2022 and June 30, 2021, the Company's stake in Wella was 25.9% and 40.0%, respectively. The following table presents summarized financial information of the Company’s equity method investees for the period ending March 31, 2022. Amounts presented represent combined totals at the investee level and not the Company’s proportionate share: Three Months Ended Nine Months Ended 2022 2021 (a) 2022 2021 (a) Summarized Statements of Operations information: Net revenues $ 552.8 $ 528.5 $ 1,916.3 $ 743.7 Gross profit 376.4 361.4 1,314.5 508.4 Operating income 18.1 (56.6) 119.9 (61.7) Income before income taxes (50.6) (89.2) 6.3 (102.7) Net income (31.5) (78.8) 10.5 (91.5) (a) As the sale of the Wella Business occurred on November 30, 2020, Wella's prior year summarized financials only comprise of four month of activity.
Summary of movement in equity investments	The following table summarizes movements in equity investments with fair value option that are classified within Level 3 for the period ended March 31, 2022. There were no internal movements to or from Level 3 from Level 1 or Level 2 for the period ended March 31, 2022. Equity investments at fair value: Balance as of June 30, 2021 $ 1,260.0 First Exchange (390.6) Second Exchange (212.7) Wella Distribution (210.7) Total gains/(losses) included in earnings 579.0 Balance as of March 31, 2022 $ 1,025.0
Summary of significant unobservable inputs used in Level 3 valuation	The following table summarizes the significant unobservable inputs used in Level 3 valuation of the Company's investments carried at fair value as of March 31, 2022. Included in the table are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments. Fair value Valuation technique Unobservable Range Equity investments at fair value $ 1,025.0 Discounted cash flows Discount rate 11.75% (a) Growth rate 1.5% - 7.2% (a) Market multiple Revenue multiple 2.0x (b) EBITDA multiple 12.0x – 19.0x (b) (a) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a discounted cash flow method, are the discount rate and revenue growth rate. Significant increases (decreases) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement. The Company estimates the discount rate based on the investees' projected cost of equity and debt. The revenue growth rate is forecasted for future years by the investee based on their best estimates. Significant increases (decreases) in the revenue growth rate in isolation would result in a significantly higher (lower) fair value measurement. (b) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a market multiple method, are the revenue multiple and EBITDA multiple. Significant increases (decreases) in the revenue multiple or EBITDA multiple in isolation would result in a significantly higher (lower) fair value measurement. The market multiples are derived from a group of guideline public companies.

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)	9 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of goodwill	Goodwill as of March 31, 2022 and June 30, 2021 is presented below: Prestige Consumer Beauty Total Gross balance at June 30, 2021 $ 6,384.0 $ 1,774.2 $ 8,158.2 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at June 30, 2021 $ 3,273.7 $ 844.4 $ 4,118.1 Changes during the period ended March 31, 2022 Foreign currency translation (74.8) (18.1) (92.9) Gross balance at March 31, 2022 $ 6,309.2 $ 1,756.1 $ 8,065.3 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at March 31, 2022 $ 3,198.9 $ 826.3 $ 4,025.2
Schedule of indefinite-lived intangible assets	Other intangible assets, net as of March 31, 2022 and June 30, 2021 are presented below: March 31, June 30, Indefinite-lived other intangible assets $ 992.6 $ 1,018.7 Finite-lived other intangible assets, net 3,146.6 3,444.3 Total Other intangible assets, net $ 4,139.2 $ 4,463.0 The changes in the carrying amount of indefinite-lived other intangible assets are presented below: Trademarks Total Gross balance at June 30, 2021 $ 1,932.2 $ 1,932.2 Accumulated impairments (913.5) (913.5) Net balance at June 30, 2021 $ 1,018.7 $ 1,018.7 Changes during the period ended March 31, 2022 Foreign currency translation (26.1) (26.1) Gross balance at March 31, 2022 $ 1,906.1 $ 1,906.1 Accumulated impairments (913.5) (913.5) Net balance at March 31, 2022 $ 992.6 $ 992.6
Schedule of finite-lived intangible assets	Other intangible assets, net as of March 31, 2022 and June 30, 2021 are presented below: March 31, June 30, Indefinite-lived other intangible assets $ 992.6 $ 1,018.7 Finite-lived other intangible assets, net 3,146.6 3,444.3 Total Other intangible assets, net $ 4,139.2 $ 4,463.0 Intangible assets subject to amortization are presented below: Cost Accumulated Amortization Accumulated Impairment Net June 30, 2021 License agreements and collaboration agreements $ 4,192.9 $ (1,229.1) $ (19.6) $ 2,944.2 Customer relationships 803.1 (486.3) (5.5) 311.3 Trademarks 330.2 (168.7) (0.5) 161.0 Product formulations and technology 90.2 (62.4) — 27.8 Total $ 5,416.4 $ (1,946.5) $ (25.6) $ 3,444.3 March 31, 2022 License agreements and collaboration agreements $ 4,023.0 $ (1,306.3) $ (19.6) $ 2,697.1 Customer relationships 760.3 (477.6) (5.5) 277.2 Trademarks 325.4 (176.6) (0.5) 148.3 Product formulations and technology 87.9 (63.9) — 24.0 Total $ 5,196.6 $ (2,024.4) $ (25.6) $ 3,146.6

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Schedule of lease cost	The following chart provides additional information about the Company’s operating leases: Three Months Ended Nine Months Ended Lease Cost: 2022 2021 2022 2021 Operating lease cost $ 22.1 $ 21.4 $ 64.2 $ 60.4 Short-term lease cost 0.4 0.1 1.0 0.5 Variable lease cost 9.9 8.3 28.8 38.6 Sublease income (5.1) (5.6) (15.8) (10.1) Net lease cost $ 27.3 $ 24.2 $ 78.2 $ 89.4 Other information: Operating cash outflows from operating leases $ (18.7) $ (29.2) $ (64.0) $ (109.1) Right-of-use assets obtained in exchange for lease obligations $ 73.1 $ 16.6 $ 100.1 $ 27.4 Weighted-average remaining lease term - real estate 7.8 years 6.5 years Weighted-average discount rate - real estate leases 3.81 % 3.55 %
Schedule of future minimum lease payments for operating leases	Future minimum lease payments for the Company’s operating leases are as follows: Fiscal Year Ending June 30, 2022, remaining $ 21.9 2023 77.7 2024 66.3 2025 54.6 2026 45.8 Thereafter 177.9 Total future lease payments 444.2 Less: imputed interest (68.4) Total present value of lease liabilities 375.8 Current operating lease liabilities 68.5 Long-term operating lease liabilities 307.3 Total operating lease liabilities $ 375.8

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of debt	The Company’s debt balances consisted of the following as of March 31, 2022 and June 30, 2021, respectively: March 31, June 30, Short-term debt $ 4.8 $ — Senior Secured Notes 2026 Dollar Senior Secured Notes due April 2026 900.0 900.0 2026 Euro Senior Secured Notes due April 2026 781.2 833.3 2029 Dollar Senior Secured Notes due January 2029 500.0 — 2018 Coty Credit Agreement 2018 Coty Revolving Credit Facility due April 2023 — 670.0 2021 Coty Revolving Credit Facility due April 2025 — — 2018 Coty Term A Facility due April 2023 — 114.0 2018 Coty Term B Facility due April 2025 1,277.4 1,461.7 Senior Unsecured Notes 2026 Dollar Notes due April 2026 550.0 550.0 2023 Euro Notes due April 2023 613.8 654.7 2026 Euro Notes due April 2026 279.0 297.6 Other long-term debt and capital lease obligations 0.1 0.2 Total debt 4,906.3 5,481.5 Less: Short-term debt and current portion of long-term debt (516.5) (24.2) Total Long-term debt 4,389.8 5,457.3 Less: Unamortized financing fees (45.8) (51.7) Less: Discount on long-term debt (27.1) (4.6) Total Long-term debt, net $ 4,316.9 $ 5,401.0
Schedule of debt instrument redemption	At any time on or after the Early Redemption Dates, the Company may redeem some or all of the respective notes at the redemption prices (expressed in percentage of principal amount) set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates, if redeemed during the twelve-month period beginning on respective dates of each of the years indicated below: Price For the period beginning 2026 Dollar Senior Secured Notes 2026 Euro Senior Secured Notes 2029 Dollar Senior Secured Notes Year April 15, January 15, 2023 102.500% 101.938% N/A 2024 101.250% 100.969% N/A 2025 100.000% 100.000% 102.375% 2026 N/A N/A 101.188% 2027 and thereafter N/A N/A 100.000%
Summary total net leverage ratio requirement	In the case of the 2021 Coty Revolving Credit Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below: Pricing Tier Total Net Leverage Ratio: LIBOR plus: Alternative Base Rate Margin: 1.0 Greater than or equal to 4.75:1 2.000% 1.000% 2.0 Less than 4.75:1 but greater than or equal to 4.00:1 1.750% 0.750% 3.0 Less than 4.00:1 but greater than or equal to 2.75:1 1.500% 0.500% 4.0 Less than 2.75:1 but greater than or equal to 2.00:1 1.250% 0.250% 5.0 Less than 2.00:1 but greater than or equal to 1.50:1 1.125% 0.125% 6.0 Less than 1.50:1 1.000% —% Pricing Tier Debt Ratings S&P/Moody’s: LIBOR plus: Alternative Base Rate Margin: 5.0 Less than BB+/Ba1 2.000% 1.000% 4.0 BB+/Ba1 1.750% 0.750% 3.0 BBB-/Baa3 1.500% 0.500% 2.0 BBB/Baa2 1.250% 0.250% 1.0 BBB+/Baa1 or higher 1.125% 0.125% The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period. Quarterly Test Period Ending Total Net Leverage Ratio (a) March 31, 2022 5.00 to 1.00 June 30, 2022 4.75 to 1.00 September 30, 2022 4.50 to 1.00 December 31, 2022 4.25 to 1.00 March 31, 2023 through April 5, 2025 4.00 to 1.00 (a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended). Adjusted EBITDA, as defined in the 2018 Coty Credit Agreement, as amended, includes certain add backs related to cost savings, unusual events such as COVID-19, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement, as amended.
Schedule of line of credit facilities	Fair Value of Debt March 31, 2022 June 30, 2021 Carrying Fair Carrying Fair Senior Secured Notes $ 2,181.2 $ 2,109.0 $ 1,733.3 $ 1,749.1 2018 Coty Credit Agreement 1,277.4 1,248.0 2,245.7 2,188.5 Senior Unsecured Notes 1,442.8 1,434.0 1,502.3 1,500.5
Schedule of maturities of long-term debt	Aggregate maturities of the Company’s long-term debt, including the current portion of long-term debt and excluding capital lease obligations as of March 31, 2022, are presented below: Fiscal Year Ending June 30, 2022, remaining $ 493.9 2023 23.5 2024 23.5 2025 1,350.3 2026 2,510.2 Thereafter 500.0 Total $ 4,901.4

INTEREST EXPENSE, NET (Tables)

INTEREST EXPENSE, NET (Tables)	9 Months Ended
	Mar. 31, 2022
Interest Income (Expense), Net [Abstract]
Schedule of interest expense, net	Interest expense, net for the three and nine months ended March 31, 2022 and 2021, respectively, is presented below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Interest expense $ 60.9 $ 51.7 $ 185.4 $ 171.3 Foreign exchange losses (gains), net of derivative contracts 3.4 (0.6) 1.0 3.1 Interest income (1.4) (0.8) (2.8) (2.8) Total interest expense, net $ 62.9 $ 50.3 $ 183.6 $ 171.6

EMPLOYEE BENEFIT PLANS (Tables)

EMPLOYEE BENEFIT PLANS (Tables)	9 Months Ended
	Mar. 31, 2022
Retirement Benefits [Abstract]
Schedule of net benefit costs	The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below: Three Months Ended March 31, Pension Plans Other Post- Employment Benefits U.S. International Total 2022 2021 2022 2021 2022 2021 2022 2021 Service cost $ — $ — $ 2.4 $ 2.6 $ 0.2 $ 0.3 $ 2.6 $ 2.9 Interest cost 0.1 0.1 1.6 1.7 0.3 0.3 2.0 2.1 Expected return on plan assets — — (1.2) (1.1) — — (1.2) (1.1) Amortization of prior service credit — — — — (0.1) (0.9) (0.1) (0.9) Amortization of net loss 0.1 0.4 (0.1) (0.1) — — — 0.3 Settlement loss recognized — — 0.1 — — — 0.1 — Curtailment gain recognized — — — (2.7) — — — (2.7) Net periodic benefit cost (credit) $ 0.2 $ 0.5 $ 2.8 $ 0.4 $ 0.4 $ (0.3) $ 3.4 $ 0.6 Nine Months Ended March 31, Pension Plans Other Post- U.S. International Total 2022 2021 2022 2021 2022 2021 2022 2021 Service cost $ — $ — $ 7.1 $ 14.5 $ 0.6 $ 0.9 $ 7.7 $ 15.4 Interest cost 0.3 0.3 4.8 6.4 0.9 0.9 6.0 7.6 Expected return on plan assets — — (3.4) (4.8) — — (3.4) (4.8) Amortization of prior service cost (credit) — — — (0.2) (0.3) (2.6) (0.3) (2.8) Amortization of net (gain) loss 0.3 1.1 (0.3) (0.2) — — — 0.9 Settlement loss recognized — — 2.1 — — — 2.1 — Curtailment gain recognized — — (0.2) (8.0) — — (0.2) (8.0) Net periodic benefit cost (credit) $ 0.6 $ 1.4 $ 10.1 $ 7.7 $ 1.2 $ (0.8) $ 11.9 $ 8.3

DERIVATIVE INSTRUMENTS (Tables)

DERIVATIVE INSTRUMENTS (Tables)	9 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of amount of gains and losses recognized in Other comprehensive income (loss)	The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below: Gain (Loss) Recognized in OCI Three Months Ended Nine Months Ended 2022 2021 2022 2021 Foreign exchange forward contracts $ (4.7) $ — $ (3.0) $ (0.4) Interest rate swap contracts 7.9 3.9 9.8 4.3 Cross-currency swap contracts — — — (25.1) Net investment hedges 5.3 156.4 24.2 (191.1)
Schedule of amount of gains and losses recognized in Other comprehensive income (loss)	The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below: Gain (Loss) Recognized in OCI Three Months Ended Nine Months Ended 2022 2021 2022 2021 Foreign exchange forward contracts $ (4.7) $ — $ (3.0) $ (0.4) Interest rate swap contracts 7.9 3.9 9.8 4.3 Cross-currency swap contracts — — — (25.1) Net investment hedges 5.3 156.4 24.2 (191.1)
Schedule of amount of gains and losses reclassified from AOCI(L)	The amount of gains and losses reclassified from AOCI/(L) to the Condensed Consolidated Statements of Operations related to the Company’s derivative financial instruments which are designated as hedging instruments is presented below: Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Three Months Ended March 31, 2022 2021 Net revenues Cost of sales Interest expense, net Net revenues Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ — $ 1.2 $ — $ — $ — $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — — (2.2) — — (6.3) Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Nine Months Ended March 31, 2022 2021 Net revenues Cost of sales Interest expense, net Net revenues Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ — $ 1.4 $ — $ 1.0 $ — $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — — (12.0) — — (27.6)
Schedule of derivatives not designated as hedging	The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below: Condensed Consolidated Statements of Operations Three Months Ended Nine Months Ended 2022 2021 2022 2021 Foreign exchange contracts Selling, general and administrative expenses $ (0.4) $ — $ (0.3) $ 0.1 Foreign exchange contracts Interest expense, net (1.5) 7.5 18.7 23.7 Foreign exchange contracts Other expense, net 2.8 (0.1) 2.3 (0.5)

EQUITY AND CONVERTIBLE PREFER_2

EQUITY AND CONVERTIBLE PREFERRED STOCK (Tables)	9 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Schedule of accumulated other comprehensive income (loss)	Accumulated Other Comprehensive Income (Loss) Foreign Currency Translation Adjustments (Loss) gain on Cash Flow Hedges (Loss) gain on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans (a) Total Balance—July 1, 2021 $ (15.5) $ (32.2) $ (259.3) $ (14.9) $ (321.9) Other comprehensive income (loss) before reclassifications 6.3 24.2 (239.2) — (208.7) Net amounts reclassified from AOCI/(L) 8.2 — — 2.1 10.3 Net current-period other comprehensive income (loss) 14.5 24.2 (239.2) 2.1 (198.4) Balance—March 31, 2022 $ (1.0) $ (8.0) $ (498.5) $ (12.8) $ (520.3) (a) For the nine months ended March 31, 2022, net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial gains of $2.7, net of tax of $0.6. Foreign Currency Translation Adjustments Loss on Cash Flow Hedges Gain (loss) on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans Total Balance—July 1, 2020 $ (43.0) $ 261.9 $ (683.8) $ 8.7 $ (456.2) Other comprehensive income (loss) before reclassifications 2.8 (228.7) 250.8 — 24.9 Net amounts reclassified from AOCI/(L) 20.4 — — (15.1) 5.3 Net current-period other comprehensive income (loss) 23.2 (228.7) 250.8 (15.1) 30.2 Balance—March 31, 2021 $ (19.8) $ 33.2 $ (433.0) $ (6.4) $ (426.0)

SHARE-BASED COMPENSATION PLANS

SHARE-BASED COMPENSATION PLANS (Tables)	9 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of share-based compensation expense	Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Equity plan expense (a) $ 29.1 $ 6.0 $ 163.8 $ 24.6 Equity plan modified and cash settled — — — 0.9 Liability plan (income) expense (0.6) 0.7 0.5 1.4 Fringe expense 0.3 — 2.5 0.4 Total share-based compensation expense $ 28.8 $ 6.7 $ 166.8 $ 27.3 (a) Equity plan share-based compensation expense of $29.1 and $6.0 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the three months ended March 31, 2022 and 2021, respectively. Equity plan share-based compensation expense of $163.8 and $26.6 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the nine months ended March 31, 2022 and 2021, respectively. Of the $6.0 and $26.6 for the three and nine months ended March 31, 2021, $0.0 and $2.0, respectively, were reclassified to discontinued operations.

NET INCOME (LOSS) ATTRIBUTABL_2

NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC. PER COMMON SHARE (Tables)	9 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of reconciliation of numerators and denominators of basic and diluted EPS computations	Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Amounts attributable to Coty Inc.: Net income from continuing operations $ 52.9 $ 32.9 $ 536.5 $ 132.9 Convertible Series B Preferred Stock dividends (3.3) (34.1) (195.0) (78.1) Net income from continuing operations attributable to common stockholders 49.6 (1.2) 341.5 54.8 Net income from discontinued operations, net of tax 0.7 (17.3) 4.5 (148.2) Net income (loss) attributable to common stockholders $ 50.3 $ (18.5) $ 346.0 $ (93.4) Weighted-average common shares outstanding: Weighted-average common shares outstanding—Basic 838.4 765.4 814.8 764.6 Effect of dilutive stock options and Series A Preferred Stock (a) — — — — Effect of restricted stock and RSUs (b) 14.5 — 12.7 5.4 Effect of Convertible Series B Preferred Stock (c) — — — 162.1 Weighted-average common shares outstanding—Diluted 852.9 765.4 827.5 932.1 Earnings per common share: Earnings from continuing operations per common share - basic $ 0.06 $ — $ 0.42 $ 0.07 Earnings from continuing operations per common share - diluted (d) 0.06 — 0.42 0.07 Losses from discontinued operations - basic — (0.02) — (0.19) Losses from discontinued operations - diluted — (0.02) — (0.19) Earnings (losses) per common share - basic 0.06 (0.02) 0.42 (0.12) Earnings (losses) per common share - diluted (d) 0.06 (0.02) 0.42 (0.12) (a) For the three months ended March 31, 2022, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 6.6 million weighted average shares of Common Stock, were anti-dilutive and excluded from the computation of diluted EPS. For the three months ended March 31, 2021, there were outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase shares of Common Stock were excluded in the computation of diluted loss per share due to the net loss incurred during the period. For the nine months ended March 31, 2022 and 2021, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 8.9 million and 15.4 million weighted average shares of Common Stock, respectively, were excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. (b) For the three months ended March 31, 2022, there were 0.7 million weighted average anti-dilutive RSUs, excluded from the computation of diluted EPS. For the three months ended March 31, 2021, RSUs were excluded in the computation of diluted loss per share due to the net loss incurred during the period. For the nine months ended March 31, 2022 and 2021, there were 2.3 million and 6.2 million weighted average anti-dilutive RSUs, respectively, excluded from the computation of diluted EPS. (c) For the three months ended March 31, 2022, there were 23.7 million dilutive shares of Convertible Series B Preferred Stock excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. For the three months ended March 31, 2021, Convertible Series B Preferred Stock shares were excluded from the computation of diluted EPS due to the net loss incurred during the period. For the nine months ended March 31, 2022, and 2021, there were 79.2 million and 0.0 million, respectively, weighted average dilutive shares of Convertible Series B Preferred Stock excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. (d) Diluted EPS is adjusted by the effect of dilutive securities, including awards under the Company's equity compensation plans and the convertible Series B Preferred Stock. When calculating any potential dilutive effect of stock options, Series A Preferred Stock, restricted stock and RSUs, the Company uses the treasury method and the if-converted method for the Convertible Series B Preferred Stock. The treasury method typically does not adjust the net income attributable to Coty Inc., while the if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $3.3 and $34.1 for the three months ended March 31, 2022 and 2021, respectively, and $195.0 and $78.1 for the nine months ended March 31, 2022 and 2021, respectively, on net income applicable to common stockholders during the period.

COMMITMENT AND CONTINGENCIES (T

COMMITMENT AND CONTINGENCIES (Tables)	9 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Summary of income tax contingencies	The Company’s Brazilian subsidiaries receive tax assessments from local, state and federal tax authorities in Brazil from time to time. Current open tax assessments as of March 31, 2022 are: Assessment received Type of assessment Type of Tax Tax period impacted Estimated amount, including interest and penalties as of March 31, 2022 Mar-18 State sales tax credits, which the Treasury Office of the State of Goiás considers as improperly registered ICMS 2016-2017 R$1.0 million (approximately $0.2) (a) Aug-20 ICMS 2017-2019 R$686.5 million (approximately $143.9) Oct-20 Federal excise taxes, which the Treasury Office of the Brazil’s Internal Revenue Service considers as improperly calculated IPI 2016-2017 R$355.7 million (approximately $74.6) Nov-20 State sales taxes, which the Treasury Office of the State of Minas Gerais considers as improperly calculated ICMS 2016-2019 R$193.8 million (approximately $40.6) Jun-21 State sales tax, which the Treasury Office of the State of Goiás considers as improperly calculated ICMS 2016-2020 R$78.3 million (approximately $16.4) (a) During the first quarter of fiscal 2022, assessments amounting in R$360.7 million (approximately $66.6) were dismissed by the Goiás State Treasury's Attorney Office in favor of the Company.

DESCRIPTION OF BUSINESS (Detail

DESCRIPTION OF BUSINESS (Details)	Mar. 31, 2022	Nov. 30, 2020
Wella Business
Schedule of Equity Method Investments [Line Items]
Ownership percentage	25.90%	40.00%

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Accounting Policies [Abstract]
Restricted cash	$ 31.6		$ 31.6		$ 56.9
Effective income tax rate, percentage	0.90%	(177.80%)	23.20%	178.00%
Effective income tax rate reconciliation, preliminary income tax benefit				$ 220.5
Gross unrecognized tax benefits	$ 271.5		$ 271.5		279.9
Unrecognized tax benefits that would impact effective tax rate	151.3		151.3
Unrecognized tax benefits, net	173.9		173.9		181.2
Interest and penalties expense	1.3	$ (1.4)	1	$ 0.3
Gross accrued interest and penalties	22.7		22.7		$ 21.7
Reasonably possible decrease in UTBs (up to)	$ 22.2		$ 22.2

DISCONTINUED OPERATIONS - Narra

DISCONTINUED OPERATIONS - Narrative (Details) - USD ($)	Dec. 22, 2021	Mar. 31, 2022	Dec. 31, 2021	Nov. 30, 2020	Jun. 01, 2020
Wella Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership percentage		25.90%		40.00%
Wella Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal group, including discontinued operation, assets					$ 4,300,000,000
Contingent consideration gain	$ 0
Unearned contingent proceeds received, liability			$ 34,000,000

DISCONTINUED OPERATIONS (Detail

DISCONTINUED OPERATIONS (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Net income (loss) from discontinued operations	$ 0.7	$ (17.3)	$ 4.5	$ (148.2)
Discontinued Operations, Held-for-sale or Disposed of by Sale | Wella Business
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Net revenues	0	0	0	986.3
Cost of sales	0	0	0	322.5
Gross profit	0	0	0	663.8
Selling, general and administrative expenses	0	0	0	443.7
Restructuring costs	0	0	0	(0.7)
Operating income	0	0	0	220.8
Interest expense, net	0	0	0	21.3
(Gain) loss on sale of business	(1.3)	27.5	(6.1)	246.6
Other income, net	0	0	0	(1)
Income (loss) from discontinued operations before income taxes	1.3	(27.5)	6.1	(46.1)
Provision for income taxes on discontinued operations	0.6	(10.2)	1.6	102.1
Net income (loss) from discontinued operations	$ 0.7	$ (17.3)	$ 4.5	(148.2)
NON-CASH OPERATING ITEMS
Depreciation and amortization				0
CASH FLOW FROM INVESTING ACTIVITIES
Capital expenditures				$ 8.7

SEGMENT REPORTING - Reporting S

SEGMENT REPORTING - Reporting Segments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Net revenues	$ 1,186.2	$ 1,027.8	$ 4,136.1	$ 3,567.5
Operating income (loss)	57.1	(1.4)	318.3	(50.4)
Interest expense, net	62.9	50.3	183.6	171.6
Other income, net	(60.6)	(62.5)	(572.9)	(50.7)
Income (loss) from continuing operations before income taxes	54.8	10.8	707.6	(171.3)
Operating Segments | Prestige
Segment Reporting Information [Line Items]
Net revenues	726.4	601.3	2,605.1	2,149.5
Operating income (loss)	83.8	30.9	357.5	175.7
Operating Segments | Consumer Beauty
Segment Reporting Information [Line Items]
Net revenues	459.8	426.5	1,531	1,418
Operating income (loss)	(20.4)	9.1	34.3	25.8
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Operating income (loss)	$ (6.3)	$ (41.4)	$ (73.5)	$ (251.9)

SEGMENT REPORTING - Reportable

SEGMENT REPORTING - Reportable Segments, Revenue by Product Category (Details) - Product Concentration Risk - Sales Revenue	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Percentage of consolidated revenues	100.00%	100.00%	100.00%	100.00%
Fragrance
Segment Reporting Information [Line Items]
Percentage of consolidated revenues	57.60%	56.20%	60.30%	59.10%
Color Cosmetics
Segment Reporting Information [Line Items]
Percentage of consolidated revenues	29.60%	31.20%	27.80%	27.90%
Body Care & Other
Segment Reporting Information [Line Items]
Percentage of consolidated revenues	12.80%	12.60%	11.90%	13.00%

BUSINESS COMBINATIONS, ASSET _3

BUSINESS COMBINATIONS, ASSET ACQUISITIONS AND DIVESTITURES - KKW Beauty Business Transaction (Details) - KKW Beauty $ in Millions	Jan. 04, 2021USD ($)
Business Acquisition [Line Items]
Percentage of equity interests acquired	20.00%
Call or put option, additional percentage of voting interests to be acquired	31.00%
Payments to acquire businesses	$ 200

BUSINESS COMBINATIONS, ASSET _4

BUSINESS COMBINATIONS, ASSET ACQUISITIONS AND DIVESTITURES - Schedule of Purchase Price Allocation (Details) - KKW Beauty $ in Millions	Jan. 04, 2021USD ($)
Business Acquisition [Line Items]
Percentage of equity interests acquired	20.00%
Estimated fair value
20% equity interest in KKW Holdings	$ 19.4
Total purchase consideration	200
Collaboration Agreement
Estimated fair value
KKW Collaboration Agreement	$ 180.6
Estimated useful life (in years)	20 years

BUSINESS COMBINATIONS, ASSET _5

BUSINESS COMBINATIONS, ASSET ACQUISITIONS AND DIVESTITURES - Business Divestitures (Details) - USD ($) $ in Millions	Nov. 30, 2020	Mar. 31, 2022	Mar. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of discontinued business, net of cash disposed		$ 0	$ 2,374.1
Repayments of long-term lines of credit		$ 1,114.7	$ 2,963.7
2018 Coty Term A and Term B Facilities
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Repayments of long-term lines of credit	$ 2,015.5
2018 Coty Credit Agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture, amount allocated to reinvestment in the business	$ 500
Wella Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership percentage	40.00%	25.90%
Wella Business | Discontinued Operations, Held-for-sale or Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership percentage after transaction	40.00%
Cash proceeds from divestiture	$ 2,451.7
Cash disposed from divestiture	65.5
Proceeds from sale of discontinued business, net of cash disposed	$ 2,386.2
Wella Business | KKR | Discontinued Operations, Held-for-sale or Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership percentage after transaction	60.00%

ACQUISITION AND DIVESTITURE-R_2

ACQUISITION AND DIVESTITURE-RELATED COSTS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition- and divestiture-related costs	$ 0		$ 0
Divestiture-related costs	$ 3,300,000	$ 26,400,000	$ 14,200,000	$ 124,900,000
Discontinued Operations, Held-for-sale or Disposed of by Sale | Wella Business
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition- and divestiture-related costs		$ 3,300,000		$ 2,800,000

RESTRUCTURING COSTS - Restructu

RESTRUCTURING COSTS - Restructuring Costs by Program (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ (6.8)	$ 0	$ 1.5	$ 89.7
Transformation Plan
Restructuring Cost and Reserve [Line Items]
Restructuring costs	(6.8)	4.7	1.5	98.4	$ 73.2	$ 156.6
Other Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 0	$ (4.7)	$ 0	$ (8.7)

RESTRUCTURING COSTS - Narrative

RESTRUCTURING COSTS - Narrative (Details) - USD ($) $ in Millions	Jul. 01, 2019	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2021
Turnaround Plan
Restructuring Cost and Reserve [Line Items]
Restructuring and related activities, plan term (in years)	4 years
Transformation Plan
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred to date			$ 231.3
Additional restructuring charges			15
Restructuring reserve			79.3			$ 122.8
Payments for restructuring			$ 38.9
Transformation Plan | Forecast
Restructuring Cost and Reserve [Line Items]
Payments for restructuring		$ 20.5		$ 0.6	$ 58.2

RESTRUCTURING COSTS - Restruc_2

RESTRUCTURING COSTS - Restructuring Costs by Type (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ (6.8)	$ 0	$ 1.5	$ 89.7
Transformation Plan
Restructuring Cost and Reserve [Line Items]
Restructuring costs	(6.8)	$ 4.7	1.5	$ 98.4	$ 73.2	$ 156.6
Cumulative through March 31, 2022	231.3		231.3
Severance and Employee Benefits | Transformation Plan
Restructuring Cost and Reserve [Line Items]
Restructuring costs			1.8		73.4	151.2
Cumulative through March 31, 2022	226.4		226.4
Fixed Asset Write-offs | Transformation Plan
Restructuring Cost and Reserve [Line Items]
Restructuring costs			0		(0.5)	(1.1)
Cumulative through March 31, 2022	(1.6)		(1.6)
Other Exit Costs | Transformation Plan
Restructuring Cost and Reserve [Line Items]
Restructuring costs			(0.3)		$ 0.3	$ 6.5
Cumulative through March 31, 2022	$ 6.5		$ 6.5

RESTRUCTURING COSTS - Restruc_3

RESTRUCTURING COSTS - Restructuring Roll Forward (Details) - Transformation Plan $ in Millions	9 Months Ended
	Mar. 31, 2022USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 122.8
Restructuring charges	13.5
Payments	(38.9)
Changes in estimates	(12)
Non-cash utilization	(0.8)
Effect of exchange rates	(5.3)
Ending balance	79.3
Severance and Employee Benefits
Restructuring Reserve [Roll Forward]
Beginning balance	122.5
Restructuring charges	13.5
Payments	(38.7)
Changes in estimates	(11.7)
Non-cash utilization	(0.8)
Effect of exchange rates	(5.5)
Ending balance	79.3
Fixed Asset Write-offs
Restructuring Reserve [Roll Forward]
Beginning balance	0
Restructuring charges	0
Payments	0
Changes in estimates	0
Non-cash utilization	0
Effect of exchange rates	0
Ending balance	0
Other Exit Costs
Restructuring Reserve [Roll Forward]
Beginning balance	0.3
Restructuring charges	0
Payments	(0.2)
Changes in estimates	(0.3)
Non-cash utilization	0
Effect of exchange rates	0.2
Ending balance	$ 0

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 162.7	$ 159.5
Work-in-process	7.5	12.5
Finished goods	472.9	478.8
Total inventories	$ 643.1	$ 650.8

EQUITY INVESTMENTS - Schedule o

EQUITY INVESTMENTS - Schedule of Equity Investments (Details) - USD ($) $ in Millions	Nov. 30, 2021	Oct. 20, 2021	Nov. 30, 2020	Mar. 31, 2022	Mar. 31, 2022	Jun. 30, 2021	Jan. 04, 2021
Debt and Equity Securities, FV-NI [Line Items]
Total equity investments				$ 1,038.9	$ 1,038.9	$ 1,276.2
KKW Beauty
Debt and Equity Securities, FV-NI [Line Items]
Percentage of equity interests acquired							20.00%
KKW Beauty
Debt and Equity Securities, FV-NI [Line Items]
Equity method investments				13.9	13.9	16.2
Loss from equity method investments				(0.9)	(2.3)
Wella Business
Debt and Equity Securities, FV-NI [Line Items]
Equity investments at fair value				$ 1,025	$ 1,025	$ 1,260
Equity method investment, amount sold (percentage)	4.70%	9.40%	60.00%
Equity securities, FV-NI, ownership percentage			40.00%	25.90%	25.90%	40.00%

EQUITY INVESTMENTS - Narrative

EQUITY INVESTMENTS - Narrative (Details) - USD ($) $ in Millions	Mar. 03, 2022	Nov. 30, 2021	Oct. 20, 2021	Nov. 30, 2020	Mar. 31, 2022	Mar. 31, 2021
Schedule of Equity Method Investments [Line Items]
Return of capital from equity investments					$ 210.7	$ 448
Wella Business
Schedule of Equity Method Investments [Line Items]
Equity method investment, amount sold (percentage)		4.70%	9.40%	60.00%
Convertible Series B preferred stock redeemed for sale of ownership interest (in shares)			290,465
Ownership percentage				40.00%	25.90%
Return of capital from equity investments	$ 210.7

EQUITY INVESTMENTS - Summarized

EQUITY INVESTMENTS - Summarized Statements of Operations Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Debt and Equity Securities, FV-NI [Line Items]
Net revenues	$ 1,186.2	$ 1,027.8	$ 4,136.1	$ 3,567.5
Gross profit	763.1	636.1	2,647.1	2,126.9
Operating income	57.1	(1.4)	318.3	(50.4)
Income before income taxes	54.8	10.8	707.6	(171.3)
Net income (loss)	55	12.7	547.6	(14.6)
KKW Beauty And Wella
Debt and Equity Securities, FV-NI [Line Items]
Net revenues	552.8	528.5	1,916.3	743.7
Gross profit	376.4	361.4	1,314.5	508.4
Operating income	18.1	(56.6)	119.9	(61.7)
Income before income taxes	(50.6)	(89.2)	6.3	(102.7)
Net income (loss)	$ (31.5)	$ (78.8)	$ 10.5	$ (91.5)

EQUITY INVESTMENTS - Summary of

EQUITY INVESTMENTS - Summary of Movement in Equity Investments (Details) - Wella Business $ in Millions	9 Months Ended
	Mar. 31, 2022USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance as of June 30, 2021	$ 1,260
Wella Distribution	(210.7)
Total gains/(losses) included in earnings	579
Balance as of March 31, 2022	1,025
First Exchange
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Gains/(losses) included in earnings	(390.6)
Second Exchange
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Gains/(losses) included in earnings	$ (212.7)

EQUITY INVESTMENTS - Summary _2

EQUITY INVESTMENTS - Summary of Significant Unobservable Inputs used in Level 3 Valuation (Details) - Wella Business $ in Millions	Mar. 31, 2022USD ($)	Jun. 30, 2021USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ 1,025	$ 1,260
Fair Value, Inputs, Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ 1,025
Fair Value, Inputs, Level 3 | Discounted cash flows | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unobservable input percentage	0.1175
Fair Value, Inputs, Level 3 | Discounted cash flows | Growth rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unobservable input percentage	0.015
Fair Value, Inputs, Level 3 | Discounted cash flows | Growth rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unobservable input percentage	0.072
Fair Value, Inputs, Level 3 | Market multiple | Revenue multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unobservable input percentage	2
Fair Value, Inputs, Level 3 | Market multiple | EBITDA multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unobservable input percentage	12
Fair Value, Inputs, Level 3 | Market multiple | EBITDA multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unobservable input percentage	19

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Changes in Goodwill (Details) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Goodwill [Roll Forward]
Gross beginning balance	$ 8,158.2
Accumulated impairments	(4,040.1)	$ (4,040.1)
Net beginning balance	4,118.1
Foreign currency translation	(92.9)
Gross ending balance	8,065.3
Accumulated impairments	(4,040.1)	(4,040.1)
Net ending balance	4,025.2
Prestige
Goodwill [Roll Forward]
Gross beginning balance	6,384
Accumulated impairments	(3,110.3)	(3,110.3)
Net beginning balance	3,273.7
Foreign currency translation	(74.8)
Gross ending balance	6,309.2
Accumulated impairments	(3,110.3)	(3,110.3)
Net ending balance	3,198.9
Consumer Beauty
Goodwill [Roll Forward]
Gross beginning balance	1,774.2
Accumulated impairments	(929.8)	(929.8)
Net beginning balance	844.4
Foreign currency translation	(18.1)
Gross ending balance	1,756.1
Accumulated impairments	(929.8)	$ (929.8)
Net ending balance	$ 826.3

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details) - USD ($) $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Indefinite-lived other intangible assets	$ 992.6	$ 1,018.7
Finite-lived other intangible assets, net	3,146.6	3,444.3
Total Other intangible assets, net	$ 4,139.2	$ 4,463

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Schedule of Indefinite Lived Intangible Assets (Details) $ in Millions	9 Months Ended
	Mar. 31, 2022USD ($)
Indefinite-lived Intangible Assets [Roll Forward]
Gross beginning balance	$ 1,932.2
Accumulated impairments beginning balance	(913.5)
Net beginning balance	1,018.7
Foreign currency translation	(26.1)
Gross ending balance	1,906.1
Accumulated impairments ending balance	(913.5)
Net ending balance	992.6
Trademarks
Indefinite-lived Intangible Assets [Roll Forward]
Gross beginning balance	1,932.2
Accumulated impairments beginning balance	(913.5)
Net beginning balance	1,018.7
Foreign currency translation	(26.1)
Gross ending balance	1,906.1
Accumulated impairments ending balance	(913.5)
Net ending balance	$ 992.6

GOODWILL AND OTHER INTANGIBLE_6

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Schedule of Intangible Assets Subject to Amortization (Details) - USD ($) $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Finite-Lived Intangible Assets [Line Items]
Cost	$ 5,196.6	$ 5,416.4
Accumulated Amortization	(2,024.4)	(1,946.5)
Accumulated Impairment	(25.6)	(25.6)
Net	3,146.6	3,444.3
License agreements and collaboration agreements
Finite-Lived Intangible Assets [Line Items]
Cost	4,023	4,192.9
Accumulated Amortization	(1,306.3)	(1,229.1)
Accumulated Impairment	(19.6)	(19.6)
Net	2,697.1	2,944.2
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Cost	760.3	803.1
Accumulated Amortization	(477.6)	(486.3)
Accumulated Impairment	(5.5)	(5.5)
Net	277.2	311.3
Trademarks
Finite-Lived Intangible Assets [Line Items]
Cost	325.4	330.2
Accumulated Amortization	(176.6)	(168.7)
Accumulated Impairment	(0.5)	(0.5)
Net	148.3	161
Product formulations and technology
Finite-Lived Intangible Assets [Line Items]
Cost	87.9	90.2
Accumulated Amortization	(63.9)	(62.4)
Accumulated Impairment	0	0
Net	$ 24	$ 27.8

GOODWILL AND OTHER INTANGIBLE_7

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 50.2	$ 62.2	$ 158.6	$ 189.4

LEASES - Narrative (Details)

LEASES - Narrative (Details)	Mar. 31, 2022
Minimum
Lessee, Lease, Description [Line Items]
Lessee, operating lease, term of contract	5 years
Maximum
Lessee, Lease, Description [Line Items]
Lessee, operating lease, term of contract	25 years

LEASES - Lease cost (Details)

LEASES - Lease cost (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Lease Cost:
Operating lease cost	$ 22.1	$ 21.4	$ 64.2	$ 60.4
Short-term lease cost	0.4	0.1	1	0.5
Variable lease cost	9.9	8.3	28.8	38.6
Sublease income	(5.1)	(5.6)	(15.8)	(10.1)
Net lease cost	27.3	24.2	78.2	89.4
Other information:
Operating cash outflows from operating leases	(18.7)	(29.2)	(64)	(109.1)
Right-of-use assets obtained in exchange for lease obligations	$ 73.1	$ 16.6	$ 100.1	$ 27.4
Weighted-average remaining lease term - real estate	7 years 9 months 18 days	6 years 6 months	7 years 9 months 18 days	6 years 6 months
Weighted-average discount rate - real estate leases	3.81%	3.55%	3.81%	3.55%

LEASES - Minimum lease payments

LEASES - Minimum lease payments (Details) - USD ($) $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Minimum lease payments
2022, remaining	$ 21.9
2023	77.7
2024	66.3
2025	54.6
2026	45.8
Thereafter	177.9
Total future lease payments	444.2
Less: imputed interest	(68.4)
Total present value of lease liabilities	375.8
Current operating lease liabilities	68.5	$ 75.7
Long-term operating lease liabilities	307.3	$ 269.3
Total operating lease liabilities	$ 375.8

DEBT - Schedule of Debt (Detail

DEBT - Schedule of Debt (Details) - USD ($)	Mar. 31, 2022	Jun. 30, 2021
Debt Instrument [Line Items]
Short-term debt	$ 4,800,000	$ 0
Long-term debt	4,901,400,000
Other long-term debt and capital lease obligations	100,000	200,000
Total debt	4,906,300,000	5,481,500,000
Less: Short-term debt and current portion of long-term debt	(516,500,000)	(24,200,000)
Total Long-term debt	4,389,800,000	5,457,300,000
Less: Unamortized financing fees	(45,800,000)	(51,700,000)
Less: Discount on long-term debt	(27,100,000)	(4,600,000)
Total Long-term debt, net	4,316,900,000	5,401,000,000
Senior Secured Notes | 2026 Dollar Senior Secured Notes due April 2026
Debt Instrument [Line Items]
Long-term debt	900,000,000	900,000,000
Senior Secured Notes | 2026 Euro Senior Secured Notes due April 2026
Debt Instrument [Line Items]
Long-term debt	781,200,000	833,300,000
Senior Secured Notes | 2029 Dollar Senior Secured Notes due January 2029
Debt Instrument [Line Items]
Long-term debt	500,000,000	0
Line of Credit | 2018 Coty Revolving Credit Facility due April 2023 | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term debt	0	670,000,000
Line of Credit | 2021 Coty Revolving Credit Facility due April 2025 | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term debt	0	0
Line of Credit | 2018 Coty Term A Facility due April 2023 | Term Loan
Debt Instrument [Line Items]
Long-term debt	0	114,000,000
Line of Credit | 2018 Coty Term B Facility due April 2025 | Term Loan
Debt Instrument [Line Items]
Long-term debt	1,277,400,000	1,461,700,000
Line of Credit | 2026 Dollar Notes due April 2026 | Term Loan
Debt Instrument [Line Items]
Long-term debt	550,000,000	550,000,000
Line of Credit | 2023 Euro Notes due April 2023 | Term Loan
Debt Instrument [Line Items]
Long-term debt	613,800,000	654,700,000
Line of Credit | 2026 Euro Notes due April 2026 | Term Loan
Debt Instrument [Line Items]
Long-term debt	$ 279,000,000	$ 297,600,000

DEBT - Narrative (Details)

DEBT - Narrative (Details)

Nov. 30, 2021USD ($)

Nov. 30, 2021EUR (€)

Sep. 30, 2021USD ($)

Jun. 16, 2021EUR (€)

Apr. 21, 2021USD ($)

Nov. 30, 2020USD ($)

Jun. 27, 2019USD ($)

Jun. 26, 2019

Apr. 05, 2018USD ($)

Jan. 31, 2022USD ($)

Jan. 31, 2022EUR (€)

Oct. 31, 2021USD ($)

Oct. 31, 2021EUR (€)

Mar. 31, 2022USD ($)fiscalQuarter

Mar. 31, 2022USD ($)fiscalQuarter

Mar. 31, 2021USD ($)

Jun. 30, 2021USD ($)

Apr. 05, 2018EUR (€)

Debt Instrument [Line Items]

Short-term debt

$ 4,800,000

$ 4,800,000

$ 0

Debt discount capitalized

0

27,000,000

Deferred issuance costs capitalized

500,000

8,900,000

Deferred financing fees write-offs

100,000

3,400,000

Writeoff of debt discounts

$ 100,000

400,000

Repayments of long-term lines of credit

$ 1,114,700,000

$ 2,963,700,000

Wella Business

Debt Instrument [Line Items]

Equity securities, FV-NI, ownership percentage

40.00%

25.90%

25.90%

40.00%

Wella Business | KKR

Debt Instrument [Line Items]

Ownership percentage

60.00%

Discontinued Operations, Held-for-sale or Disposed of by Sale | Wella Business

Debt Instrument [Line Items]

Cash proceeds from divestiture

$ 2,451,700,000

Return of capital from equity investments

448,000,000

Senior Secured Notes

Debt Instrument [Line Items]

Redemption price, percentage

101.00%

Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

$ 2,750,000,000

Decrease in total commitments

$ 500,000,000

Total net leverage ratio, material acquisition, number of fiscal quarters | fiscalQuarter

4

4

Total net leverage ratio, after material acquisition | fiscalQuarter

2

2

Line of Credit | Maximum

Debt Instrument [Line Items]

Applicable leverage ratio following the closing of any material acquisition

5.95

Line of Credit | Minimum

Debt Instrument [Line Items]

Applicable leverage ratio following the closing of any material acquisition

1

2023 Euro Notes | Senior Secured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 613,800,000

$ 613,800,000

€ 550,000,000

Debt redemption, amount to be funded with cash on hand

488,100,000

488,100,000

Debt redemption, amount to be funded with additional debt

$ 125,700,000

$ 125,700,000

Interest rate, stated percentage

4.00%

4.00%

2018 Coty Revolving Credit Facility

Debt Instrument [Line Items]

Reduction of borrowing capacity

$ 700,000,000

2021 Coty Revolving Credit Facility due April 2025

Debt Instrument [Line Items]

Aggregate principal amount

$ 700,000,000

2021 Coty Revolving Credit Facility

Debt Instrument [Line Items]

Aggregate principal amount

$ 2,000,000,000

2018 Coty Credit Agreement

Debt Instrument [Line Items]

Repayments of long-term debt

394,000,000

Proceeds from divestiture, amount allocated to reinvestment in the business

500,000,000

2018 Coty Credit Agreement | Line of Credit

Debt Instrument [Line Items]

Proceeds from divestiture, amount allocated to reinvestment in the business

500,000,000

2018 Coty Term A and Term B Facilities

Debt Instrument [Line Items]

Repayments of long-term lines of credit

2,015,500,000

2018 Coty Term A Facility

Debt Instrument [Line Items]

Repayments of long-term debt

100,400,000

€ 89,500,000

$ 7,200,000

€ 6,200,000

Aggregate principal amount | €

€ 2,035,000,000

Repayments of long-term lines of credit

1,135,700,000

2018 Coty Term A Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

2018 Coty Term B Facility

Debt Instrument [Line Items]

Repayments of long-term debt

$ 91,900,000

Aggregate principal amount | €

€ 850,000,000

Repayments of long-term lines of credit

$ 879,800,000

2018 Coty Term B Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

1,400,000,000

Quarterly repayment percentage

0.25%

0.25%

2018 Coty Term B Facility, Euro Portion

Debt Instrument [Line Items]

Repayments of long-term debt

$ 15,700,000

€ 13,900,000

2018 Coty Term B Facility, Dollar Portion

Debt Instrument [Line Items]

Repayments of long-term debt

$ 22,300,000

Coty Term Loan B Facility due October 2022

Debt Instrument [Line Items]

LIBOR floor

0.00%

0.00%

Coty Term Loan B Facility due October 2022 | LIBOR

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

2.25%

Coty Term Loan B Facility due October 2022 | Alternative Base Rate

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

1.25%

Coty Term Loan B Facility due October 2022 | Euro Interbank Offered Rate (Euribor)

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

2.50%

2029 Dollar Senior Secured Notes due January 2029

Debt Instrument [Line Items]

Proceeds from issuance of senior long-term debt

500,000,000

2029 Dollar Senior Secured Notes due January 2029 | Senior Secured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 500,000,000

Interest rate, stated percentage

4.75%

Debt instrument, early redemption premium, percent of outstanding principal amount

1.00%

1.00%

Debt instrument, base redemption price, percentage

100.00%

100.00%

2029 Dollar Senior Secured Notes due January 2029 | Senior Secured Notes | US Treasury (UST) Interest Rate

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

0.50%

0.50%

2026 Euro Senior Secured Notes due April 2026 | Senior Secured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount | €

€ 700,000,000

Interest rate, stated percentage

3.875%

Proceeds from issuance of senior long-term debt | €

€ 700,000,000

Debt instrument, early redemption premium, percent of outstanding principal amount

1.00%

Debt instrument, base redemption price, percentage

100.00%

2026 Euro Senior Secured Notes due April 2026 | Senior Secured Notes | US Treasury (UST) Interest Rate

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

0.50%

2026 Dollar Senior Secured Notes due April 2026 | Senior Secured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 900,000,000

Interest rate, stated percentage

5.00%

Proceeds from issuance of senior long-term debt

$ 900,000,000

Debt instrument, early redemption premium, percent of outstanding principal amount

1.00%

Debt instrument, base redemption price, percentage

100.00%

2026 Dollar Senior Secured Notes due April 2026 | Senior Secured Notes | Bund Rate

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

0.50%

2026 Dollar Notes | Senior Secured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 550,000,000

Interest rate, stated percentage

6.50%

6.50%

2026 Euro Notes | Senior Secured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount | €

€ 250,000,000

Interest rate, stated percentage

4.75%

4.75%

Letter of Credit

Debt Instrument [Line Items]

Undrawn letters of credit and bank guarantees

$ 14,300,000

$ 14,300,000

$ 15,000,000

Letter of Credit | 2018 Coty Revolving Credit Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

$ 150,000,000

Bank Guarantee

Debt Instrument [Line Items]

Undrawn letters of credit and bank guarantees

$ 20,300,000

$ 20,300,000

$ 31,200,000

Revolving Credit Facility | 2018 Coty Revolving Credit Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

3,250,000,000

Swingline loans | 2018 Coty Revolving Credit Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

150,000,000

Incurrence Incremental Facilities

Debt Instrument [Line Items]

Net leverage ratio

5

5.25

Incurrence Incremental Facilities | 2018 Coty Revolving Credit Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,700,000,000

Net leverage ratio

3

DEBT - Debt Instrument Redempti

DEBT - Debt Instrument Redemption (Details) - Senior Secured Notes	Apr. 05, 2018	Mar. 31, 2022
Debt Instrument [Line Items]
Redemption price, percentage	101.00%
2026 Dollar Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Redemption price, percentage		102.50%
2026 Dollar Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Four
Debt Instrument [Line Items]
Redemption price, percentage		101.25%
2026 Dollar Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Five
Debt Instrument [Line Items]
Redemption price, percentage		100.00%
2026 Euro Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Redemption price, percentage		101.938%
2026 Euro Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Four
Debt Instrument [Line Items]
Redemption price, percentage		100.969%
2026 Euro Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Five
Debt Instrument [Line Items]
Redemption price, percentage		100.00%
2029 Dollar Senior Secured Notes due January 2029 | Debt Instrument, Redemption, Period Five
Debt Instrument [Line Items]
Redemption price, percentage		102.375%
2029 Dollar Senior Secured Notes due January 2029 | Debt Instrument Redemption Period Six
Debt Instrument [Line Items]
Redemption price, percentage		101.188%
2029 Dollar Senior Secured Notes due January 2029 | Debt Instrument Redemption Period After Year Six
Debt Instrument [Line Items]
Redemption price, percentage		100.00%

DEBT - Pricing Tiers (Details)

DEBT - Pricing Tiers (Details)	9 Months Ended
	Mar. 31, 2022
Pricing Tier Five | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	2.00%
Pricing Tier Five | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.00%
Pricing Tier Four | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.75%
Pricing Tier Four | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.75%
Pricing Tier Three | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.50%
Pricing Tier Three | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.50%
Pricing Tier Two | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.25%
Pricing Tier Two | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.25%
Pricing Tier One | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.125%
Pricing Tier One | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.125%
Pricing Tier One | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	2.00%
Pricing Tier One | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.00%
Pricing Tier Two | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.75%
Pricing Tier Two | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.75%
Pricing Tier Three | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.50%
Pricing Tier Three | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.50%
Pricing Tier Four | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.25%
Pricing Tier Four | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.25%
Pricing Tier Five | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.125%
Pricing Tier Five | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.125%
Pricing Tier Six | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.00%
Pricing Tier Six | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.00%
Minimum | Pricing Tier One
Debt Instrument [Line Items]
Net leverage ratio	4.75
Minimum | Pricing Tier Two
Debt Instrument [Line Items]
Net leverage ratio	4
Minimum | Pricing Tier Three
Debt Instrument [Line Items]
Net leverage ratio	2.75
Minimum | Pricing Tier Four
Debt Instrument [Line Items]
Net leverage ratio	2
Minimum | Pricing Tier Five
Debt Instrument [Line Items]
Net leverage ratio	1.50
Maximum | Pricing Tier Two
Debt Instrument [Line Items]
Net leverage ratio	4.75
Maximum | Pricing Tier Three
Debt Instrument [Line Items]
Net leverage ratio	4
Maximum | Pricing Tier Four
Debt Instrument [Line Items]
Net leverage ratio	2.75
Maximum | Pricing Tier Five
Debt Instrument [Line Items]
Net leverage ratio	2
Maximum | Pricing Tier Six
Debt Instrument [Line Items]
Net leverage ratio	1.50

DEBT - Schedule of Fair Value o

DEBT - Schedule of Fair Value of Debt (Details) - USD ($) $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Carrying Amount | Secured Debt
Debt Instrument [Line Items]
Fair value of debt	$ 2,181.2	$ 1,733.3
Carrying Amount | Unsecured Debt
Debt Instrument [Line Items]
Fair value of debt	1,442.8	1,502.3
Fair Value | Secured Debt
Debt Instrument [Line Items]
Fair value of debt	2,109	1,749.1
Fair Value | Unsecured Debt
Debt Instrument [Line Items]
Fair value of debt	1,434	1,500.5
2018 Coty Credit Agreement | Carrying Amount
Debt Instrument [Line Items]
Fair value of debt	1,277.4	2,245.7
2018 Coty Credit Agreement | Fair Value
Debt Instrument [Line Items]
Fair value of debt	$ 1,248	$ 2,188.5

DEBT - Schedule of Maturities o

DEBT - Schedule of Maturities of Long-Term Debt (Details) $ in Millions	Mar. 31, 2022USD ($)
Debt Disclosure [Abstract]
2022, remaining	$ 493.9
2023	23.5
2024	23.5
2025	1,350.3
2026	2,510.2
Thereafter	500
Total	$ 4,901.4

DEBT - Total Net Leverage Ratio

DEBT - Total Net Leverage Ratio (Details)	9 Months Ended
	Mar. 31, 2021
March 31, 2022
Debt Instrument [Line Items]
Net leverage ratio	5
June 30, 2022
Debt Instrument [Line Items]
Net leverage ratio	4.75
September 30, 2022
Debt Instrument [Line Items]
Net leverage ratio	4.50
December 31, 2022
Debt Instrument [Line Items]
Net leverage ratio	4.25
March 31, 2023 through April 5, 2025
Debt Instrument [Line Items]
Net leverage ratio	4

INTEREST EXPENSE, NET (Details)

INTEREST EXPENSE, NET (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Interest Income (Expense), Net [Abstract]
Interest expense	$ 60.9	$ 51.7	$ 185.4	$ 171.3
Foreign exchange losses (gains), net of derivative contracts	3.4	(0.6)	1	3.1
Interest income	(1.4)	(0.8)	(2.8)	(2.8)
Total interest expense, net	$ 62.9	$ 50.3	$ 183.6	$ 171.6

EMPLOYEE BENEFIT PLANS - Narrat

EMPLOYEE BENEFIT PLANS - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Curtailment gain	$ 0	$ 2,700,000	$ 200,000	$ 8,000,000
Settlement loss recognized	100,000	0	2,100,000	0
Net periodic benefit cost	3,400,000	600,000	11,900,000	8,300,000
Discontinued Operations
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost		0		6,200,000
International | Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Curtailment gain	0	2,700,000	200,000	8,000,000
Settlement loss recognized	100,000	0	2,100,000	0
Net periodic benefit cost	2,800,000	400,000	10,100,000	7,700,000
Transformation Plan | International | Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Curtailment gain	0	$ 2,700,000	200,000	$ 8,000,000
Settlement loss recognized	100,000		2,100,000
Settlement loss related to restructuring activities	$ 700,000		$ 700,000

EMPLOYEE BENEFIT PLANS - Schedu

EMPLOYEE BENEFIT PLANS - Schedule of Components of Net Periodic Benefit Cost (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 2.6	$ 2.9	$ 7.7	$ 15.4
Interest cost	2	2.1	6	7.6
Expected return on plan assets	(1.2)	(1.1)	(3.4)	(4.8)
Amortization of prior service credit	(0.1)	(0.9)	(0.3)	(2.8)
Amortization of net (gain) loss	0	0.3	0	0.9
Settlement loss recognized	0.1	0	2.1	0
Curtailment gain recognized	0	(2.7)	(0.2)	(8)
Net periodic benefit cost (credit)	3.4	0.6	11.9	8.3
Other Post- Employment Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.2	0.3	0.6	0.9
Interest cost	0.3	0.3	0.9	0.9
Expected return on plan assets	0	0	0	0
Amortization of prior service credit	(0.1)	(0.9)	(0.3)	(2.6)
Amortization of net (gain) loss	0	0	0	0
Settlement loss recognized	0	0	0	0
Curtailment gain recognized	0	0	0	0
Net periodic benefit cost (credit)	0.4	(0.3)	1.2	(0.8)
U.S. | Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	0	0	0	0
Interest cost	0.1	0.1	0.3	0.3
Expected return on plan assets	0	0	0	0
Amortization of prior service credit	0	0	0	0
Amortization of net (gain) loss	0.1	0.4	0.3	1.1
Settlement loss recognized	0	0	0	0
Curtailment gain recognized	0	0	0	0
Net periodic benefit cost (credit)	0.2	0.5	0.6	1.4
International | Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	2.4	2.6	7.1	14.5
Interest cost	1.6	1.7	4.8	6.4
Expected return on plan assets	(1.2)	(1.1)	(3.4)	(4.8)
Amortization of prior service credit	0	0	0	(0.2)
Amortization of net (gain) loss	(0.1)	(0.1)	(0.3)	(0.2)
Settlement loss recognized	0.1	0	2.1	0
Curtailment gain recognized	0	(2.7)	(0.2)	(8)
Net periodic benefit cost (credit)	$ 2.8	$ 0.4	$ 10.1	$ 7.7

DERIVATIVE INSTRUMENTS - Narrat

DERIVATIVE INSTRUMENTS - Narrative (Details) € in Millions, $ in Millions	1 Months Ended		9 Months Ended
	Dec. 31, 2021USD ($)	Sep. 30, 2020USD ($)	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)	Mar. 31, 2022EUR (€)	Jul. 31, 2021	Jun. 30, 2021USD ($)	Jun. 30, 2021EUR (€)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Payment for termination of derivative			$ 0	$ 37.6
Derivative, percentage of external debt with associated forward contracts						80.00%
Accumulated other comprehensive income (loss)			(520.3)				$ (321.9)
Net investment hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount | €					€ 1,500
Foreign exchange risk exposure amount (in Euros) | €					€ 352.6			€ 1,809.5
Net investment hedge | Other Foreign Currency Translation Adjustments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Accumulated other comprehensive income (loss)			29.6				5.4
Cross-currency swap contracts | Net investment hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount terminated		$ 550
Payment for termination of derivative		$ 37.6
Interest rate swap contracts | Interest Rate Risk
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount terminated	$ 200
Notional amount			800				1,900
Derivative exchange settlement amount	$ 1.9
Foreign exchange forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cash flow hedges in AOCI, net of tax			(1)				(15.5)
Cash flow hedge to be reclassified during next 12 months			(0.3)
Foreign exchange forward contracts | Net investment hedge | Other Foreign Currency Translation Adjustments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Accumulated other comprehensive income (loss)			$ (37.6)				$ (37.6)

DERIVATIVE INSTRUMENTS - Gains

DERIVATIVE INSTRUMENTS - Gains and Losses Recognized in OCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Derivative [Line Items]
Net investment hedges	$ 5.3	$ 156.4	$ 24.2	$ (191.1)
Foreign exchange forward contracts
Derivative [Line Items]
Gain (Loss) Recognized in OCI	(4.7)	0	(3)	(0.4)
Interest rate swap contracts
Derivative [Line Items]
Gain (Loss) Recognized in OCI	7.9	3.9	9.8	4.3
Cross-currency swap contracts
Derivative [Line Items]
Gain (Loss) Recognized in OCI	$ 0	$ 0	$ 0	$ (25.1)

DERIVATIVE INSTRUMENTS - Amount

DERIVATIVE INSTRUMENTS - Amount of Gains and Losses Reclassified from AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Net revenues | Foreign exchange forward contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	$ 0	$ 0	$ 0	$ 1
Net revenues | Interest rate swap contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	0	0	0	0
Cost of sales | Foreign exchange forward contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	1.2	0	1.4	0
Cost of sales | Interest rate swap contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	0	0	0	0
Interest expense, net | Foreign exchange forward contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	0	0	0	0
Interest expense, net | Interest rate swap contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	$ (2.2)	$ (6.3)	$ (12)	$ (27.6)

DERIVATIVE INSTRUMENTS - Deriva

DERIVATIVE INSTRUMENTS - Derivatives Not Designated as Hedging (Details) - Foreign exchange forward contracts - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Selling, general and administrative expenses
Derivative [Line Items]
Gain (loss) recognized in operations	$ (0.4)	$ 0	$ (0.3)	$ 0.1
Interest expense, net
Derivative [Line Items]
Gain (loss) recognized in operations	(1.5)	7.5	18.7	23.7
Other expense, net
Derivative [Line Items]
Gain (loss) recognized in operations	$ 2.8	$ (0.1)	$ 2.3	$ (0.5)

EQUITY AND CONVERTIBLE PREFER_3

EQUITY AND CONVERTIBLE PREFERRED STOCK - Narrative (Details)	Nov. 30, 2021USD ($)	Nov. 10, 2021USD ($)shares	Nov. 06, 2021shares	Oct. 29, 2021shares	Oct. 20, 2021USD ($)shares	Sep. 30, 2021USD ($)	Sep. 10, 2021USD ($)shares	Nov. 30, 2020	Jul. 31, 2020USD ($)shares	May 26, 2020USD ($)shares	May 11, 2020USD ($)$ / sharesshares	Oct. 31, 2021USD ($)	Mar. 31, 2022USD ($)voteclassOfStock$ / sharesshares	Dec. 31, 2021USD ($)	Sep. 30, 2021USD ($)	Mar. 31, 2021USD ($)shares	Dec. 31, 2020USD ($)	Sep. 30, 2020USD ($)	Mar. 31, 2022USD ($)voteclassOfStock$ / sharesshares	Mar. 31, 2021shares	Jun. 30, 2021USD ($)$ / sharesshares	Nov. 16, 2020shares	Jun. 30, 2020shares	Feb. 03, 2016USD ($)
Class of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares													$ 0.01						$ 0.01		$ 0.01
Common stock, shares authorized (in shares)													1,250,000,000						1,250,000,000		1,250,000,000
Common stock, shares outstanding (in shares)													839,200,000						839,200,000		766,000,000
Preferred stock, shares authorized (in shares)													20,000,000						20,000,000		20,000,000
Number of classes of preferred stock | classOfStock													2						2
Preferred stock, par value (in dollars per share) | $ / shares													$ 0.01						$ 0.01		$ 0.01
Preferred stock, shares issued (in shares)													1,500,000						1,500,000		1,500,000
Preferred stock, shares outstanding (in shares)													1,500,000						1,500,000		1,500,000
Preferred stock value | $													$ 0						$ 0		$ 0
Deemed dividend | $														$ 800,000	$ 6,700,000	$ 10,500,000
Deemed dividend - exchange agreement | $															93,600,000
Preferred stock dividends paid during the period, previously declared | $												$ 25,100,000
Deemed contributions, Convertible Series B Preferred Stock | $												$ 4,400,000		4,400,000
Dividends declared | $													$ 3,300,000	5,900,000	22,700,000	$ 23,600,000	$ 23,200,000	$ 20,800,000
Number of shares repurchased (in shares)													0			0			0	0
Changes in dividends accrued | $													$ 100,000	$ 200,000	$ 500,000	$ 500,000	$ 400,000	$ 800,000	$ 800,000
Dividends, common stock, no longer expected to vest, forfeitures | $													800,000						800,000
First Exchange
Class of Stock [Line Items]
Non-monetary loss | $					$ (2,900,000)
Wella Business
Class of Stock [Line Items]
Equity method investment, amount sold (percentage)	4.70%				9.40%			60.00%
Convertible Series B preferred stock redeemed for sale of ownership interest (in shares)					290,465
Restricted Stock Units
Class of Stock [Line Items]
Payment for previously accrued dividends | $																			1,300,000
Restricted Stock Units | CEO | Cottage Holdco B.V.
Class of Stock [Line Items]
Shares contributed by related party (in shares)				10,000,000
Restricted Stock Units and Phantom Units | Accrued Expenses and Other Current Liabilities
Class of Stock [Line Items]
Dividends payable | $													1,500,000						1,500,000
Restricted Stock Units and Phantom Units | Other Noncurrent Liabilities
Class of Stock [Line Items]
Dividends payable | $													$ 500,000						$ 500,000
Common Class A
Class of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares													$ 0.01						$ 0.01
Votes per share | vote													1						1
Common stock, shares authorized (in shares)													1,250,000,000						1,250,000,000
Common stock, shares outstanding (in shares)													839,200,000						839,200,000
Common shares issued upon conversion (in shares)		19,944,701					50,000,088
Shares registered for purchase (in shares)																							19,300,000
Option to receive dividend, percentage reinvested in common stock																							50.00%
Common Class A | KKR
Class of Stock [Line Items]
Sale of stock, number of shares issued (in shares)		19,944,701					50,000,088
Common Class A | Incremental Repurchase Program
Class of Stock [Line Items]
Authorized repurchase amount | $																								$ 500,000,000
Number of shares repurchased (in shares)													0						0
Share repurchase program, remaining authorized repurchase amount | $													$ 396,800,000						$ 396,800,000
Common Class A | Cottage Holdco B.V.
Class of Stock [Line Items]
Parent ownership percentage													54.00%						54.00%
Common Class A | Restricted Stock Units | CEO
Class of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares																					$ 0.01
Series A Preferred Stock
Class of Stock [Line Items]
Votes per share | vote													0						0
Preferred stock, shares authorized (in shares)													1,500,000						1,500,000
Preferred stock, par value (in dollars per share) | $ / shares													$ 0.01						$ 0.01
Preferred stock, shares issued (in shares)													1,500,000						1,500,000
Preferred stock, shares outstanding (in shares)													1,500,000						1,500,000
Series A Preferred Stock | Other Noncurrent Liabilities
Class of Stock [Line Items]
Preferred stock value | $													$ 1,000,000						$ 1,000,000
Series A-1 Preferred Stock
Class of Stock [Line Items]
Votes per share | vote													0						0
Preferred stock, shares authorized (in shares)													0						0
Preferred stock, par value (in dollars per share) | $ / shares													$ 0.01						$ 0.01
Preferred stock, shares issued (in shares)													0						0
Preferred stock, shares outstanding (in shares)													0						0
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, par value (in dollars per share) | $ / shares											$ 0.01
Sale of stock, shares authorized (in shares)											1,000,000
Sale of stock, maximum purchase price received | $											$ 1,000,000,000
Sale of stock, price per share (in dollars per share) | $ / shares											$ 1,000
Sale of stock, number of shares issued (in shares)									250,000	750,000
Sale of stock, consideration received | $									$ 250,000,000	$ 750,000,000
Conversion of convertible series B preferred stock (in shares)		123,219					285,576
Unpaid preferred stock dividends converted to common stock | $		$ 1,200,000					$ 26,400,000												$ 1,200,000
Proceeds from secondary sale of Series B stock | $		0					0
Deemed dividend | $		$ 800,000			$ (6,500,000)		$ 6,700,000
Preferred stock, dividend rate																			9.00%
Dividends declared | $													$ 3,300,000						$ 31,900,000
Preferred stock dividends declared and paid during the period | $													3,300,000						27,400,000
Dividends payable | $													$ 3,300,000						$ 3,300,000		$ 74,100,000
Series B Preferred Stock | Wella Business
Class of Stock [Line Items]
Convertible Series B preferred stock redeemed for sale of ownership interest (in shares)			154,683		290,465
Convertible Series B preferred stock accrued dividends redeemed for sale of ownership interest | $					$ 22,500,000
Deemed dividend - exchange agreement | $	$ 66,400,000					$ 93,600,000
Series B Preferred Stock | HFS | KKR
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)																						146,057
Series B Preferred Stock | Sale of Stock, Initial Issuance
Class of Stock [Line Items]
Sale of stock, shares authorized (in shares)											750,000
Series B Preferred Stock | Sale of Stock, Second Issuance
Class of Stock [Line Items]
Sale of stock, shares authorized (in shares)											250,000

EQUITY AND CONVERTIBLE PREFER_4

EQUITY AND CONVERTIBLE PREFERRED STOCK - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	$ 3,062.2	$ 3,228.8
Other comprehensive income (loss) before reclassifications	(208.7)	24.9
Net amounts reclassified from AOCI/(L)	10.3	5.3
Net current-period other comprehensive income (loss)	(198.4)	30.2
Balance, end of period	3,792.9	3,170.5
Total
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(321.9)	(456.2)
Balance, end of period	(520.3)	(426)
(Loss) gain on Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(15.5)	(43)
Other comprehensive income (loss) before reclassifications	6.3	2.8
Net amounts reclassified from AOCI/(L)	8.2	20.4
Net current-period other comprehensive income (loss)	14.5	23.2
Balance, end of period	(1)	(19.8)
(Loss) gain on Net Investment Hedge
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(32.2)	261.9
Other comprehensive income (loss) before reclassifications	24.2	(228.7)
Net amounts reclassified from AOCI/(L)	0	0
Net current-period other comprehensive income (loss)	24.2	(228.7)
Balance, end of period	(8)	33.2
Other Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(259.3)	(683.8)
Other comprehensive income (loss) before reclassifications	(239.2)	250.8
Net amounts reclassified from AOCI/(L)	0	0
Net current-period other comprehensive income (loss)	(239.2)	250.8
Balance, end of period	(498.5)	(433)
Pension and Other Post-Employment Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(14.9)	8.7
Other comprehensive income (loss) before reclassifications	0	0
Net amounts reclassified from AOCI/(L)	2.1	(15.1)
Net current-period other comprehensive income (loss)	2.1	(15.1)
Balance, end of period	(12.8)	$ (6.4)
Reclassification from accumulated other comprehensive income (loss), current period, before tax	2.7
Other comprehensive income (loss), tax	$ 0.6

SHARE-BASED COMPENSATION PLAN_2

SHARE-BASED COMPENSATION PLANS - Schedule of Share-based Compensation (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	$ 28.8			$ 6.7			$ 166.8	$ 27.3
Share-based compensation expense	29.1	$ 26.9	$ 107.8	6	$ 14.4	$ 6.2
Additional Paid-in Capital
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	29.1	$ 26.9	$ 107.8	6	$ 14.4	$ 6.2
Equity plan expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	29.1			6			163.8	24.6
Equity plan expense | Additional Paid-in Capital
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	29.1			6			163.8	26.6
Equity plan expense | Additional Paid-in Capital | Discontinued Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense				0				2
Equity plan modified and cash settled
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	0			0			0	0.9
Liability plan (income) expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	(0.6)			0.7			0.5	1.4
Fringe expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	$ 0.3			$ 0			$ 2.5	$ 0.4

SHARE-BASED COMPENSATION PLAN_3

SHARE-BASED COMPENSATION PLANS - Narrative (Details) - USD ($)	Oct. 29, 2021	Jun. 30, 2021	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense			$ 28,800,000	$ 6,700,000	$ 166,800,000	$ 27,300,000
Forfeitures of share-based compensation instruments			$ 0	0	$ (4,200,000)	(3,100,000)
Common stock, par value (in dollars per share)		$ 0.01	$ 0.01		$ 0.01
Series A Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized share-based compensation expense			$ 0		$ 0
Weighted-average period for unrecognized share-based compensation					0 years
Awards granted (in shares)			0		0
Common Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, par value (in dollars per share)			$ 0.01		$ 0.01
Series A-1 Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)			0		0
Series A and A-1 Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense			$ (700,000)	400,000	$ 200,000	800,000
Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized share-based compensation expense			2,500,000		$ 2,500,000
Weighted-average period for unrecognized share-based compensation					2 years 1 month 28 days
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense			700,000	200,000	$ 1,200,000	700,000
Total unrecognized share-based compensation expense			$ 3,600,000		$ 3,600,000
Weighted-average period for unrecognized share-based compensation					1 year 7 months 6 days
Awards granted (in shares)			0		400,000
Restricted Stock Units and Other Share Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense			$ 29,400,000	4,500,000	$ 166,600,000	21,600,000
Total unrecognized share-based compensation expense			$ 184,700,000		$ 184,700,000
Weighted-average period for unrecognized share-based compensation					1 year 8 months 1 day
Awards granted (in shares)			700,000		5,100,000
Restricted Stock Units | CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense			$ 22,600,000	0	$ 146,600,000	0
Restricted Stock Units | CEO | Cottage Holdco B.V.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares contributed by related party (in shares)	10,000,000
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares to be granted for restricted stock awards (in shares)		10,000,000
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche One | Cottage Holdco B.V.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares to be contributed by related party (in shares)		10,000,000
Period for shares to be contributed by related party		60 days
Shares contributed by related party (in shares)	10,000,000
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares to be granted for restricted stock awards (in shares)		10,000,000
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares to be granted for restricted stock awards (in shares)		10,000,000
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Three | Cottage Holdco B.V.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares to be contributed by related party (in shares)		5,000,000
Restricted Stock Units | Common Class A | CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, par value (in dollars per share)		$ 0.01
Non-Qualified Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense			$ (600,000)	1,600,000	$ (1,200,000)	4,200,000
Options granted (in shares)			0		0
Selling, general and administrative expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense			$ 28,800,000	$ 6,700,000	$ 171,000,000	$ 30,400,000

NET INCOME (LOSS) ATTRIBUTABL_3

NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC. PER COMMON SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Amounts attributable to Coty Inc.
Net income from continuing operations	$ 52.9	$ 32.9	$ 536.5	$ 132.9
Convertible Series B Preferred Stock dividends	(3.3)	(34.1)	(195)	(78.1)
Net income (loss) from continuing operations attributable to common stockholders	49.6	(1.2)	341.5	54.8
Net income from discontinued operations, net of tax	0.7	(17.3)	4.5	(148.2)
Net income (loss) attributable to common stockholders	$ 50.3	$ (18.5)	$ 346	$ (93.4)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding—Basic (in shares)	838.4	765.4	814.8	764.6
Effect of dilutive stock options and Series A Preferred Stock (in shares)	0	0	0	0
Effect of restricted stock and RSUs (in shares)	14.5	0	12.7	5.4
Effect of Convertible Series B Preferred Stock (in shares)	0	0	0	162.1
Weighted-average common shares outstanding—Diluted (in shares)	852.9	765.4	827.5	932.1
Earnings per common share:
Earnings from continuing operations per common share - basic (in dollars per share)	$ 0.06	$ 0	$ 0.42	$ 0.07
Earnings from continuing operations per common share - diluted (in dollars per share)	0.06	0	0.42	0.07
Losses from discontinued operations - basic (in dollars per share)	0	(0.02)	0	(0.19)
Losses from discontinued operations - diluted (in dollars per share)	0	(0.02)	0	(0.19)
Earnings (losses) per common share - basic (in dollars per share)	0.06	(0.02)	0.42	(0.12)
Earnings (losses) per common share - diluted (in dollars per share)	$ 0.06	$ (0.02)	$ 0.42	$ (0.12)
Stock Options and Series A Preferred Stock
Earnings per common share:
Anti-dilutive shares (in shares)	6.6		8.9	15.4
RSUs
Earnings per common share:
Anti-dilutive shares (in shares)	0.7		2.3	6.2
Series B Preferred Stock
Earnings per common share:
Anti-dilutive shares (in shares)	23.7		79.2	0

MANDATORILY REDEEMABLE FINANC_2

MANDATORILY REDEEMABLE FINANCIAL INTERESTS AND REDEEMABLE NONCONTROLLING INTERESTS - Mandatorily Redeemable Financial Interest (Details) - United Arab Emirates Joint Venture $ in Millions	1 Months Ended
	Jul. 31, 2021USD ($)
Noncontrolling Interest [Line Items]
Additional ownership percentage purchased	25.00%
Payments to acquire additional interest in subsidiaries	$ 7.1

MANDATORILY REDEEMABLE FINANC_3

MANDATORILY REDEEMABLE FINANCIAL INTERESTS AND REDEEMABLE NONCONTROLLING INTERESTS - Redeemable Noncontrolling Interests (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020
Redeemable Noncontrolling Interest [Line Items]
Non-cash redeemable noncontrolling interest for business combinations	$ 71.9	$ 83.7	$ 83.4	$ 84.1	$ 87.4	$ 79.5	$ 83.1	$ 79.1
Middle East Subsidiary
Redeemable Noncontrolling Interest [Line Items]
Ownership percentage by noncontrolling owners	25.00%

COMMITMENT AND CONTINGENCIES (D

COMMITMENT AND CONTINGENCIES (Details) R$ in Millions, $ in Millions	3 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2021BRL (R$)	Mar. 31, 2022USD ($)	Mar. 31, 2022BRL (R$)	Jun. 30, 2021USD ($)
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued			$ 22.7		$ 21.7
Brazilian Tax Assessments | Foreign State Tax Authority
Loss Contingencies [Line Items]
Assessments dismissed	$ 66.6	R$ 360.7
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2016-2017
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued			0.2	R$ 1.0
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2017-2019
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued			143.9	686.5
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2016-2019
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued			40.6	193.8
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2016-2020
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued			16.4	78.3
Brazilian Tax Assessments | Pending Litigation | Foreign Federal Tax Authority | 2016-2017
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued			$ 74.6	R$ 355.7

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details)	Nov. 30, 2021	Nov. 10, 2021USD ($)shares	Oct. 20, 2021	Sep. 10, 2021USD ($)shares	Jun. 30, 2021	Nov. 30, 2020	Jul. 31, 2020shares	May 26, 2020shares	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)	Mar. 31, 2021USD ($)	Mar. 31, 2022USD ($)renewalTerm	Mar. 31, 2021USD ($)	Jun. 30, 2021USD ($)
Related Party Transaction [Line Items]
Expenses														$ 7,600,000
Share-based compensation expense									$ 28,800,000	$ 6,700,000		$ 166,800,000	$ 27,300,000
Sublease income									5,100,000	5,600,000		15,800,000	10,100,000
Transition Services Agreement Fees | Wella Business
Related Party Transaction [Line Items]
Revenue from related parties									15,700,000			86,000,000
Related Party Transaction, Other Fees | Wella Business
Related Party Transaction [Line Items]
Revenue from related parties									1,700,000			4,800,000
Wella Business
Related Party Transaction [Line Items]
Long-term payables									72,000,000			72,000,000
Share-based compensation expense									$ 1,000,000	0		$ (400,000)	$ 500,000
Wella Business
Related Party Transaction [Line Items]
Equity method investment, amount sold (percentage)	4.70%		9.40%			60.00%
Ownership percentage						40.00%			25.90%			25.90%
Series B Preferred Stock
Related Party Transaction [Line Items]
Conversion of convertible series B preferred stock (in shares) | shares		123,219		285,576
Unpaid preferred stock dividends converted to common stock		$ 1,200,000		$ 26,400,000								$ 1,200,000
Sale of stock, number of shares issued (in shares) | shares							250,000	750,000
Common Class A
Related Party Transaction [Line Items]
Common shares issued upon conversion (in shares) | shares		19,944,701		50,000,088
Common Class A | KKR
Related Party Transaction [Line Items]
Sale of stock, number of shares issued (in shares) | shares		19,944,701		50,000,088
CEO
Related Party Transaction [Line Items]
Contribution agreement, percentage of total number of shares of common stock owed, to be transferred upon vesting					0.50
KKR | Consulting and Advisory Services
Related Party Transaction [Line Items]
Expenses												0		$ 0
Wella Business
Related Party Transaction [Line Items]
Accounts receivable, related parties									$ 81,000,000			81,000,000
Accounts payable, related parties									26,300,000			26,300,000
Sublease income									$ 3,000,000	4,100,000	$ 5,500,000	$ 10,100,000
Wella Business | Transition Services Agreement Fees
Related Party Transaction [Line Items]
Revenue from related parties										40,000,000	54,700,000
Wella Business | Related Party Transaction, Other Fees
Related Party Transaction [Line Items]
Revenue from related parties										$ 1,000,000	$ 1,600,000
Orveda
Related Party Transaction [Line Items]
License agreement, term (in years)												5 years
License agreement, number of automatic renewals | renewalTerm												2
License agreement, automatic renewal term duration (in years)												5 years

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - Subsequent event - Russia $ in Millions	Apr. 27, 2022USD ($)
Subsequent Event [Line Items]
Expected pretax charges for wind down of business operations	$ 100
Expected cash charges for wind down of business operations	$ 40

Uncategorized Items - coty-2022

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2016-13 [Member]